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RESUMEN 
 
Bacillus thuringiensis (Berliner, 1915) (Bt) es una bacteria Gram positiva 
que forma una espora de resistencia durante la fase estacionaria de crecimiento y 
un cristal parasporal compuesto por d-endotoxinas (proteínas Cry y Cyt) con 
actividad insecticida por ingestión. Bt es el agente entomopatógeno más empleado 
para el control de plagas en campo y su uso es compatible con otros métodos de 
control que tienen cabida en programas de Gestión Integrada de Plagas (GIP). La 
diversidad de las toxinas Bt, y su amplio espectro de huéspedes, hacen que esta 
bacteria sea utilizada: i) como recurso genético para la obtención de factores 
tóxicos utilizados en la construcción de plantas resistentes contra las plagas, y ii) 
para el desarrollo de insecticidas basados en Bt.  
Desde los años 70, la potencia de los insecticidas basados en Bt se 
expresa en Unidades Internacionales (UI). Este valor, se determina para cada lote 
de producto técnico comparandolo con la potencia de una cepa estándar de Bt a la 
cual se le ha atribuido un valor arbitrario frente a larvas de un insecto de referencia. 
Sin embargo, este dato no aporta ninguna información relevante sobre la actividad 
insecticida del producto cuando el objeto del tratamiento son otras especies plaga 
distintas al insecto de referencia. El principal objetivo de esta tesis ha sido 
desarrollar un método proteómico que permite analizar cualitativa y 
cuantitativamente las proteínas que componen el cristal producido por distintas 
cepas silvestres de Bt. El método emplea un sistema de cromatografía líquida 
acoplada a un espectro de masas (LC-MS/MS) en combinación con una 
monitorización de múltiples reacciones (MRM). Para llevar a cabo el análisis, es 
necesario conocer la secuencia del genoma de la cepa Bt para determinar los 
potenciales genes insecticidas que podrían formar parte del cristal parasporal. El 
uso de herramientas bioinformáticas permite la selección de péptidos proteotípicos 
que detectan de forma específica la presencia de cada una de las proteínas de la 
mezcla. Estos péptidos proteotípicos, marcados isotópicamente, permiten 
determinar la proporción relativa de cada proteína en el cristal. El método fue 
validado utilizando dos mezclas artificiales de tres proteínas recombinantes 
(Cry1Aa, Cry2Aa y Cry6Aa), donde la proporción relativa de cada proteína era 
conocida. La aplicación del método permitió detectar las tres proteínas de forma 
independiente y cuantificar la proporción relativa de cada una de ellas con gran 
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fiabilidad y precisión. Una vez verificada su validez, el método fue aplicado para 
determinar la composición del cristal de cuatro cepas Bt silvestres que component 
el ingrediente activo de los productos comerciales más vendidos a nivel mundial 
para el control de distintos órdenes de insecto: DiPel® y XenTari® para lepidópteros, 
VectoBac® para dípteros, y Novodor® para coleópteros. El cristal parasporal de la 
cepa ser. kurstaki ABTS-351 (DiPel®) resultó estar compuesto por cuatro proteínas: 
Cry1Aa (13-22%), Cry1Ab (16-29%), Cry1Ac (6-12%) y Cry2Aa (40-64%); al igual 
que la cepa ser. aizawai ABTS-1857 (XenTari®) Cry1Aa (26-33%), Cry1Ab (57-
60%), Cry1Ca (7-11%) y Cry1Da (3-4%). La cepa AM65-52 (VectoBac®) sintetizó 
un cristal formado por Cry4Aa (2-4%), Cry4Ba (10-28%), Cry11Aa (10-27%), 
Cry60Aa (2-4%), Cry60Ba (5-12%) y Cyt1Aa (38-61%) y el ingrediente activo de 
Novodor®, la cepa ser. tenebrionis NB-176, contenía Cry3Aa (70-75%), Cry23Aa 
(14-16%) y Cry37Aa (10-14%). Adicionalmente, se determinó la actividad de la cepa 
ABTS-1857 en larvas de tres especies del género Spodoptera: S. exigua, S. littoralis 
y S. frugiperda. S. exigua fue la especie más susceptible (CL50= 7.8 ng/µl), seguida 
de S. littoralis (CL50= 28 ng/µl). S. frugiperda se mostró como la especie más 
tolerante (CL50= 120.2 ng/µl). Para determinar la contribución de cada proteína 
individual a la toxicidad general de la cepa ABTS-1857 contra cada una de las tres 
especies de insectos, se construyeron cepas Bt recombinantes que producían 
individualmente las proteínas Cry1Aa, Cry1Ab, Cry1Ca y Cry1Da. Los resultados 
de los bioensayos, utilizando el “droplet feeding method”, revelarón una elevada 
toxicidad de Cry1Ca para las larvas de S. exigua y S. littoralis y de Cry1Da frente a 
S. littoralis y S. frugiperda. Las mezclas artificiales de dos o tres proteínas 
produjeron mortalidades atribuibles a la cantidad de Cry1Ca, en el caso de S. 
exigua, de Cry1Ca y Cry1Da, en el caso de S. littoralis, y de Cry1Da en el caso de 
S. frugiperda. La mezcla artificial de cuatro proteínas, que reflejaba la composición 
natural del cristal, dio valores de actividad concordantes con los producidos por el 
cristal natural de la cepa ABTS-1857. Aumentos de la proteína Cry1Da, en 
detrimento de las proteías Cry1Aa y Cry1Ab, produjo incrementos en la actividad 
insecticida para larvas de S. littoralis y S. frugiperda. Estos resultados indicaron que 
la metodología empleada para el análisis de los cristales es válida para su empleo 
en la caracterización y estandarización de los productos comerciales basados en 
Bt, aportando la información necesaria para expresar su potencia insecticida.
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SUMMARY 
 
Bacillus thuringiensis (Berliner, 1915) (Bt) is a Gram-positive bacterium 
that forms a resistance spore during the stationary phase of growth and a parasporal 
crystal which is comprised by d-endotoxins (Cry and Cyt proteins) that show 
insecticidal activity when ingested. Bt is the most commonly used 
entomopathogenic agent for pest control in the field and its use is compatible with 
other control methods in Integrated Pest Management (IPM) programs. The 
diversity of Bt toxins, and their broad spectrum of hosts, allow the use of this 
bacterium: 1) as a genetic resource for obtaining toxic factors used to engineer 
plants resistant to pests, and 2) for the development of Bt-based insecticides. 
Since the 1970s, the potency of Bt-based insecticides is expressed in 
International Units (IU). This value is determined for each batch of technical product 
by comparison with the potency of a standard Bt strain, which has been assigned 
an arbitrary value against larvae of a reference insect. However, this data does not 
provide any relevant information concerning the insecticidal activity of the product 
when the targets of the treatment are other pest species than the reference insect. 
The main aim of this thesis has been the development of a proteomic method that 
allows a qualitative and quantitative analysis of the proteins that make up the crystal 
produced by different wildtype Bt strains. The method uses a liquid chromatography 
system coupled to a mass spectrum (LC-MS/MS) in combination with a multiple 
reaction monitoring (MRM). To carry out the analysis, it is necessary to know the 
genome sequence of the Bt strain to determine the potential insecticidal genes that 
could be part of the parasporal crystal. The use of bioinformatic tools, allow the 
selection of proteotypic peptides that specifically detect the presence of each of the 
proteins in the mixture. These proteotypic peptides, isotopically labelled, allow to 
determine the relative proportion of each protein within the crystal. The method was 
validated using two artificial mixtures containing three recombinant proteins 
(Cry1Aa, Cry2Aa and Cry6Aa), in a known relative proportion. The application of the 
method allowed the detection of the three proteins independently and the 
quantification of the relative proportion of each of them with great reliability and 
precision. Once the method was validated, it was applied to determine the crystal 
composition of the Bt strains used as active ingredients of four of the best sold 
commercial products worldwide for the control of different insect orders: DiPel® and 
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XenTari® for Lepidoptera, VectoBac® for Diptera, and Novodor® for Coleoptera. The 
parasporal crystal of the Bt subsp. kurstaki strain ABTS-351 (DiPel®) was comprised 
by four proteins, including: Cry1Aa (13-22%), Cry1Ab (16-29%), Cry1Ac (6-12%) 
and Cry2Aa (40-64%); in the Bt subsp. aizawai strain ABTS-1857 (XenTari®) four 
proteins were also detected: Cry1Aa (26-33%), Cry1Ab (57-60%), Cry1Ca (7-11%) 
and Cry1Da (3-4%). The Bt subsp. israelensis strain AM65-52 (VectoBac®) 
synthesized a crystal formed by Cry4Aa (2-4%), Cry4Ba (10-28%), Cry11Aa (10-
27%), Cry60Aa (2-4%), Cry60Ba (5-12%) and Cyt1Aa (38-61%). Finally, the active 
ingredient of Novodor®, the Bt subsp. tenebrionis strain NB-176, contained Cry3Aa 
(70-75%), Cry23Aa (14-16%) and Cry37Aa (10-14%). Additionally, the activity of the 
strain ABTS-1857 was determined for three species of the genus Spodoptera, 
including: S. exigua, S. littoralis and S. frugiperda. S. exigua was the most 
susceptible species (LC50 = 7.8 ng/μl), followed by S. littoralis (LC50 = 28 ng/μl). S. 
frugiperda was the most tolerant insect (LC50 = 120.2 ng/μl). To determine the 
contribution of each individual protein to the overall toxicity of the strain ABTS-1857 
against each of the three insect species, recombinant Bt strains producing Cry1Aa, 
Cry1Ab, Cry1Ca and Cry1Da proteins, were engineered. 
The results of the bioassays, using the droplet feeding method, revealed 
a high toxicity of Cry1Ca for S. exigua and S. littoralis larvae and Cry1Da against S. 
littoralis and S. frugiperda. Artificial mixtures containing two or three proteins 
produced mortalities attributed to the amounts of Cry1Ca, in the case of S. exigua, 
of Cry1Ca and Cry1Da, in the case of S. littoralis, and of Cry1Da in the case of S. 
frugiperda. The obtained activity values for the artificial mixture containing the four 
proteins, which reflected the natural composition of the crystal, were consistent with 
those obtained with the natural crystal of the strain ABTS-1857. Increasing amounts 
of Cry1Da protein, in combination with decreasing quantities of either Cry1Aa or 
Cry1Ab proteins, produced an enhanced insecticidal toxicity for S. littoralis and S. 
frugiperda larvae. These results indicated that the method used for the analysis of 
the Bt crystals is valid for its use in the characterization and standardization of Bt 
based commercial products, providing the necessary information to express its 
insecticidal potency. 
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1. GENERAL INTRODUCTION 
In 1939, the Swiss Paul Hermann Müller discovered the insecticidal 
properties of DichloroDiphenylTrichloroethane (DDT) (Metcalf, 1973). The use of 
this synthetic chemical became significantly extensive during the second half of 
World War II to prevent Allied soldiers from contracting insect-transmitted diseases, 
such as malaria, dengue fever and schistosomiasis (Fishel, 2016). By the end of the 
war, its use was confined to solving problems related to crop protection. Since then, 
synthetic pesticides such as organochlorines (e.g. DDT), organophosphates (e.g. 
glyphosate, malathion), carbamates (e.g. aldicarb) and synthetic pyrethroids (e.g. 
fenvalerate) (Nicolopoulou-Stamati et al., 2016), were massively sprayed in 
agricultural practices. This lead to the rise of the chemical industry, initiating a new 
era in pest control (Fishel, 2016).  
Chemical insecticides in general have contributed to significantly increase 
agricultural production by providing season-long protections against a wide variety 
of insect pests at a relatively low cost. DDT and other synthetic organic pesticides 
work through similar mechanisms either by disrupting the ion balance of nerve 
axons, thus producing tremors, convulsions and eventually death; or by inhibiting 
cholinesterase, leading to the accumulation of acetylcholine at the neuron synapsis 
and causing paralysis (Das, 2013). Due to their unspecific mode of action, non-
target organisms such as beneficial insects or pollinators may be negatively 
affected. As a result, reductions in the yield and quality of crops or outbreaks of 
secondary pests may occur (Devine and Furlong, 2007; Sánchez-Bayo et al., 2016). 
One of the most notorious disadvantages of chemical pesticide usage is the 
appearance of resistant insect biotypes in the pest populations due to a high 
selection pressure  (Tabashnik, 2008). A few years after the introduction of DDT as 
the ultimate solution for crop protection, populations of resistant insects arose and 
in some cases even developed cross resistance to all classes of chemical 
insecticides (Das, 2013). High stability (low degradation) and long persistence of 
chemical residues played an important role in their effectiveness, but at the same 
time they were also key factors in producing negative impacts on the environment. 
In 1962, Rachel Carson published The Silent Spring (Carson et al., 2002), where 
she expressed her concerns for generic pesticides and their negative impact as they 
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bioaccumulated in the adipose tissue of animals and lead to their biomagnification 
higher up in the food chain (Jarman and Ballschmiter, 2012). A decade later, the 
U.S Environmental Protection Agency (EPA) banned the use of DDT in the United 
States (Fishel, 2016). 
Concerning human health, skin contact, inhalation, ingestion or high 
occupational exposure to synthetic chemical insecticides may result in cancer, 
immune system disorders and dermatological, gastrointestinal, neurological, 
respiratory, reproductive and endocrine effects (Alewu B, 2018; Gunnell et al., 2007; 
Nicolopoulou-Stamati et al., 2016; WHO, 1990). Usually the limits of pesticide 
residues that can be found in fruit juices, water or cooked meals among others, do 
not exceed the safety levels indicated in the legislation. Nevertheless, the potential 
risk on human health when exposed to two or more of these substances 
simultaneously has been traditionally overlooked (Kortenkamp, 2007; WHO, 1990). 
Moreover, the chemical compounds found in these type of insecticides are often 
bioaccumulated in the fatty tissues of the human body, which may affect neonates 
through breast feeding, endangering their health (Pirsaheb et al., 2015). 
The increasing awareness of chemical pesticide hazards has resulted in 
a critical need for the development of new safe control products from a health and 
environment viewpoint (Nicolopoulou-Stamati et al., 2016). Such urge for an 
alternative strategy to conventional pesticides has been made evident by the EU 
through Directive 2009/128/EC, which aims at the use of sustainable pesticides in 
order to reduce the risk and negative impact of chemical molecules in human health 
and the ecosystems. According to this, Integrated Pest Management (IPM) must be 
promoted and new techniques for crop protection that avoid the introduction of 
chemicals should be explored. Microbial insecticides based on bacteria, virus, fungi 
or protozoa constitute a real alternative and have been proven as a potential 
alternative for pest management (Chandler et al., 2011; Lacey et al., 2001). When 
compared to chemical pesticides, microbial control agents (MCA) present numerous 
advantages in terms of efficacy and cost. Similar to natural enemies, many 
entomopathogens are often specific to certain species or group of insects, which 
translates into high safety levels for humans and other nontarget organisms such as 
honey bees, parasitoids or predators (Hokkanen and Hajek, 2003). Analogously, 
reduction of pesticide residues on food and increased activity of natural enemies 
  Introduction 
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and biodiversity in managed ecosystems are considered beneficial side effects of 
the use of MCAs in comparison with chemical pesticides. However, their brief 
persistence in the field, reduced speed of kill and elevated production costs are 
some of their still unresolved limitations. Despite their numerous advantages, MCAs 
should not be used as a unique solution for crop protection. Instead they may be 
considered as invaluable components of integrated pest management programs 
with natural enemies, resistant plants or even soft pesticides (Lacey, 2016). 
Although several researchers experimented with MCA in the late 19th century, it was 
not until the development of Bacillus thuringiensis (Bt) based biopesticides that the 
use of microbes for pest control became widespread. This bacterium produces 
highly specific toxins to target insects which are innocuous to humans, mammals 
and plants, and are completely biodegradable (Meher et al., 2002), making it a 
viable alternative for pest control and disease vectors of importance in human public 
health. 
2. THE ENTOMOPATHOGENIC BACTERIUM Bacillus thuringiensis 
2.1. Discovery and history 
B. thuringiensis was first identified in 1902 by the Japanese biologist 
Shigetane Ishiwata, who found the microorganism infecting a silkworm larva 
(Bombix mori) and named it Bacillus sotto (Beegle and Yamamoto, 1992). About a 
decade later, in the region of Thuringia (Germany), Ernest Berliner isolated a Gram-
positive bacterium causing an infection to the Mediterranean flour moth larvae 
(Ephestia küehniella) and named it Bacillus thuringiensis. Although it was the same 
bacterial species previously described by Ishiwata, the new name was quickly 
adopted by the scientific community and has persisted until our days (Melo et al., 
2016). Berliner observed that a crystal inclusion body was formed when the 
microorganism reached the sporulation phase. Later, Angus demonstrated that 
such parasporal crystals that were formed during the sporulation were responsible 
for Bt insecticidal activity (Angus, 1956).  
2.2. Interspecific classification  
The genus Bacillus is a very diverse genera in the class Bacilli and 
includes Gram-positive, spore-forming, rod-shaped, aerobic and facultative 
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anaerobic bacteria with a G+C content ranging from 32-69% (Garbeva et al., 2003). 
B. thuringiensis has been included as a member of the Bacillus cereus group, also 
known as B. cereus sensu lato (Helgason et al., 2000), in the Bacillaceae family (de 
Barjac and Frachon, 1990). It comprises six closely related species: B. cereus, B. 
anthracis, B. thuringiensis, B. mycoides, B. pseudomycoides and B. 
weihenstaphanensis. Although these species share a similar genetic background 
they clearly differ in virulence, host range and environmental distribution (Vilas-Bôas 
et al., 2007).  B. anthracis is responsible for anthrax, an acute disease that might be 
lethal for humans and animals (Mock and Fouet, 2001). Some strains of B. cereus 
are opportunistic human pathogens causing food poisoning leading to diarrhoeas, 
eye infections and periodontal disease (Drobniewski, 1993; Helgason et al., 2000), 
while other strains may be non-pathogens acting as animal probiotics and 
biostimulant promoting plant growth (Jadamus et al., 2001; Saharan et al., 2011). 
B. thuringiensis is mainly distinguished from other Bacillus species due to its ability 
to synthetize a crystalline inclusion of proteinaceous nature in the mother cell during 
the sporulation process, making it phenotypically different (Baumann et al., 1984). 
However, the bacteria may occasionally lose this ability and become 
indistinguishable from other Bacillus as the genes coding for the crystal proteins are 
generally conferred to plasmids which can be transferred by matting to different 
subspecies (González and Carlton, 1984; Yamamoto, 2001). Within Bt strains, 
these may be distinguished among others according to crystal characteristics at the 
structural and size level and their host range. The crystal inclusion body has shown 
to be specifically toxic to some insect pests and some of them have been developed 
as biological control agents against a range of insect species of different orders (Van 
Frankenhuyzen, 2009).  
2.3. Intraspecific classification  
Since the early 1960s several characteristics, such as biochemical and 
serological, along with toxicity records, have been used in order to classify the 
uprising number of Bt isolated worldwide ever since (Sanchis et al., 1996). The 
immunological reaction to the bacterial flagellar antigen (H serotyping) was 
stablished as a typing method of choice for the characterization within Bt isolates 
(de Barjac and Bonnefoi, 1962) and has been used until date (de Barjac and 
Frachon, 1990). In B. thuringiensis, the hag gene is responsible for the expression 
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of flagellin, the protein that gives the immunological reaction in H serotyping. 
Specific flagellin amino acid sequences correlates to specific Bt serotypes, and 
today, B. thuringiensis strains are classified into at least 69 H serotypes (Lecadet et 
al., 1999). Although generally serotypes do not contain H antigen variation, some of 
them have shown to contain few antigen distinct subfactors, which has led to the 
subdivision of the 69 H serotypes into 82 serological varieties, referred to as 
serovars (Xu and Côté, 2008). Although there is a good correlation between Bt 
subspecies and host range at the family level, a classification of isolates based on 
their pathotype turns into a hopeless task. Frequently, multiple toxin genes are 
present in a single isolate, and combinations of them can be endless, so an 
overlapping of the host profiles may occur breaking down the correlation at the 
genus and species level (Lecadet et al., 1999). Besides, phylogenetic analysis of 
the bacterium have been performed by using the gyrB gene (Yamamoto and 
Harayama, 1995) to complement the 16S rRNA gene and discrimination among Bt 
H serotypes, serovars belonging to the same serotype and strains from the same 
serovar has been accomplished (Soufiane and Côté, 2009). Today, the serotyping 
techniques seem to be in disuse due to the inability to certainly correlate H serotype 
with biological activity. Thus, different tools including determination of number and 
size of plasmids, characterization of toxic genes, analysis of protein fragments by 
polyacrylamide gel electrophoresis (SDS-PAGE) and toxicity bioassays may be 
applied in order to characterize a Bt isolate (Iriarte et al., 2000). 
2.4. Genome  
B. thuringiensis has a larger genome than B. cereus and B. anthracis, 
consisting of a circular chromosome ranging from 2.4 to 5.7 Mb (Carlson et al., 
1994). Its organization near the replication origin is similar to the one that occurs in 
B. cereus, but greater variability can be adverted in the terminal half of it (Carlson 
et al., 1996). The pathogenicity exerted by Bt is due to virulent components that 
reside in large circular or linear plasmids (Carlson et al., 1994). Some strains, like 
Bt subsp. kurstaki, may harbor up to 17 virulence plasmids ranging from 2 to 250 kb 
(Baum and Gonzalez, 1992; Lereclus et al., 1982) and horizontal plasmid transfer 
by conjugation between strains may happen. It is well known that these plasmids 
are the main reservoir for cry and cyt genes (Berry et al., 2002; Li et al., 2015) which 
encode crystal proteins (Cry proteins) and cytolytic toxins (Cyt proteins), 
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respectively, although they may be also present in the chromosome (Kronstad et 
al., 1983). 
2.5. Life cycle  
The cycle life cycle of B. thuringiensis has two clearly differentiated growth 
phases (Bulla et al., 1980). The first phase, also known as the vegetative phase of 
growth, takes place when favourable conditions occur, in terms of nutrients and 
aeration, the spore germinates, rising a vegetative cell where the formation of a 
septum through the plasma membrane will divide the mother cell into two identical 
daughter cells, and so on (Figure 1) (Osman et al., 2015). Although the growth 
temperature may vary between 15-45 °C, the optimal range goes from 26 to 30 °C, 
as above 42 °C plasmids containing the insecticidal genes may be cured (Mikesell 
and Vodkin, 1985). In terms of pH, conditions may vary from 5.5 to 8.5, but normally 
pH around 7 is the most suitable for its proliferation (Bernhard and Utz, 1993).  
 
Figure 1. Schematic representation of the life cycle of Bacillus thuringiensis. During the 
vegetative phase of growth, the bacterium experiences an exponential growth forming collar 
chains. The lack of nutrients forces the bacterium to enter a stationary phase in which it 
sporulates and the proteins aggregate to form the parasporal crystal. Finally, the cell lysis 
releases the crystal and the spore, which will germinate again in favorable conditions, closing 
the cycle of this bacterium. 
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The cells form pairs or short chains, during the exponential proliferation 
of the bacterium, until the nutrients in the medium become scarce. At that moment 
the cell enters the stationary phase of its cycle, otherwise referred as the sporulation 
phase, in which the formation of a resistance spore takes place in the apical extreme 
of the cell, leaving room for the formation of a parasporal crystal of a proteinaceous 
nature at the other end. In the whole process the microorganisms undergoes up to 
7 stages where the division turns asymmetric (Figure 1) (Bechtel and Bulla, 1982). 
The production of delta endotoxins is genetically regulated and give the 
microorganism a survival advantage, by exerting a lethal action against the insect 
host, providing sufficient nutrients for the germination of the dormant bacterial 
spores initiating the vegetative growth phase (de Maagd et al., 2001).  
2.6. Ecology  
B. thuringiensis is a Gram-positive, rod shaped, facultative anaerobe 
spore-forming bacterium (Claus and Fritze, 1989) which size varies between 1-1,2 
µm in width and 2-5 µm in length. It has been isolated worldwide from many diverse 
environments, including soil samples (Vilas-Bôas and Lemos, 2004), the 
rhizosphere, the phylloplane (Smith and Couche, 1991), aquatic systems, grain 
dust, and dead insects (Iriarte et al., 1998; Raymond et al., 2010). Recently new 
isolates from marine sediments (Maeda et al., 2000) and Antarctic soil samples 
(Forsyth and Logan, 2000) have been reported. Despite its ubiquity, it has been 
always linked to the soil, presumable deposited by insects, where it may remain 
latent even in adverse conditions for its development (Glare and O’Callaghan, 2000) 
until the nutrients layout and growth conditions are propitious once again (Saleh et 
al., 2010). Unlike other Gram positive spore-forming bacteria, B. thuringiensis is able 
to live in the environment free and independent, without the need to interact with 
other microorganisms, even in unique environments such as the midgut and the 
hemocoel of insects (Nielsen-LeRoux et al., 2012; Raymond et al., 2010; Schnepf 
et al., 1998). Nonetheless, its role of the crystal in ecology is poorly understood and 
stills an enigma. Bt is an opportunistic pathogen, but it is not generally known for 
causing natural epizootics, although it occurred when it was first isolated by Ishiwata 
(Milner, 1994). It is part of the natural inhabitants that occur inside arthropods and 
may not provoke any injury to its host unless it is weakened by an infection caused 
by other pathogen (Eilenberg et al., 2000). Crystal toxins may provide a greater 
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chance for the proliferation of the bacterium in these situations by binding to the 
brush border, which seems to stimulate spore germination in the insect gut (Du and 
Nickerson, 1996) and subsequent vegetative cell proliferation (Hendriksen and 
Hansen, 2003) even in the dead corpse. When nutrients start to be limited 
sporulation occurs along with toxin production (Hansen and Salamitou, 2000) until 
suitable conditions arise. These crystal proteins may suppose up to 25-30% of the 
dry weight of the bacteria (Agaisse and Lereclus, 1995). In the case of mammals Bt 
appears as a transient microorganism in the intestine that have shown no harm for 
animals (Swiecicka et al., 2002) or humans after long term exposure (Jensen et al., 
2002).  
3. B. thuringiensis TOXIC FACTORS 
Different toxins, including alpha(a)-exotoxin, beta(b)-exotoxin, gamma(g)-
exotoxin, delta(d)-endotoxin, enterotoxin, louse and mouse factor exotoxins, water-
soluble exotoxin and vegetative toxins (Heimpel, 1966; Osman et al., 2015), have 
been describe in B. thuringiensis strains. Thus toxins reporting insecticidal activity 
have been the most widely studied due to their commercial exploitation as active 
ingredients of biopesticides in the agricultural industry (Montesinos, 2003; Sanchis, 
2011). 
During the vegetative phase of growth Bt is capable of secreting soluble 
proteins to the medium, starting at mid-log phase and extending during sporulation, 
named vegetative insecticidal proteins (Vip) and secreted insecticidal proteins (Sip) 
(Palma et al., 2014). During the stationary phase of growth cry and cyt genes will 
encode the d-endotoxins that accumulate in the cell forming the parasporal crystal, 
which may be composed by a single protein or a combination of Cry proteins and 
also, but less frequently, Cry and Cyt proteins (de Maagd et al., 2003).  
3.1. Toxin nomenclature and classification 
Since the earlies 1980s, when the first crystal protein gene was cloned in 
E. coli from the Bt strain HD1 (Schnepf and Whiteley, 1981), more than 700 cry 
genes, coding for Cry proteins have been reported during the last decades, and 
around two hundred of these have already been cloned (Crickmore, 2013). The 
increasing number of novel genes isolated from a wide range of Bt strains generated 
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the need for an organized nomenclature system (Crickmore et al., 1998).The first 
nomenclature system was based on the toxicity spectra of the crystal proteins and 
grouped them in four classes: CryI for lepidopteran-active toxins, which were 130-
140 kDa in size; CryII for proteins yielding 65kDa that targeted both, lepidopterans 
and dipterans; CryIII consisted of proteins exhibiting toxicity against coleopterans; 
and CryIV was constituted of proteins exclusively toxic for dipterans (Höfte and 
Whiteley, 1989). A separate nomenclature was adopted for a toxin from a Bt subsp. 
israelensis that showed to have cytolytic activity, and so named CytA (Ward et al., 
1986). But this system soon led to problems as toxins had to be tested against a 
wide range of insects in order to classify them, some did not show the expected 
activity and many others were named the same by their discoverers mixing up the 
classification. That how the B. thuringiensis Toxin Nomenclature Committee was 
created and a new nomenclature system, accepted until date, was proposed 
(Crickmore et al., 1998). This new system classified toxins exclusively on their 
amino acid sequence, not considering their structure, mode of action or biocidal 
activity. The nomenclature was based in a four-rank name according to the degree 
of pairwise amino acid identity to previously named toxins. For the first and fourth 
rank Arabic numbers were used and uppercase and lowercase letters for the second 
and third rank, respectively (Figure 2).  
 
Figure 2. Nomenclature system adopted for insecticidal toxins produced by Bacillus 
thuringiensis. Four ranks are used to group up toxins according to their amino acid sequence 
identity. Primary, secondary and tertiary rank distinguish proteins with at least 45, between 45 
and 78 and up to 95% sequence identities, respectively. Quaternary rank differentiates 
between alleles of the same gene found in different Bt isolates, although they may share the 
exact same sequence. 
< 45% ≤ 78% ≤ 95% > 95%
Rank 1 Rank 2 Rank 3 Rank 4
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Proteins that shared at least 45% sequence identity were assigned a 
different primary rank (an Arabic number, e.g. Cry1 and Cry2); a different secondary 
rank was used to distinguish proteins sharing between 45% and 78% pairwise 
identity (an uppercase letter, e.g. Cry1A and Cry1B); a tertiary rank was reserved 
for differentiating those proteins between 79% and 95% identity (a lowercase letter, 
e.g. Cry1Aa and Cry1Ab); and finally different clones sharing more than 95% 
pairwise identity were assigned a different quaternary rank (an Arabic number, e.g. 
Cry1Aa1 and Cry1Aa2) (Crickmore et al., 2018). This nomenclature system is 
applied to d-endotoxins (Cry and Cyt proteins), vegetative insecticidal proteins (Vip) 
and secreted insecticidal proteins (Sip).  
3.2. Toxic factors produced during the vegetative phase of growth 
3.2.1. Vip proteins 
The vegetative insecticidal proteins (Vip) (Estruch et al., 1996) are 
synthetize and secreted to the culture medium during the vegetative phase of 
growth. The transcription of vip genes is detected at the start of the logarithmic 
phase of growth, reaching a high level of expression during the stationary phase (Bi 
et al., 2015; Shi et al., 2004). In contrast to crystal toxins, which can be effective in 
absence of a viable Bt cell, a vegetative growing cell is clearly required for secreted 
toxins to exert a pathogenic effect (Donovan et al., 2001; Zhu et al., 2006). The 
increasing cases of resistance to Cry proteins promoted the activation of screening 
programs focused on the identification of new insecticidal components, contained in 
the supernatant of Bt strains. These components were evaluated and found to be 
proteinaceous, rendering different band patterns when resolved in acrylamide gels 
(SDS-PAGE). Their toxicity was evaluated against different insect orders. To date, 
a total of four different classes of Vip proteins (Vip1, Vip2, Vip3 and Vip4) have been 
classified (Crickmore et al., 2018). The vip1 and vip2 genes encode proteins of 885 
(80 kDa) and 462 (45 kDa) amino acidic residues, respectively. These proteins act 
as binary toxins, such as the cholera toxin, where two functional domains or subunits 
must assemble in order to compose a toxicity complex (Madshus and Stenmark, 
1992). Although the molecular mechanism of their insecticidal activity is not well 
understood, it is believed that Vip1 inserts in the membrane and forms a pore 
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(Leaber et al., 2006) providing Vip2 a pathway to enter the cell via endocytosis in 
order to exert the lethal toxicity to the host (Barth et al., 2004). A total of 15 Vip1 and 
20 Vip2 proteins have been reported, exhibiting insecticidal toxicity against species 
of the order Coleoptera (e.g. Diabrotica spp) (Shi et al., 2004) and Hemiptera (e.g., 
Aphis spp) (Sattar and Maiti, 2011). No activity has been reported when inoculated 
individually, supporting the fact that these toxins must act together to exhibit activity 
(Chakroun et al., 2016). The vip3 genes encode proteins of 791 amino acids (88.5 
kDa) which are processed in the insect midgut and consequently activated, binding 
to brush border membrane vesicles where ion channels are formed, provoking the 
disruption of the epithelial cells (Lee et al., 2006). Until date, 101 Vip3 proteins 
(http://www.btnomenclature.info/) with insecticidal activity against a broad spectrum 
of lepidopteran insect larvae of economic importance, that are less susceptible to d-
endotoxins (Estruch et al., 1996), have been described. So far, a new subfamily 
composed by the vip4 gene has been classified, encoding a protein of 965 amino 
acids (108 kDa). No target insects have been found yet, although phylogenetically 
Vip4 seems to be closer to Vip1, sharing up to 34% amino acid identity, than to the 
rest of Vip proteins. An interesting feature of Vip proteins is that no homology with 
d-endotoxins is shared, showing a different mode of action and binding to non-
competitive sites in the insect midgut (Lee et al., 2006, 2003; Sena et al., 2009). 
This feature opens a new field for control strategies where Vip proteins could be 
included to overcome resistance problems that have arisen due to constant 
applications of Bt sprays (Ferré and Van Rie, 2002). Also, combination of secreted 
and crystal toxins may broaden the host range of Bt-based biopesticides (Bravo et 
al., 2011).  
3.2.2. Sip proteins 
The secreted insecticidal proteins (Sip) are also synthetized and secreted 
to the culture medium during the vegetative phase of growth. The first and only sip 
gene described in this new Bt insecticidal family, was identified in the strain EG2158 
and encodes a protein of 367 amino acidic residues (41 kDa). Although the mode 
of action of this protein remains unknown, its limited homology with Mtx3 
mosquitocidal toxins (Liu et al., 1996), suggests that pore formation would be 
responsible for its insecticidal activity against coleopteran larvae, including 
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Leptinotarsa decemlineata (Coleoptera: Chrysomelidae) or Diabrotica 
undecimpunctata howardi (Coleoptera: Chrysomelidae) (Donovan et al., 2006). No 
homology in the amino acidic sequences has been found with Cry or Vip proteins 
(Donovan et al., 2001).  
3.2.3. Other secreted toxic factors 
Bt also produces several other toxins, such as a-exotoxin, hemolysin, 
enterotoxins, phospholipases and chitinases (Hansen and Salamitou, 2000). In 
some cases, certain Bt strains are capable of producing the well-studied ß-exotoxin, 
also referred to as thuringiensin (Šebesta et al., 1981; Vafskov, 1978), a heat-stable 
adenine-nucleotide analog which inhibits DNA directed RNA-polymerase competing 
with ATP (Gohar and Perchat, 2001; Horská et al., 1976; Šebesta and Horská, 
1970). Although it is believed that the role of this low molecular weight molecule 
(700 Da) is to regulate the transcription of d-endotoxins, its toxicity affects a wide 
range of animals, including mammals (McClintock et al., 1995). This feature 
impedes its inclusion Bt-based insecticidal formulations (Glare and O’Callaghan, 
2000). Nowadays, improved high-performance liquid chromatography separation 
techniques are used for the detection and quantification of ß-exotoxin in B. 
thuringiensis culture supernatants (Hernández et al., 2003; Levinson et al., 1990). 
3.3. Toxic factors produced during the stationary phase of growth 
During the stationary phase the bacterium synthetize the d-endotoxins, 
oligomers commonly known as Cry and Cyt proteins, that will accumulate and 
crystallize forming the parasporal crystal. This is the defining feature of Bt. The 
bacterium will lysate and this inclusion body will be released to the medium along 
with the spore after the cell wall disintegrates. In some strains the crystal is found 
within the exosporium (Aronson and Fitz-James, 1976), but usually these two 
structures are not physically connected.  
3.3.1. Cry proteins 
Parasporal crystals can be composed by a single or a combination of Cry 
proteins cross-linked by disulphide bonds. The shape of the crystal keeps a certain 
correlation with the type of proteins that make it up. Those formed by Cry1 are 
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bipyramidal, Cry2 produce cubic forms, Cry3 form flat-rectangular crystals, those 
composed of Cry4 are spherical and Cry11 proteins form rhomboidal crystals. 
(Schnepf et al., 1998). The most common shapes among natural isolates are mainly 
bipyramidal and spherical (Bernhard et al., 1997; Martin and Travers, 1989). 
Usually, cry genes are conferred to one or more plasmids, although copies of them 
can also be located in the bacterial chromosome (Kronstad et al., 1983). The 
expression of these insecticidal genes is controlled at the transcriptional, post-
transcriptional and post-translational level, and represents a huge metabolic 
investment, as the crystal may represent up to 20-30% of the dry weight in the 
sporulated cell. Cry proteins report a high and specific toxicity to a wide range of 
insect species, including different insect orders, such as Lepidoptera, Coleoptera, 
Diptera, Hemiptera, Hymenoptera, Orthoptera, Mallophaga, (Schnepf et al., 1998; 
Van Frankenhuyzen, 2009) but also nematodes, mites and protozoa (Iatsenko et 
al., 2014). However, there are many Bt strains obtained from diverse environments 
which have no known invertebrate target (Abulreesh et al., 2012) and are referred 
to as parasporins for exhibiting strong and cytocidal activity against human cancer 
cell lines of various origins (Okassov et al., 2015). This parasporin group of Cry 
proteins have both, Cry and Parasporin designations: parasporin-1 (PS1 or Cry31), 
parasporin-2 (PS2 or Cry46), parasporin-3 (PS3 or Cry41), parasporin-4 (PS4 or 
Cry45), parasporin-5 (PS5 or Cry64 ) and parasporin-6 (PS6 or Cry63), respectively 
(Ohba et al., 2009). Although the toxicity effect of Bt strains resides in the inclusion 
crystal proteins, as these have proved effective against arthropods when tested 
alone, it is believed that the spore may act as a synergistic factor enhancing the 
toxicity effect (Burges et al., 1976). This has been confirmed by irradiating the 
spores in order to avoid germination, which resulted in a reduction of the synergistic 
effect as expected (Asano et al., 2002). Also spore-coat proteins have shown to be 
contributors for this matter (Du and Nickerson, 1996). Nevertheless, it does not 
seem to be an universal fact, as it depends on the strain, the spore, the toxin and 
the proportion of them in the mixture (Liu et al., 1998).  
3.3.2. Cyt proteins 
Cytolytic (Cyt) proteins are parasporal inclusion toxins also referred to as 
d-endotoxins. The characteristic features of these toxins are their cytolytic activity in 
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vitro, against a range of cultured cells, and their haemolytic effect in erythrocytes 
(de Maagd et al., 2003; Thomas and Ellar, 1983). According to the Bt Toxin 
Nomenclature Committee (Crickmore et al., 2018), putative proteins with a high 
sequence similarity with other previously described Cyt toxins are also defined as 
cytolytic protein. No sequence similarities are found with Cry or Vip toxins. Until 
date, three cyt gene families have been described, including a total of 11 holotypes 
according to their toxin nomenclature (Soberón et al., 2013). These were first 
detected as low molecular proteins specific to Bt subsp. israelensis (Tyrell et al., 
1981) and showed to be soluble in alkaline buffers in absence of reducing agents, 
unlike the well-known lepidopteran-specific toxic proteins (Thomas and Ellar, 1983). 
In contrast to Cry proteins, Cyt proteins are mostly found in Bt strains active against 
dipteran species, being able to kill mosquitoes and blackflies (de Maagd et al., 2003) 
although activity against some coleopteran insects has also been reported 
(Guerchicoff et al., 1997; Van Frankenhuyzen, 2009). An interesting feature about 
Cyt toxins is their ability to synergize the activity of Cry or Vip proteins reducing the 
resistance levels in some pest species (Becker, 2000; Guerchicoff et al., 1997). 
3.4. Structure and function of delta-endotoxins 
The d-endotoxins belong to a class of bacterial toxins known as the pore-
forming toxins (PFT). Generally, PFT-producing bacteria secrete their toxins which 
interact with specific receptors located in the membrane brush border. There are 
two main groups of PFT: (i) the a-helical toxins, in which a-helix regions form the 
trans-membrane pore (3-domain Cry proteins), and (ii) the b-barrel toxins, that insert 
into the membrane by forming a b-barrel composed of b-sheet hairpins from each 
monomer (Cyt proteins) (Parker and Feil, 2005). The crystal protein family should 
be divided into four distinct homology groups which are not phylogenetically related, 
a) the 3-Domain Cry family, b) the MTX-like toxins, related to B. sphaericus, c) the 
binary-like toxins, and d) the parasporins.  
3.4.1. The three-domain proteins 
The three-domain Cry toxins are globular molecules containing three 
differentiated domains connected by single linkers. The three-dimensional structure 
of Cry3Aa was the first to be resolved using X-ray crystallography (Li et al., 1991). 
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Since then, the structure of different Cry proteins, such as Cry1Aa (Grochulski et 
al., 1995), Cry2Aa (Morse et al., 2001), Cry3Bb1 (Galitsky et al., 2001), Cry4Aa 
(Boonserm et al., 2006), Cry4Ba (Boonserm et al., 2005) and Cry8Ea1 (Guo et al., 
2009) has been determined and provided considerable insight into the mechanism 
of toxin function, elucidating differences in toxin specificity (Figure 3). Multiple 
alignments of the aminoacidic sequences of several Cry proteins have revealed a 
low sequence similarity among them, with over 50 different subgroups with more 
than 200 members. This high diversity of toxins is responsible for the wide insect 
range specificities, although a high similarity in the overall topology structure is 
observed (de Maagd et al., 2003). Despite this low sequence identity, five conserved 
blocks of amino acidic residues (1 – 5) located in the N-terminal of protoxins, are 
defined among diverse Cry toxins (Höfte and Whiteley, 1989; Schnepf et al., 1998). 
A particular feature concerning the three-domain Cry protoxins is their production 
during sporulation of the bacteria as protoxins of two different lengths: either 130-
140 kDa or approximately 70 kDa. The main difference between these is that in 
large protoxins the C-terminal cleaved by proteases in the insect midgut that remove 
about 500 to 600 amino acid residues and about 20-25 at the N-terminal. 
Nevertheless, short protoxins are only processed at the N-terminal. This suggests 
that C-terminal extension found in 130 kDa protoxins is dispensable for toxicity. In 
both cases the resulting activated toxin constitutes a protease resistant core of 60 
kDa that presents the three mentioned domains (de Maagd et al., 2001). The 
mentioned five conserved blocks are located along the toxic core sequence (Höfte 
and Whiteley, 1989), while three additional blocks (6 – 8) are distributed in the C-
terminal halves of large protoxins, where an extra domain, not found in smaller 
proteins, is found.  
Domain I (the N-terminal domain) was first described in Cry3Aa (Li et al., 
1991). It comprises a bundle of seven a-helices, in which six of them (amphipathic) 
surround a central helix (a5) which is hydrophobic. Its structural similarity to the 
pore-forming domain of colicin (Parker et al., 1989), along with its proteolytic 
cleavage during toxin activation, led to the hypothesis that Domain I may be 
responsible for membrane insertion and pore formation in Cry proteins (Li et al., 
1991; Xu et al., 2014). Domain I contain the conserved blocks 1 and 2 (the C-
terminal half of helix a6 and all of a7) (Figure 3). Site-directed mutagenesis 
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experiments showed alterations in toxicity when amino acidic residues were altered, 
but interactions of the toxin with the brush border were not disturbed (Ahmad, 2003; 
Wu and Aronson, 1992). Nevertheless, substitutions or mutations of Domain I 
targeting block 2 suggested its importance in crystallization and stability (Park and 
Federici, 2004). 
 
Figure 3. Primary and tertiary structure of Cry toxins. A. Position of the conserved five blocks, 
if present, among different Cry protoxins. The three domains are marked for protoxin Cry1. 
Domain I contains the conserved block 1 and part of block 2. Domain II contains the rest of 
the conserved block 2 and part of block 3. Domain III contains the rest of the conserved blocks 
3, 4 and 5. The rest of the protoxins follow a similar structure with an N-terminal (20-40 amino 
acidic residues) before the conserved block 1 and a C-terminal followed by block 2 in long 
protoxins, which is digested when activated in the midgut of the insect. B. Three-dimensional 
structure of a Cry1A protein. Three domains can be differentiated: domain I (red) is involved 
in membrane insertion and pore formation; domains II and III (blue and green, respectively) 
are involved in specific recognition and receptor binding. (de Maagd et al., 2001). 
Domain II consists of three anti-parallel b-sheets, forming a b-prism, with 
exposed loop regions. It is the most variable of the toxin domains and plays an 
important role in toxin-receptor interactions which is determinant for host specificity 
(Boonserm et al., 2006; Li et al., 1991). Domain II contains part of the conserved 
blocks 2 (the first b-strand) and 3 (the last b-strand). Mutations in loops of this 
domain have revealed their role in specific interaction with host receptors, 
suggesting that toxins with high sequence similarity in this region may share some 
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binding sites in the epithelial cells of the midgut (Hernández and Ferré, 2005; Jurat-
Fuentes and Adang, 2001). Domain III is a two antiparallel b-sheet sandwich, each 
of them composed by five strands (Li et al., 1991). It is proteolytically cleaved in 
some three-domain Cry proteins and is also involved in receptor binding, pore 
formation and host range definition, although it shows less structural variability than 
Domain II  (Schnepf et al., 1998). Domain III contains the conserved blocks 3 (the 
N-terminal segment of the first b-strand), 4 (the second b-strand) and 5, located at 
the C-terminus of the domain (Jurat-Fuentes and Jackson, 2012). Mutations in block 
4 in Cry1Aa revealed alterations in toxicity by forming truncated channels in brush 
border membrane vesicles (Chen et al., 1993; Wolfersberger et al., 1996), while 
block 5 showed to be involved in toxin stability in Cry4A, providing higher protection 
against protease digestion (Nishimoto et al., 1994).  
3.4.2. Cyt proteins 
Cyt proteins have a single a-b domain that comprises two outer layers of 
a-helix hairpins wrapped around a b-sheet. The three-dimensional structures of 
three Cyt proteins (Cyt1Aa, Cyt2Aa and Cyt2Ba) have been solved by 
crystallography showing similar topology. Although the mechanism of action of Cry 
and Cyt families is thought to be the same, no similarities are shared between them 
(Li et al., 1996, 1991). Both toxins produce a 1-2 mm pore in the membrane of 
epithelial insect cells that lead to an osmotic decompensation (Knowles and Ellar, 
1987). After solubilization, the proteolytic activation of Cyt protoxins is required for 
toxicity. Insect gut enzymes cleave the C and N-terminal of the protoxin (27 kDa) 
and the active toxin (24 kDa) (Thomas and Ellar, 1983) is released as a monomer 
that interacts directly with membrane lipids forming a pore (Promdonkoy and Ellar, 
2005, 2000) or by a detergent-like interaction (Butko, 2003). 
3.5. Models of action of Cry proteins in lepidopteran species 
Bt insecticidal proteins exhibit insecticidal activity against a wide range of 
different insect orders like Lepidoptera, Coleoptera, Diptera, Hemiptera and also 
other non-insect organisms such as mites (Van Frankenhuyzen, 2013) and 
nematodes (Wei et al., 2003). The mode of action of Cry proteins has been deeply 
studied during the last decade mainly focused on lepidopteran species. The 
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knowledge of how these insecticidal toxins interact with the host producing a lethal 
effect is of crucial interest for pest control and avoidance of resistance appearance. 
Crystal proteins sharing molecular elements in their mode of action may promote 
the premature selection of resistant biotypes in the insect population. Three different 
models for the mode of action of crystal proteins have been proposed. 
3.5.1. The classical model 
The “classical” model mode of action (Bravo et al., 2007) proposes that 
when the inert crystal proteins are ingested by a susceptible host the alkaline 
conditions of the insect midgut promotes its solubilization, releasing them in their 
protoxin form. These are then proteolytically converted to smaller protease-resistant 
toxic polypeptides, either by host proteases, spontaneous proteolysis or by the 
intervention of proteases associated to the spore (Cannon, 1996), yielding the active 
toxin. Solubilization and protease activation are two interactive processes, where 
the first one promotes a structural change in the insecticidal molecule facilitating the 
access of proteases to the target residues. Regardless of the size of the protoxin 
(130kDa for Cry1 and 70 kDa for Cry2 and Cry3 proteins) the active crystal proteins 
usually present a size of 60 kDa, so in some cases, these enzymes remove about 
half of the crystallized toxin in a process believed to activate it (Bravo et al., 2002). 
The activated toxin subsequently binds to specific receptors located on the brush 
border membrane of the midgut epithelium columnar cells before inserting into the 
membrane. Toxin subunits oligomerize to form pore structures in the microvilli of 
apical cell membranes allowing permeability to inorganic ions, amino acids and 
sugars (Carroll and Ellar, 1993; Kirouac et al., 2002). Such pores cause ion leakage 
that lead to cell lysis due to massive influx of solutes from the midgut lumen 
(Knowles and Ellar, 1987) and midgut disarrangements ending in insect death 
(Figure 4).  
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Figure 4. Mode of action of Cry toxins. After ingestion the parasporal crystal is dissolved in 
the insect gut due to alkaline conditions. A proteolytic activation of the protoxin clips off the C-
terminal of long proteins (130 kDa) and a small fraction of the N-terminal. The toxin core binds 
to specific receptor located in the brush border of epithelial cells where domain II and III are 
involved. Finally, domain I forms a lytic pore that cause ion disarrangements resulting in cell 
lysis and insect death. 
However, there are some details including the assembly of the toxins and 
the structure of the pore that still need to be clarified. In contrast, some advances 
have been made in the toxin-receptor recognition process and resistance to toxins 
(Gómez et al., 2007; Likitvivatanavong et al., 2011). In some occasions spores may 
colonize the hemocoel where they may germinate, replicate and cause a 
septicaemia killing the insect (Höfte and Whiteley, 1989; Schnepf et al., 1998). 
These mentioned conditions are responsible for the narrow spectrum of the 
microorganism and its safety for mammals. 
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3.5.2. The sequential binding model 
The sequential binding model attempts to explain the pore formation 
event as a consequence of a multiple receptor contribution (Bravo et al., 2004; 
Gómez et al., 2002; Pacheco et al., 2009). The solubilization and proteolytic 
activation of the toxin would follow the same steps as the “classical” model. 
However, the first interaction takes place between the activated toxin and two 
specific receptors located on the luminal membrane of midgut epithelial cells. The 
toxin binds to a cadherin-like protein (receptor 1) that promotes a conformational 
change in the insecticidal molecule that favours a proteolytic cleavage of the N-
terminal of the pore-forming domain of the toxin. This leads to removal of helix a1 
and oligomerization of the toxic molecule that will form a pre-pore structure (Gómez 
et al., 2002). The oligomer then binds to a glycosyl-phosphati-dylinositol (GPI)-
anchored aminopeptidase N (receptor 2), showing a greater affinity to it than the 
monomeric form of the toxin (Bravo et al., 2004). Finally, insertion into the 
membrane results in the formation of a pore structure that leads to a major 
permeability of the epithelial cells. This model suggest that alteration in the 
expression of either of the two mentioned receptors, cadherins or aminopeptidase 
N (Gahan et al., 2010; Morin et al., 2003; Xu et al., 2005; Zhang et al., 2009), can 
cause resistance events to Cry proteins, without undergoing any structural 
modification.  
3.5.3. The signalling pathway model 
The signalling pathway model of Bt mode of action, however, discards the 
importance of pore formation in toxicity as a cause but as a consequence (Zhang et 
al., 2006, 2005). This model is partially based on the observation that insect cell 
cultures expressing the BT-R1 cadherin are sensible to Cry1Ab binding that 
activates a magnesium-dependent signalling pathway associated with cell death.  
  
  Introduction 
 35 
4. BIOASSAYS OF B. thuringiensis AGAINST LEPIDOPTERAN PESTS 
A bioassay is a technique used to measure the amount of a substance, 
such as a toxin, needed to cause an effect on a living organism (Robertson et al., 
2017). Bioassays are performed for several purposes, such as assessment of the 
activity of formulated and non-formulated pathogens, to serve as quality control of 
commercial products or to determine the mode of action of the active ingredients. 
The experimental design depends on some key parameters including the active 
ingredient, food source, treatment supply, host range, speed of kill and activity 
against different larval instars. In order to estimate the pathogenicity of the active 
ingredient of interest a range of 5-6 concentrations are usually applied to precisely 
estimate the amount of toxin required to cause mortality in larval insects. Single 
discriminating concentrations of the active ingredient are recommended in order to 
fix the appropriate range of dilutions (Navon, 2000).  
4.1. Artificial diet 
The purpose to use an artificial diet is to accurately evaluate the activity 
of, for example, a mixture of spores and crystals in absence of the chemical and 
physical barriers that are present in a host plant. A large number of insects, 
preferably reared with low cost and high performance (Zou et al., 2015), are 
employed for laboratory toxicity studies. Diet-based assays overcome the need to 
maintain a constant supply of plants in the greenhouse or in the field. In order to 
determine if an artificial diet is appropriate for the production of insects in the 
laboratory, it should supply the insect all nutrients needed, be innocuous to use and 
easy to prepare, have a long term shelf storage, and at least a total insect viability 
above 75% should be reached (Singh, 1983). A first diet was proposed to determine 
the activity of the French E-61 standard Bt subsp. thuringiensis against Trichoplusia 
ni or Ephestia küehniella (Dulmage et al., 1971). However, the increasing interest 
to characterize new Bt isolates against the wider possible insect range required the 
development of new bioassay diets specific to each pest. Thus, some authors 
proposed standardized diet recipes for rearing a wider range of lepidopteran insect 
species (Han et al., 2012; Navon et al., 1990; Singh, 1983).  
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4.2. Natural food 
The main difference with dietary bioassays is the presence of chemical 
and physical barriers that provide the crop a particular defence. The plant generate 
an alkaline environment on the leaf surface due to the exudation of magnesium and 
potassium cations (Ellman and Entwistle, 1982; Navon et al., 1988) that may 
negatively affect the activity of d-endotoxins if the pH rises above 10 (Behle et al., 
1997). This feature opens the opportunity to test different adjuvants, that can be 
included in formulation recipes, in order to determine their effect on the potency of 
Bt and the insect feeding behaviour. Cotton is one of the most common hosts used 
as natural food, as several lepidopteran species can feed on it. Plants also grow 
fast, so within a few weeks the size and the number of leaves may be appropriate 
for either leaf or plotted-plant experiments. 
4.3. Toxin supply 
4.3.1. Superficial contamination of diet 
Knowledge about the feeding behaviour of the target insect is crucial in 
order to determine the most suitable way to supply the toxin. For example, 
Spodoptera exigua, Helicoverpa armigera or Mamestra brassicae, feed by grazing 
across the surface, so superficial contamination of the synthetic diet seems to be 
the most suitable option. An important factor to take into account is that the active 
ingredient used must be stable in the diet, as many recipes include antimicrobial 
agents that could affect the activity of bacteria. This is the reason why a 
conscientious screening to determine the role of diet ingredients in the activity of B. 
thuringiensis is mandatory. In order to conduct this type of bioassay a known volume 
of the aqueous toxin solution is added to cover the semi-synthetic diet, contained in 
plastic cups, followed by agitation to ensure even coverage. The dosage is thus 
expressed in ng/cm2. Larvae are then added individually one per well (if gregarious, 
mass feeding can be employed) and fed on the diet for a certain period of time. This 
method can be used either to calculate the median lethal dose (LD50) or the median 
lethal concentration (LC50), depending on whether the amount of active ingredient 
ingested by the treated larva is known or not. In the first case the entire amount of 
diet, which must be ascertained by trial and error, is consumed in a known short 
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time. In the second case a known concentration of the treatment is applied on the 
surface of the diet, but it is not entirely consumed (Evans and Shapiro, 1997). 
4.3.2. Leaf contamination 
Some insects cannot be reared on artificial diets so natural food plant 
should be used instead. Leaf discs, submerged in a treatment aqueous suspension, 
can be also used as source of food for the insect during the experiment. Individuals 
will ingest the toxin with the plant material, which will determine mortality. If the target 
insect shows cannibalistic tendencies, it is advisable to offer a leaf disk to 
individually confined larvae, however, an alternative using the whole leaf is available 
for lepidopteran species that can be grouped together without eating each other. 
For leaf disc bioassays a standardized size is used, and discs are submerged in an 
aqueous concentration of toxin to be evaluated (Iriarte et al., 1998). A wetting agent 
(0.1% concentration), is generally used to avoid the formation of drops by reducing 
surface tension and to improve the correct and homogeneous impregnation of the 
surface. These are then dried at room temperature and transferred to individual 
wells of 2 cm2 containing a layer of 1.5-3 % agar (w/v) to maintain moisture of the 
leaf tissue. Larvae are individualized in wells by means of a camel-hair brush, and 
boxes are maintained at controlled conditions during the appropriate period of time 
before mortality is registered. For whole leaf bioassays a similar procedure is 
followed. The serial aqueous solutions (0.1% wetter) are poured over the leaf tissue 
and allowed to dry. The petiole is cut at 2 cm distance from the leaf and inserted 
into the agar layer. Then a certain number of neonate larvae are carefully placed on 
the leaf and mortality is registered after 3 days (Navon and Ascher, 2000). 
4.3.3. Plotted-plant and field bioassays  
Whole plants can be used to conduct a toxicity assay by caging first, 
second or third instars on leaves of potted plants. Several factors, including 
percentage of mortality, leaf consumption and feeding inhibition under greenhouse 
conditions (Navon et al., 1987) can be evaluated. Important advantages over leaf 
bioassays can be highlighted, such as; testing the activity of B. thuringiensis on 
intact plants, spraying or dusting the plants with the biological product with a higher 
concentration accuracy than in the field, extending the bioassay period as long as 
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the plant is consumed by the pest larvae and assaying the possible residual effect 
of the Bt-based product. Cages consist of a plastic cylinder, that surrounds the 
whole plant, closed by a plastic or metal mesh. Hatching eggs are placed in the plant 
and neonate larvae are allowed to stablish along the leaves. Then the corresponding 
treatment is sprayed over the plant and is allowed to dry. The cage is closed until 
mortality registration. These bioassays are usually handled as a previous step to 
field bioassays, which are conducted under natural and environmental conditions. 
A natural or artificial infestation can be used in order to stablish a population in the 
crop and a certain spraying volume is determined per hectare. Usually, mortality in 
neonate larvae is high due to natural entomopathogenic microorganisms or natural 
enemies. For this reason, second and third instar larvae are often evaluated. 
Portable meteorological stations can be useful to measure temperature and 
humidity conditions during the bioassay period (McGuire et al., 1997; Navon and 
Ascher, 2000). 
4.3.4. Diet incorporation bioassays 
The choice of diet incorporation relates to the behavior of the test insect. 
There are some lepidopteran species, such as Cydia pomonella, that bore into the 
diet spending very little time on the surface, reducing the chances to ingest the 
desired amount of toxin (Stará and Kocourek, 2007). In these cases, the 
incorporation of the toxin directly into the diet can be a better approach, where 
accuracy increases as the active ingredient is more evenly distributed through the 
food. To perform this bioassay, plastic, uniform and clean containers able to hold 
larvae individually, are preferred. Spore and crystal mixtures or the crystal 
suspensions should be prepared and diluted in sterile distilled water (supplied with 
2.5ml of a 1% Tween 80 solution). Before adding the treatment to the diet, it should 
be cooled down enough (45°C) to avoid thermal inactivation of the proteins, but still 
be liquid to be poured into the containers. Larvae must be then carefully transferred 
individually to cups, which may be checked after 4-7 days for mortality record. This 
bioassay method is most conveniently employed to estimate the LC50 in 
lepidopteran species with gregarious feeding habits. Nevertheless, LD50 studies can 
be performed if diet plugs of known volume are removed and let to be entirely 
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consumed by individual larvae (Evans and Shapiro, 1997; Martignoni and Ignoffo, 
1980). 
4.3.5. Droplet feeding method 
The droplet feeding method (Hughes et al., 1986; Hughes and Wood, 
1981) turns to be a simple and fast assay with high precision and accuracy results 
that can be conducted with lepidopteran species that drink liquids on surfaces, 
especially after a short period of starvation. The most characteristic feature of this 
bioassay method is that treatments are prepared containing 5% sucrose (w/v) and 
20% of food colouring Fluorella Blue (Figure 5).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Droplet feeding method bioassay. A. S. frugiperda second instar larvae feeding on 
drops containing a known concentration of Bt toxin. B. Detailed S. frugiperda larvae staining 
blue while ingesting a colored protein suspension with Fluorella Blue. C. Bioassay tray 
containing artificial diet where larvae are placed after the treatment. 
A 
B C 
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Newly moulted starved larvae are carefully placed on a surface, by using 
a camel-hair brush, and numerous tiny droplets (0.2-0.8 µl) of the aqueous 
suspensions are supplied using a pipette. If larvae are trapped in the droplets due 
to the surface tension of the water, a perforated parafilm could be used to feed them. 
Larvae immediately move to the droplets and feed within the first 10 min, dispersing 
then to the edges and not returning to imbibe a second time. Larvae that have 
ingested the sufficient dose, according to the colorant appearance of their tegument, 
are individually transferred to containers supplied with synthetic diet (Figure 5, C). 
Assays are conducted under controlled conditions until mortality is registered 
(Evans and Shapiro, 1997).  
4.4. Types of bioassays  
4.4.1. Concentration-mortality response 
The goal of the bioassay is to determine either the mean lethal 
concentration (LC50), concentration required to kill 50% of the target pest, or the 
mean lethal dose (LD50), dose required to kill 50% of insects. LC50 is a standard 
measure to express virulence. The standard approach is to use five or more serial 
dilutions of the microbe of interest and register the mortality after a single period of 
time, depending on the larval instar. Establishing concentrations above and below 
the LC50 is considered a good practice. However, it is recommended to conduct a 
preliminary assay using two concentrations, one high and one low, to ensure a 
correct range of dilutions. For neonate larvae the stablished period for counting the 
biological effect is limited to 2-4 days, while this range comes up to 7 or 8 days for 
third instars. In order to determine the potency of an active ingredient, the mortality 
is referenced against the international standard, which is expressed in international 
units per mg (IU mg-1) (Dulmage et al., 1971; Navon and Ascher, 2000).  
4.4.2. Mortality-response 
This type of bioassay is reserved to determine the mean lethal time (LT50), 
which is defined as the period needed by the entomopathogenic agent to kill 50% 
of the insect population. It is suitable for second and third instar larvae, as neonate 
larvae are too sensible to the treatments and mortality occurs too quickly to obtain 
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time-mortality slopes. Hatching individuals are not able to survive without feeding, 
whereas third instars may starve for several days owing to the fat body, which is 
used as an energy reserve. Mortality should be counted every 6 to 8 hours on 
successive days allowing estimation of the LT50 with good slopes (Navon and 
Ascher, 2000). Alternatively, the mean time to death (MTD) may be calculated. 
4.4.3. Feeding inhibition assays 
Bioassays conducted with this goal estimate the concentration of the 
active ingredient needed to cause a 50% reduction in larval weigh of the treated 
individuals compared to the control larvae. The feeding inhibition assays are 
generally conducted with second and third instars (Navon and Ascher, 2000).  
5. FORMULATION 
As well as chemical products, microbial pesticides need to be formulated 
before application in the field. Formulation is the process by which the technical 
product that contains the active ingredient (e.g. mixture of spores and crystals in Bt-
based products) is converted into the final product by the addition of adjuvants 
aimed at increasing the effectivity. Formulation must be achieved in a cost-effective 
manner to have a competitive price in the market. Commercial formulations are 
mainly liquid (aqueous liquid suspensions), dry solid (wettable powders, water 
dispersible granules, dusts or pellets) or oil emulsifiable suspensions. (Angus and 
Lüthy, 1971; Charles et al., 2000; Frey, 2001). 
Bt products generally contain spores, crystals, vegetative insecticidal 
proteins, enzymes (such as chitinases, proteases and phospholipases), unknown 
virulent factors and inert materials. Ingredients used in formulation must be 
approved by the appropriate regulatory authorities that recognize them as safe. 
Addition of formulation additives to improve performance in plant coverage and field 
stability have been of major concern to optimize the effectiveness of microbial 
insecticides. 
5.1. Additives that counter foliage factors 
As mentioned previously (see section 4.2), the alkaline environment found 
in the surface of some plants, may alter the efficacy of Bt toxin as pH values as high 
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as 11 dissolve the crystal toxins. Protection agents must be used to retain the 
structure of insecticidal proteins, and thus, maintain their toxicity at extreme 
alkalinity conditions (Behle et al., 1997). The presence of allelochemicals (e.g. 
tannins and nicotine), produced by plants as part of their natural defence against 
herbivores, inactivate the toxins depressing the activity of Bt. They are also 
responsible for a decreasing effect in the feeding of insects, which is directly linked 
to a decrease in the amount of ingested toxin (Morris et al., 1995; Navon, 1993, 
1992). Encapsulation of spores and crystals in an insoluble polymer (McGuire et al., 
1996) or formulation in oil may overcome extreme pH conditions in the surface of 
the phylloplane. This negative effect due to antibacterial or allelochemical 
substances may be partially counteracted by the use of other formulation ingredients 
such as stickers or phagostimulants.  
5.2. Wetters 
Wetters are adjuvants that facilitate plant coverage by reducing the 
interfacial tension and surface tension of water (Burges and Jones, 1998). Mainly 
the concentration at which wetters should be applied vary from 0.01 to 0.5% in tank 
mixes. The most preferable components are Tweens, Tritons and non-ionic wetters. 
Tween 80 and Triton X-100 have been successfully used in spray contaminations. 
Surfactants do not seem to harm microbials when exposed during short periods of 
time, but they may cause deterioration when included in formulation and stored. In 
practice, wetters are best incorporated in the tank mixer before application in 
quantities that assure good dispersion and cover (Burges and Jones, 1998).  
5.3. Stickers 
Several authors have reported spores to last between 0.5 to 3 days 
depending on the addition of adjuvants (Ignoffo et al., 1974). In the field 
meteorological factors such as rain, must be taken into account, as the product can 
be rapidly removed from the target zone. The use of sticker (0.1-2%) improve the 
adherence of sprayed products to foliage and enhance the potency of the product, 
as it remains in the target zone during a larger period of time for its potential 
ingestion (Burges and Jones, 1998). 
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5.4. Phagostimulants  
Bt-contaminated surfaces usually repel insects from feeding, unlike the 
untreated control, hindering the appropriate intake of a lethal dose (Glare and 
O’Callaghan, 2000). Phagostimulants are mainly added as adjuvants in commercial 
formulations (Burges and Jones, 1998) for the insect to ingest a lethal amount of 
toxin before it loses its insecticidal activity due to adverse environmental factors. 
Phagostimulants are mainly derives from host plants of target pests and they have 
not shown evidence of incompatibility with entomopathogenic agents. Feeding 
stimulants such as molasses or sugar, are used to facilitate larval intake of spores 
and crystals (Burges and Jones, 1998). 
5.5. Sunscreens 
Sunlight is the most destructive environmental factor for microbial 
insecticides (Ignoffo et al., 1977; Pozsgay et al., 1987). Potency of Bt is drastically 
reduced after UV light exposure and negatively contributes to its persistence on the 
phylloplane. Sunscreens absorb, block or reflect the sunlight, converting damaging 
UV light to harmless wavelengths (Burges and Jones, 1998). 
5.6. Synergists  
No matter the mode of action, a synergist is a substance that increases 
somehow the mortality produced by solely the active ingredient. Many of the 
additives used as synergists are inexpensive (Morris et al., 1995), however they 
may have a huge economic impact due to their performance (Salama et al., 1986). 
Combination of two or more synergists may also have a synergistic effect. 
Concentration of these substances may vary from 0.01 to 0.5% (w/w) (Burges and 
Jones, 1998). 
6. COMMERCIAL PRODUCTS BASED ON Bacillus thuringiensis  
6.1. Bt-based insecticides 
Back in the 1920s, B. thuringiensis was already used by farmers for pest 
control in Hungary, and also in Yugoslavia at the beginning of the 1930s, as 
synthetic chemicals were not yet developed (Husz, 1928; Vouk and Klas, 1931). 
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The first commercial product was manufactured in France in 1938 by Laboratoire 
Libec (Aronson et al., 1986), under the name Sporeine® (Lambert and Peferoen, 
1992), for the control of flour moths, but also other lepidopteran species (Milner, 
1994). Thuricide®, based on Bt subsp. thuringiensis, was launched to the market in 
1958, setting the starting point of Bt-based products commercialization in the United 
States. In 1961 Bt was first registered by the US Environmental Protection Agency 
(EPA) (Starnes et al., 1993). Ever since, efforts in the identification of strains with 
greater potency, whether due to the presence of novel insecticidal genes, new 
insecticidal gene combinations or higher gene expression levels, have been 
intensified for controlling different ranges of pests (Kuo and Chak, 1996; Porcar and 
Juárez-Pérez, 2003). 
Bt-based products can be classified according to their active ingredient 
(AI). First generation products are those which AI is comprised by a mixture of 
spores and crystals of a natural strain (Kaur, 2000) (Figure 6). This generation 
products are fairly represented by several Bt-based preparations. In the 1970s 
Dulmage isolated the Bt HDI strain from Pectinophora gossypiella (Saunders) larvae 
(Dulmage, 1970), which resulted to be a new subspecies of Bt according to the 
flagellar serotyping, and so named kurstaki (de Barjac and Lemille, 1970). This new 
strain expressed four proteins, Cry1Aa, Cry1Ab, Cry1Ac (130-40 kDa) and Cry2Ab 
(65-70kDa), responsible for its host range, covering more than 167 species, 
including some of the most important species of noctuids (Lepidoptera; Noctuidae) 
such as Trichoplusia ni, Helicoverpa zea, Helicoverpa armigera among others 
(Glare and O’Callaghan, 2000; Hall et al., 1977; Sharpe and Baker, 1979; 
Yamamoto and McLaughlin, 1981). A significant activity against mosquito larvae 
has also been reported (Hall et al., 1977). Several commercial products based on 
Bt subsp. kurstaki have entered the market under different trademarks, including 
DiPel®, Bactospeine® and Biobit®(Abbot Laboratories) or Thuricide®(Thermo Trilogy) 
(Kaur, 2000; Starnes et al., 1993). In 1962 Keio Aizawa of Kyushu University in 
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Japan discovered a new isolate that belonged to a new subspecies, which was 
named after the researcher (Aizawa and Lida, 1963).  
Figure 6. Commercial products based on a mixture of spores and crystals from natural Bt 
strains. The most popular products for the control of lepidopteran species are DiPel® and 
XenTari®, VectoBac® for dipteran species and Novodor® for coleopteran species. 
Susbspecies aizawai reported to be very effective against Galleria 
melonella and several species of the genus Spodoptera, including S. exempta, S. 
exigua, and S. littoralis (Basedow et al., 2008; Van Frankenhuyzen, 2009). This 
effectivity was attributed to the presence of a plasmid in the Bt strain (Zakharyan et 
al., 1976) carrying genes responsible for the expression of Cry1Aa, Cry1Ab, Cry1C 
and Cry1D proteins (130-140 kDa) (Gonçalves et al., 2018). Different formulations 
based on Bt subsp. aizawai are commercialized, such as XenTari® or Florbac® 
(Abbott Laboratories) (Kaur, 2000). The discovery of Bt subsp. israelensis strain H-
14 (Israel 1976) showed to be effective against dipteran larvae including mosquitoes 
and blackflies (Das and Dominic Amalraj, 1997; Goldberg and Margalit, 1977). The 
proteins responsible for the insecticidal activity are the Cry proteins, Cry4Aa, 
Cry4Ba, Cry10Aa and Cry11Aa, and the two cytolytic proteins Cyt1Aa and Cyt2Ba 
which are located in a mega plasmid called pBtoxis (Berry et al., 2002). Formulations 
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based on these Bt strains have been applied to water courses and stagnant pools 
in order to control the human disease vector such as malaria, yellow fever or 
dengue, including Aedes aegypti ,Culex species and Anopheles gambiae  (Becker, 
2000; Margalith and Ben-Dov, 2000; Pardo-López et al., 2013; Poncet et al., 1997). 
Some of these preparations are commercialized under different trademarks, such 
as VectoBac®, Skeetal® and Bactimos® (Abbott Laboratories).  
Bt subsp. tenebrionis was isolated in 1983 and showed activity against 
coleopteran species (Krieg et al., 1983) including the Colorado potato beetle (CPB), 
L. decemlineata. This strain produces a flat and rectangular parasporal crystal with 
a major component of 65-70 kDa that corresponds with the Cry3 protein (Sekar et 
al., 1987). Some formulations have been prepared for producers to protect their 
crops, such as Novodor® (Abbott Laboratories).  
Second generation products are those which AI is comprised by a Bt 
strain that has been modified by conjugation or transformation in order to widen the 
host range or delay resistance events. A few Bt-based products are commercialized 
worldwide, including Foil® which express Cry1Ac and the imported Cry3A, Crymax® 
which express Cry1Ac, Cry2A and the imported Cry1C, or Turex® a Bt subsp. 
aizawai which has been engineered with Cry1Ac form Bt subsp. kurstaki (Baum et 
al., 1999; Carlton and Gawron-Burke, 1993). Third generation products are 
designed to overcome limitations in open field by encapsulation of Bt strains into 
dead bacteria of Pseudomonas fluorescens (MVP®, Mycogen) (Stone et al., 1989). 
6.2. Insecticidal potency of a Bt-based product 
Since the appearance of the first Bt-based products, methods for 
comparing them among different countries were developed. Before 1970s the 
standardization procedure was through spore count. However, there was no 
relationship between number of spores and activity of the strain, as toxicity varied 
with crystal count as noted by previous authors (Angus, 1954; Beegle et al., 1991). 
The need for standardization increased as it served as a guarantee of the product 
for consumers. (Martouret, 1975). 
This led to the determination of certain Bt strains as “standards” to which 
compare the toxicity of tested strains. The first standardized methodology to assess 
the potency of Bt formulated products involved the use of an “International Unit” (IU) 
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of potency (Dulmage, 1981). In order to calculate the potency of an isolate, a 
reference strain, which has been assigned a random value of IU/mg, and a 
reference susceptible insect, are required. In France, the strain E-61 was selected 
as reference standard for the commercial product Bactospeine® and assigned a 
potency of 1,000 IU/mg against E. küehniella larvae (Burges, 1967). However, in 
the United States Dulmage proposed HD-1-S1971 as standard strain which was 
assigned a potency of 18,000 IU/mg against Trichoplusia ni on the basis of assays 
compared to E-61 (Dulmage, 1981; Dulmage et al., 1971). The HD-968-1983 strain 
was selected as standard for Bt subsp. israelensis H-14 and assigned a potency of 
4,740 IU/mg against Aedes aegypti larvae (Dulmage et al., 1985). Potency is 
obtained by comparing the estimated LC50 of a tested strain or formulation to that of 
a standard material and expressed in IU/mg (Dulmage, 1981). Potency is calculated 
as follows: 
 
 
 
 
 
Although standard protocols have been suggested (McLaughlin et al., 
1984), fluctuations between laboratories still occur, even insects from the same 
population reared within a laboratory may show variations in susceptibility 
(Skovmand et al., 1998). Various authors  have reviewed the existing Bt standards 
for lepidopteran species (Tompkins et al., 1990). Nowadays, IU are used to estimate 
the potency of Bt-based products according to the strain used as active ingredient: 
DiPel® (Bt ser. kurstaki ABTS-351) is assigned 32,000 IU/mg, XenTari® (Bt ser. 
aizawai ABTS-1857) 15,000 IU/mg (Figure 7), VectoBac® (Bt ser. israelensis H-14 
AM65-52) 1,200 IU/mg and Novodor® (Bt ser. tenebrionis NB176) 15,000 IU/mg 
(www.kenogard.com). However, sometimes potency is not registered in the label 
and companies do not assure a good performance of the product because the 
potency measurements are not standardized.  
 
LC50 of a standard 
          x potency of the standard = Potency of the sample (IU/mg) 
LC50 of a sample 
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Figure 7. Detailed label of the Bt-based product XenTari® which active ingredient is the Bt 
subsp. aizawai strain ABTS-1857. The potency of the product has been estimated using 
Plutella xylostella as reference insect and assigned 15 million IU/g. 
Several methods have been applied in order to fully characterize a Bt 
strain in order to determine its true potential. Immunoassay and high pressure liquid 
chromatography (HPLC) have been used by several authors in order to determine 
the composition of the parasporal crystal of B. thuringiensis (Chestukhina et al., 
1994; Pang and Mathieson, 1991; Yamamoto, 2001). Purified crystals are 
solubilized followed by trypsin activation and chromatographic files are analysed by 
measuring time-retention peaks (Masson et al., 1998). However, to date no 
biotechnological method has been developed to determine the potency of a product 
according to the composition of its active ingredient. This task stills rely on insect 
bioassays (Beegle and Yamamoto, 1992) although these have resulted to be 
complicate and difficult to compare between laboratories. The relative abundance 
of crystal proteins in a Bt strain is crucial for the insecticidal activity. The knowledge 
of the proportion of each toxin would allow researcher to predict the potential toxicity 
of a certain product against a pest of interest, based on the interactions of toxins 
present in the inclusion body (BenFarhat-Touzri et al., 2018; Liao et al., 2002; 
Masson et al., 1998). The applications of such knowledge would have a huge impact 
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in the development of new products in order to avoid resistance using strains with 
different protein abundance.  
6.3. Transgenic crops  
6.3.1. Bt plants resistant to lepidopteran species  
The so-called “Bt crops” are plants that have been genetically transformed 
and endogenously express insecticidal toxins from B. thuringiensis. The plant 
tissues express a soluble truncated form of the Bt protein, similar to the toxin found 
in the insect gut after enzyme cleavage, rendering these plants resistance to several 
insect pests (de Maagd et al., 1999). The first crops to be engineered with an 
insecticidal gene were tomato and tobacco plants (Barton et al., 1987; Vaeck et al., 
1987). Since then, many other crops expressing truncated delta-endotoxins have 
been tested, providing excellent protection against lepidopteran species among 
others. One of the major benefits of their use is the decreased application of wide 
spectrum pesticides in the field (Carpenter et al., 2002) which render a positive 
impact on the natural enemies of insect pests as well as other beneficial insects 
including plant pollinators (Head et al., 2001). When compared to Bt sprayable 
products, transgenic crops show a longer persistence and higher resistance rates 
to environmental conditions, including UV light or rain wash off. They constitute a 
very successful delivery system with an easy application and high efficacy, showing 
a better cost-effectiveness ratio in the short term than Bt-based insecticides (Walker 
et al., 2003).The use of Bt crops has dramatically increased since 1996 and up to 
189.8 million ha have been recorded in 2017 being soybean, maize, cotton and 
canola the most significant ones. United States leads as the country with larger 
hectares planted with transgenic crops (75 million ha), followed by Brazil (50.2 
million ha) and Argentina (23.6 million ha) (James, 2017). 
6.3.2. Bt toxicity factors used in Bt plants 
The development of insect-resistant plants expressing Cry proteins has 
permitted the control of pests of economic importance (Jouzani et al., 2017; Melo et 
al., 2016; Salehi Jouzani et al., 2008), including plant pathogenic nematodes 
(Iatsenko et al., 2014). 
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The first genetically modified plants with the insecticidal capacity of Bt 
were obtained in 1986 in the United States and France. Tobacco plants expressing 
the Cry1Ab protein from Bt subsp. kurstaki strain HD-73, under the control of the 
constitutive Cauliflower mosaic virus 35S promoter, showed promising results 
against Helicoverpa zea (Hoffmann et al., 1992) and Ostrinia nubilalis (Vaeck et al., 
1987). However, the expression levels of protein in plants were not enough for pest 
control (De la Riva and Adang, 1996; Koziel et al., 1993). In order to increase the 
levels of Cry proteins produced by Bt plants, coding sequences of cry genes were 
modified for optimal codon usage in plants and subsequent enhanced production 
(Perlak et al., 1991). Transgenic potato plants expressing cry3A, from Bt susbsp. 
tenebrionis, were the first to be commercialized to control L. decemlineata 
(Wierenga et al., 1996), performing better than sprayable Bt products (Perlak et al., 
1993).  
Since 1996 several transgenic Bt plants have been commercialized 
worldwide and allowed farmers to protect their crops from pests of economic 
importance (Christou et al., 2006). Single-gene cotton varieties which express 
Cry1Ac (e.g. Bollgard®, Monsanto) prove effective control of the tobacco budworm 
(Heliothis virescens) and the bollworm (Pectinophora gossypiella) pests (Jackson 
et al., 2003; Liao et al., 2002; MacIntosh et al., 1990; Padidam, 1992; Tabashnik et 
al., 2000). Besides, single-gene maize hybrids, which express Cry1Ab provide 
efficient for the control of the European corn borer (O. nubilalis) and the 
Southwestern corn borer (Diatraea grandiosella) (Archer et al., 2001; Castro et al., 
2004). Bt corn expressing the Cry3Bb1 toxin (e.g. YieldGard® Rootworm, Monsanto) 
has shown resistance against D. virgifera virgifera (Jakka et al., 2016; Tabashnik 
and Gould, 2012), the most economical important pest of maize in the United States 
(Gray et al., 2009). However, applications of pyrethroids have been necessary in 
some fields to control other stablished pests including fall armyworm (Spodoptera 
frugiperda), black cutworm (Agrotis ipsilon), Western bean cutworm (Richia 
albicosta) and corn earworm (Helicoverpa zea) (Bacheler et al., 1997; Buntin et al., 
2001; Burd et al., 1999; Smith, 1998) in maize, and bollworm (P. gossypiella) in 
cotton, among others (Gore et al., 2001; Stewart et al., 2001). A new transgenic Bt 
maize variety that expresses the Cry1F toxin (e.g. Herculex®), as well as being 
effective against the damage of corn stem borers also confers resistance against 
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other secondary lepidopteran pests in this crop (Catangui and Berg, 2006; Sanahuja 
et al., 2011; Siebert et al., 2008). 
One of the major concerns attributed to the systematic use of Bt plants 
has been the high probability of selection of insect biotypes that overcome the 
resistance offered by the transgenic crop. In order to delay the selection of insects 
resistant to Bt toxins and also to increase the range of controlled pests, a second 
generation of Bt plants that simultaneously express two Bt toxins has been 
developed. A Bt cotton (e.g. Bollgard® II, Monsanto) was launched in 2002 
expressing two truncated genes (cry1Ac and cry2Ab2) simultaneously provided 
better control and expanded host range (Chitkowski et al., 2003; Gore et al., 2003; 
Hagerty et al., 2005; Stewart et al., 2001). No negative interaction in the expression 
of Cry1Ac was observed when introducing Cry2Ab2 (Adamczyk et al., 2001). Bt corn 
expressing Cry1Ac along with Cry1F (e.g. Smartmax®, Monsanto) were also 
commercialized in 2005. The addition of an extra protein to Cry1Ac provided better 
control of secondary pests (Greenberg and Adamczyk, 2007; Stewart et al., 2001). 
YielGard® Plus (Monsanto), a Bt corn hybrid that expresses Cry1Ab1 and Cry3Bb1, 
was the first transgenic plant to be engineered from two already existing cotton lines 
in the market (Sanahuja et al., 2011). In 2008, Bt cotton and Bt corn varieties 
expressing Vip proteins were registered in the United States. A third generation of 
Bt cotton that produced Cry1Ab, Cry2Ab and Vip3Aa (e.g. Bollgard® 3, Monsanto) 
was introduced in 2017 with the aim of increasing the longevity of the technology as 
the binding sites are different and expected cross-resistance events are low 
(Tabashnik and Carrière, 2017). Vip1 and Vip2 proteins have shown high toxicity 
levels against D. virgifera virgifera, however their expression in plants has not been 
yet possible due to the cytotoxicity of Vip2 proteins (Chakroun et al., 2016). 
Transgenic soybean that expresses Cry1Ac and Cry1F provide excellent 
control of velvetbean caterpillar (Anticarsia gemmatalis), soybean looper 
(Pseudoplusia includens) and secondary pests such as tobacco budworm (Heliothis 
virescens) in Brazil (Bernardi et al., 2014; Marques et al., 2017). Bt rice expressing 
Cry1Ab for the control of several lepidopteran pests in China (Shu et al., 2000) and 
another expressing a chimeric gene cry1Ab/cry1Ac against the rice leaffolder, 
Cnaphalocrocis medinalis (Lepidoptera: Crambidae) and the yellow stem borer; 
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Scirpophaga incertulas (Walker) (Lepidoptera:Crambidae), have been developed 
(Tu et al., 2000). 
7. INSECT RESISTANCE TO Bacillus thuringiensis 
Bacillus thuringiensis is a high potential entomopathogen for the control 
of pests in the field. Although development of resistance was considered, at once 
unlikely, many pests have become resistant to Bt toxins. Resistance events have 
been documented for lepidopteran, coleopteran and dipteran species (Ferré and 
Van Rie, 2002), but also for nematodes (Marroquin et al., 2000). The first evidence 
of resistance to Bt was observed in 1985 in Plodia interpunctella feeding on grain 
stores treated with DiPel® (Btk) (McGaughey, 1985). Since then, several cases have 
been reported in laboratory populations (Ferre´& van Rie 2008, Chaufaux et al., 
1997; Gould et al., 1995; Rahardja and Whalon, 1995; Tabashnik, 1994). The first, 
and yet only ,report in open-field was in the diamondback moth, Plutella xylostella, 
in cruciferous plants in Asia and United States sprayed with Bt kurstaki (Ferré et al., 
2008; Liu and Tabashnik, 1997; Tabashnik et al., 1990).  
Appearance of resistance is directly related to constant exposure to 
insecticides or sometimes to the ecology of the pest. On the one hand, Helicoverpa 
punctigera is a polyphagous and migratory pest, so the chance of breeding between 
different populations dilutes resistant alleles, decreasing the possibilities to evolve 
resistance (Forrester, 1994). On the other hand, P. xylostella is not a migration pest, 
so no matting with individuals of other location occur and the pressure of selection 
of more virulent biotypes results in high levels of resistance in the field (Ferré et al., 
1991; Gelernter, 1997). 
7.1. Mechanisms of resistance 
Alterations in any of the steps of the mode of action of Bt toxins could 
result in the selection of resistant insects. Several modes of resistance of insects to 
Bt toxins have been identified under laboratory conditions: reduction of binding of 
toxin to receptors, lack of solubilization of protoxins, alteration in the proteolytic 
processing of the toxin, binding site modifications, toxin degradation or precipitation 
by proteases, cell damage regeneration (Bruce et al., 2007; Ferré and Van Rie, 
2002). Many of these mechanisms of resistance have been studied, but only 
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alteration in protease gut activity, reduced binding affinity and rapid cell replacement 
have been proved.  
Alteration in the proteolytic processing of the protoxins may be a 
consequence of absence of certain proteases in the midgut of the insect that result 
in a decreased activation rate. A resistant colony of P. interpunctella to a Btk strain 
showed resistance to Cry1Ac protoxin due to the lack of activation of the protein 
(Oppert et al., 1996) caused by absence of a major trypsin-like midgut protease 
(Oppert et al., 1997). This observation was corroborated as the insect colony 
showed higher levels of resistance to the inactivated protoxin than to the activated 
toxin (Herrero et al., 2001).  
Mutations in binding sites is the most common resistance mechanism 
responsible for the so-called “cross-resistance”. Modifications in the binding sites 
may result in different events of resistance. A decreased affinity of the toxin with the 
binding site (Ferré et al., 1991) or in a total absence of its interaction (Van Rie et al., 
1990). Also a decreased event in the number of binding sites may occur (Herrero et 
al., 2001). A resistant colony of P. interpunctella showed a decreased binding affinity 
(Kd) of Cry1Ab to its receptor in the midgut of the insect, although the number of 
binding sites (Rt) remained as in a susceptible colony (Van Rie et al., 1990). 
However, mutations in the binding sites not always affect the binding affinity. It is 
the case of Cry1Ac, which did not show affinity alterations in a resistant colony of P. 
interpunctella, although sharing at least one binding site with Cry1Ab. Post-binding 
events, like membrane insertion, may be responsible for decreased susceptibility of 
the insect to Cry1Ab (Herrero et al., 2001). In some cases, mutations in a single 
binding site may affect the affinity interactions of several proteins at once (Lee et 
al., 1995). A colony of H. virescens showed high levels of resistance to Cry1Ac, 
although no binding alterations were observed. Cry1Aa, Cry1Ab and Cry1Ac shared 
common binding sites in the midgut of the insect, and modifications in the binding 
site of Cry1Aa resulted in resistance to Cry1Ac (Van Rie et al., 1989). 
Resistant colonies of H. virescens to Cry1Ac showed similar 
histopathological changes in columnar gut cells (Forcada et al., 1999; Martínez-
Ramírez et al., 1999). However, it is suggested that resistant populations are able 
to replace or regenerate damaged cells faster than susceptible insect lines.  
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7.2. Cross-resistance 
The term “cross-resistance” is used to define the phenomenon by which 
a resistant insect to a certain toxin shows resistance to other toxins to which it has 
never been exposed (Pereira et al., 2008; Xu et al., 2010). Resistance affects both, 
Bt sprayable products and transgenic crops, as the mode of action of proteins is the 
same no matter the delivery system. That how, cases of cross-resistance in any of 
the two systems may occur, although the incidence is low.  
This phenomenon is likely to happen between insects that belong to the 
same subspecies, due to similarities in midgut receptors. Populations of O. nubilalis 
and Ostrinia furnicalis (Mutuura and Munroe, 1970), showed great similarity in 
susceptibility to Cry1 proteins, suggesting shared binding sites and mechanism of 
action of toxins (Tan et al., 2011). However, cross-resistance is not always apparent. 
This is the case of Cry1Ab and Cry1F, which although being similar, show high 
affinity for different receptors (Tan et al., 2013). Notwithstanding, studies have 
revealed that a lack of cross-resistance is expected between not-related insects or 
for Bt proteins that do not share the same binding sites, such as Cry1, Cry2 and 
Vip3 toxins (Gouffon et al., 2011; Sena et al., 2009). 
In order to study cross-resistance events, selection of resistant biotypes 
among an insect population has been achieved by feeding them on contaminated 
artificial diets (Tabashnik et al., 1992). Cross-resistance may occur between 
insecticidal proteins, usually upon the same family (Ferré et al., 1991), or even 
between Bt products. In the first case, some studies revealed that P. interpunctella 
acquired resistance to Cry1Ab and Cry1Ac after reared on Btk strain HD-1, but it 
remained susceptible to Cry1Aa, Cry1B, Cry1C and Cry2 single proteins. However, 
a wider cross-resistance event was reported when reared on Bt aizawai, including 
Cry1Aa, Cry1Ab, Cry1Ac, Cry1B, Cry1C and Cry2. The most surprising result was 
the developed resistance to Cry2, as neither of the mentioned strains produced it 
(McGaughey and Johnson, 1994). This event, although unusual, has been reported 
also elsewhere (Gould et al., 1995).  
A number of reports on the selection of resistant H. virescens biotypes to 
Cry1Ac also described the acquisition of resistance to Cry1Aa, Cry1Ab, Cry1F and 
Cry2A (Gould et al., 1995, 1992; Heckel et al., 1997; Mi Kyong Lee et al., 1995), 
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and a moderate tolerance to Cry1B and Cry1C (Gould et al., 1995). Interesting 
studies have been performed on P. xylostella using commercial Bt products that 
express a battery of proteins.(Ferré and Van Rie, 2002). Although based on the 
same active ingredient (Btk) a cross-resistance event was observed towards 
Thuricide®, but not to DiPel®. However, a 200-fold cross-resistance to Cry1F, which 
is expressed in some Bt aizawai (Bta) strains, was detected (Tabashnik, 1994). No 
evidence of resistance was reported against XenTari® (Bta), as expected (Sarnthoy 
et al., 1997). Populations of H. zea cultured on artificial diet containing Cry1Ac 
developed resistance to MVPÒ formulations (Mycogen Corporation, San Diego, CA), 
which active ingredient is composed by that single protein, but not to DiPel® or 
XenTari®, that produce several toxins (Akhurst et al., 2003). 
An important issue is that no cross-resistance has been reported between 
chemical pesticides and Bt toxins as their mode of action differ (Sarnthoy et al., 
1997). Effectivity of Bt products was not altered when tested against insect 
populations that had developed resistance to chemicals (Jespersen et al., 1990). 
7.3. Strategies to evolve resistance in transgenic plants 
The ability of insects to adapt to insecticides and the rapid evolution of 
resistance endangers the success of Bt crops (Gould, 1998; Tabashnik et al., 2013). 
In populations of insect pests, associated with Bt corn crops, resistant biotypes have 
been selected for a number of species including, including B. fusca, D. virgifera 
virgifera and S. frugiperda to Cry1Ab, Cry3Bb and Cry1F, respectively, and H. zea 
and P. gossypiella to Cry1Ac in cotton (Storer et al., 2010; Tabashnik et al., 2013). 
In order to overcome this potential problem, the Bt crop industry implemented some 
strategies. The first adopted strategy to delay the evolution of resistance to 
insecticides, was the refuge strategy (Comins, 1977; Curtis et al., 1978), which 
consist in growing a refuge of non-Bt crops in association with Bt crops in order to 
dilute the resistance alleles in the insect population by encouraging the breeding 
between resistant and non-resistant biotypes (Georghiou and Taylor, 1977). 
Although this strategy seems to be the main responsible fact for the lack of 
resistance cases for the past decades, several alternative approaches have been 
proposed to evolve resistance, such as a refuge combined with high-dose 
expression of toxins. The aim of this strategy is to kill all of the offspring from 
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mattings of susceptible and resistant insects, due to the immense quantity of 
expressed protein (Gould, 1998, 1994). Nevertheless, the most robust one seems 
to be the pyramiding strategy, in which crops express two or more insecticidal toxins 
that act independently using different mechanisms of action against the same target 
pest (Roush, 1998; Zhao et al., 2003). The base of this strategy is that the chances 
of two simultaneous mutations in the receptors for two independently acting toxins 
is much lower than this event happening against a single protein (Soberón et al., 
2009; Zhao et al., 2010). This strategy is supported by observations in the field 
where in 2009 pink bollworm developed resistance to cotton varieties expressing 
Cry1Ac but turned susceptible to another variety expressing also Cry2Ab 
(Monsanto, 2010). In this case refuges are also recommended, but the required 
proportion in the field is smaller (Shelton et al., 2002). In the past decade the 
expression of fusion proteins has become a promising alternative. A certain 
approach, by combining toxins with fragments of their specific receptors, allowed 
toxins to directly assemble for immediate pore formation, enhancing the activity of 
the protein (Chen et al., 2007). This new tendency allowed to broaden the spectrum 
of hosts by using a truncated version of two proteins. In order to confer protection 
to potato plants against various pests of different orders, Cry3Ba was fused with 
domain II of Cry1Ia. The resulting fusion protein was efficient for the control of 
Leptinotarsa decemlineate (Coleoptera; Chrysomelidae), Phthorimaea operculella 
(Lepidoptera; Gelechiidae ) and O. nubilalis, simultaneously (Naimov et al., 2003). 
Research on the interaction of proteins and their binding sites showed no activity for 
individual toxins unless applied together. It is the case of Cry3A and Cry1Ab, which 
are not suitable for the control of D. virgifera virgifera as they show no toxicity to the 
pest when supplied as single proteins. However, the construction of a hybrid toxin 
that combined both of them, the so-called eCry3.1Ab, surprisingly resulted to be 
very effective against these coleopteran species (Walters et al., 2010). Although Bt 
gene expression in GM crops have resulted in multiple benefits in terms of cultivar 
yields and pest control, it is important to assure long-term usefulness of Bt crops, 
deploying appropriate strategies to delay resistance.  
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8. INSECT TARGET PESTS 
8.1. Taxonomic position and geographical distribution of Spodoptera species 
The beet armyworm, Spodoptera exigua, (Hübner, 1808), the cotton leaf 
worm Spodoptera littoralis (Boisduval, 1833) and the fall armyworm, Spodoptera 
frugiperda (J.E. Smith 1797) are among the most economically important species in 
the genus Spodoptera (Lepidoptera, Noctuidae). Most species of this genus (e.g. S. 
exigua and S. frugiperda) can make migratory flights of thousands of kilometers, 
which explains their wide geographical distribution (Zheng et al., 2011a). S. exigua 
is found in temperate zones and subtropical regions, extending all over the Asian 
countries, Europe, South and Central America and New Zeland (Brown and 
Dewhurst, 1975; Zheng et al., 2011b). S. littoralis is present in practically the entire 
African continent and the countries that make up the Mediterranean coast, with a 
limited northern distribution attributed to low winter temperatures (Miller, 1976; 
Sidibe and Lauge, 1977). Traditionally, the distribution area of S. frugiperda has 
been limited to the western hemisphere, all over the United States, north to southern 
and eastern Canada and south to Argentina (Pogue, 2002). Unexpectedly, this pest 
has recently invaded the African continent,  where outbreaks were recorder for the 
first time in 2016 (Goergen et al., 2016). Currently, it is also present in India and 
China and all the favourable conditions are present for it to be able to invade and 
establish itself in the countries of the European Union. 
8.2. Biology of Spodoptera species 
Species of the genus Spodoptera have a complex metamorphosis 
(holometabolous) and complete four stages of development during their biological 
cycle: adult, egg, larva and pupa. Under optimal environmental and nutritional 
conditions, most of these species complete their biological cycle in approximately 4 
weeks. All of them are multi-volt species so, each year, they can complete up to 6-
8 generations in the most favourable natural conditions. 
8.2.1. Egg 
Spodoptera species lay their eggs on the lower surface of the leaves in 
clusters usually distributed in different plants to ensure the survival of newly hatched 
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larvae. Eggs of S. exigua and S. frugiperda measure about 0.45 and 0.35 mm in 
width and height, respectively, and are usually laid in groups forming one or two 
layers. However, S. littoralis females lay spherical flattened eggs of 0.6 mm in 
diameter. Eggs are usually covered with brownish-yellow hairs and scales that 
protect the eggs from natural enemies. Normal egg production is about 300-600 per 
female in S. exigua, from 1000 to 3500 in S. littoralis and about 1500-2000 in the 
case of S. frugiperda. The newly laid eggs are light colored and darken as the 
embryonic development progresses which is completed in 2-3 days under optimal 
conditions of temperature (26 ± 1 °C) and relative humidity (70 ± 5%) (Peterson, 
1964; Pinhey, 1975).  
8.2.2. Larval stage 
Spodoptera larvae develop from five (S. exigua) to six (S. littoralis and S. 
frugiperda) instars. The passage from one larval instar to the next is carried out by 
replacing the cuticle with a new one, which is a process regulated by the juvenile 
hormone and ecdysone. The different larval stages, of a specific species, can also 
be recognized by the biometric characteristics of their cephalic capsule. First instars 
present a gregarious behaviour, while mature individuals are mainly solitary. S. 
exigua larvae normally have five instars, although an additional instar is sometimes 
reported, that vary in colour from pale green to yellow. As they mature larvae 
become darker and develop dorsal stripes. Neonates are 1.5 mm in size and grow 
up to 25-30 mm in the fifth instar (Figure 8).  
 
 
 
 
 
Figure 8. Fifth instars of S. exigua (A), S. littoralis (B) and S. frugiperda (C) 
A B C 
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No spines or hairs are adverted in their body. S. littoralis larvae normally 
have six instars which are variable in colour, from blackish-grey to dark green. A 
longitudinal dark and light stripe is developed in latter instars (Bishara, 1934; Brown 
and Dewhurst, 1975), where individuals can grow up to 40-45 mm in length (EPPO 
Bulletin, 2015). S. frugiperda individuals normally have six instars and vary in colour 
form light green with black lines and spots to dark brown with black dorsal and 
longitudinal stripes. An inverted yellow Y-shape on the head and four black spots 
on the last abdomen segment are differential characteristics in latter instars, which 
can reach up to 45 mm in size (Crumb, 1956; Levy and Habeck, 1976). 
8.2.3. Pupa stage 
Once larvae reach an appropriate length form a pupa. Pupae of 
Spodoptera species are shorter than larvae with a cylindrical shape, measuring 
about 15-22 mm, and usually have a dark reddish-brown color. All three species 
present a cremaster of 2 spines in the last segment, with two short extra hooks in 
the case of S. exigua (Figure 9). However, morphological similarities between 
species do not permit to differentiate S. exigua, S. littoralis and S.frugiperda until 
emergence of adults. The development period of this stage lasts between 6 to 9 
days during warm weather but can extend up to 30 days during cooler seasons. 
Pupation normally occur in the soil (Pinhey, 1975; Pitre and Hogg, 1983; Zheng et 
al., 2011a). 
 
 
 
 
 
Figure 9. Pupa individuals of S. exigua (A), S. littoralis (B) and S. frugiperda (C). 
A B C 
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8.2.4. Adult 
When adults emerge depending on the season they may migrate to warm 
regions for breeding (Feng et al., 2003). The adults of S. exigua are greyish moths 
with a wing span of 25-30 mm (Figure 10). Hindwings are white with dark veins. S. 
littoralis are grey-brown moths with a wing span of 30-38 mm and greyish-white 
hindwings with lack dark veins. In the case of S. frugiperda moths have a wing span 
of 37-38 and silver-white hindwings (Figure 10) (EPPO Bulletin, 2015). Adults life is 
estimated between 10 to 20 days in average (Sparks, 1979). 
 
 
 
 
 
 
 
 
Figure 10. Adult individuals of S. exigua (A), S. littoralis (B) and S. frugiperda (C). 
8.3. Economic damage  
Spodoptera species are naturally polyphagous pests that are primary and 
secondary pests of a huge number of crops such as tomato, corn, cotton, tobacco, 
strawberry, cabbage or alfalfa. Among the different stages of the pest it is the larvae 
the ones that cause the damage, and the greater the instar the greater the economic 
impact. The beet armyworm S. exigua is a major pest of vegetables and flower crops 
worldwide that can have an important economic effect on crop production. It feeds 
on more than 50 crops including tomato (Solanum lycopersicum), lettuce (Lactuca 
sativa), cotton (Gossypium spp.) or tobacco (Nicotiana tabacum). It is a major pest 
of greenhouse sweet pepper (Capsicum annuum), aubergene (Solanum 
melongena) and melon (Cucumis melo) in Spain, among others (Moreno et al., 
1992). This pest may cause holes in lettuce and tomatoes that lead to rotten 
producing a negative influence in crop yields. The cotton leafworm S. littoralis, 
affects more than 84 crops of economic importance (Salama et al., 1970). This pest 
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causes a considerable damage on cotton plants by feeding on the leaves and flower 
buds, but also affects tomato, maize, alfalfa and vegetables. Nowadays it causes 
important economic damages in Italy, Spain, Malta, Morocco, Cyprus, Egypt, North 
Africa and Israel. The fall armyworm, Spodoptera frugiperda (J. E. Smith) is the most 
destructive pest of maize (Zea mays) in America (Barros et al., 2010). This 
polyphagous pest also damages sorghum (Sorghum bicolor), rice (Oryza sativa L.), 
soybean (Glycine max L.) and causes defoliation of cotton plants (Gossypium spp.) 
(Ali and Luttrell, 1990). Severe infestations occur in Brazilian crops as this species 
may have up to eight generations per year (Fitt et al., 2006; Pogue, 2002). In Brazil 
S. frugiperda outbreaks result in a huge investment in insecticides and yield losses 
of more than $250 millions every year. Its recent invasion of Africa has caused 
greater crop damages than any other African Spodoptera species (IITA, 2016).  
8.4. Control Methods 
Several methods have been used to control Spodoptera pests in the field. 
Application of conventional chemical insecticides, including methomyl, cypermethrin 
and carbaryl have been used to regulate the population density of the Spodoptera 
species that habitually or occasionally exceed the economic threshold of damage in 
the different crops in which they occur (Liburd et al., 2000). However, the repetitive 
use of the latter products have exerted tremendous selective pressure on insect 
populations which has led to the selection of resistant biotypes in many of the natural 
populations of these three species of Spodoptera (Devine and Furlong, 2007). B. 
thuringiensis toxins are one of the best alternative control agent to chemical 
insecticides due to their high specificity (Roh et al., 2007; Schnepf et al., 1998). Bt 
insecticides are undoubtedly the most used control agent among insecticides of 
microbial origin for the control of these pests (Jain et al., 2008). Also the use of 
transgenic plants with the insecticidal capacity of Bt (Bt crops) currently represent 
the preferred alternative in the case of some pests (e.g. S. frugiperda) in extensive 
crops (e.g. maize and soybean). (Kumar et al., 2008).  
Several studies have been carried out in order to determine which specific 
toxins are responsible for toxicity among Spodoptera species. Cry1A is the most 
common protein in natural Bt strains and has been widely used in transgenic plants, 
however it has reported low efficacy. Bt strains expressing Cry1Bb, Cry1Ca, 
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Cry1Da, Cry1Fa, Vip3Ab, Vip3Ae and Vip3Af have proven to be the best candidates 
in order to control the genus Spodoptera (Hernández-Martínez et al., 2013, 2008; 
Ruiz De Escudero et al., 2007; Van Frankenhuyzen, 2009). As a matter of fact, 
sprayable products based on Bacillus thuringiensis subsp. aizawai have been 
commercialized worldwide due to their effectiveness. Xentari® is a registered Bt-
based biopesticide for the management of Spodoptera spp. whose active ingredient 
is composed by several Cry1 proteins (Cry1Aa, Cry1Ab, Cry1Ca and Cry1Da) 
responsible for toxicity against the beet armyworm, the cotton leafworm and the fall 
armyworm, among others (Akhurst et al., 2003; Basedow et al., 2008; Bioscience, 
2009; Gonçalves et al., 2018). Transgenic crops, like Bt maize or Bt cotton, have 
also been commercialized as a control method, and have provided promising results 
during the first years by expressing Cry1 toxins (BenFarhat-Touzri et al., 2016; 
Hernández-Martínez et al., 2008; Okumura et al., 2013; Sena et al., 2009; Sorgatto 
et al., 2015). However, low expression of proteins, along with reduced refuges and 
high rates of pressure of selection, have favoured the appearance of resistant 
populations (Farias et al., 2014; Horikoshi et al., 2019; Storer et al., 2010; Tabashnik 
and Carrière, 2017). The selection of resistant S. frugiperda biotypes and the 
increase of their relative proportion, in the populations of the insects exposed to 
transgenic crops, leads to a continuous loss of the protection originally offered by 
the Bt crop that ends up being ineffective to control the pest .The efficacy of Bt crops 
has decreased and cases of cross resistance among proteins expressed in plants, 
such as Cry1F, Cry1Ab, and Cry1Ac, and those contained in Bt commercial 
products have been reported (Burtet et al., 2017; Federici, 1998; Santos-Amaya et 
al., 2015). ). These events reduce the options for organic farmers who usually use 
Bt products for pest control (Jakka et al., 2014) and cultivars yield would decrease, 
pushing farmers to return to broad spectrum chemical insecticides with fatal 
consequences (Federici, 1998).  
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9. AIMS OF THE THESIS 
 
The main aims of this thesis are: 
1. Development of a genomic and proteomic based method capable to 
determine the qualitative and quantitative composition of toxic factors 
present in the parasporal crystal of Bacillus thuringiesis strains and its 
application to commercial Bt-based products. 
2. Design of new artificial mixtures containing the appropriate insecticidal 
components to increase the potency and expand the host range of the 
spore and crystal mixture. 
 
In order to accomplish the main aims of the thesis, the following specific aims will 
be addressed: 
1. Development of an analytical method to determine the composition of delta-
endotoxins (Cry and Cyt) that make up the parasporal crystal of the Bt 
strains used as active ingredients in commercial Bt products. 
2. Generate knowledge concerning the effect of each of the insecticidal 
components of a Bt strain on phytophagous species of agricultural 
importance. 
3. Determine the relative proportion of crystal components that allow the 
improvement of the insecticidal potency for one or more phytophagous 
lepidopteran species that cause pests. 
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CHAPTER II 
 
 
Unravelling the composition of insecticidal 
crystal proteins in Bacillus thuringiensis by 
genome sequencing and mass spectrometry  
Abstract 
Bacillus thuringiensis (Bt) is the most widely used active ingredient of 
biological insecticides. The composition of d-endotoxins (Cry and Cyt proteins) in 
the parasporal crystal determines the toxicity profile in each Bt strain. However, a 
reliable method for their identification and quantification has not been available, due 
to the high sequence identity of the genes coding for the d-endotoxins and the toxins 
themselves. Here we have developed an accurate and reproducible mass 
spectrometry-based method (LC-MS/MS-MRM), using isotopically-labelled 
proteotypic peptides for each protein in a particular mixture, to determine the relative 
proportion of each d-endotoxin within the crystal. To validate the method, artificial 
mixtures containing Cry1Aa, Cry2Aa and Cry6Aa were analyzed. Determination of 
the relative abundance of proteins (in molarity) with our method was in good 
agreement with the expected values. This method was then applied to the most 
common commercial Bt-based products: DiPel® DF, Xentari® GD, Vectobac® 12S 
and Novodor® in which between 3 and 6 d-endotoxins were identified and quantified 
in each product. This novel approach is of great value for the characterization of Bt-
based products, not only providing information on host range toxicity, but also for 
monitoring industrial crystal production and quality control of Bt-based insecticides. 
 
This chapter will be submitted to Applied and Environmental Microbiology as: 
Caballero J, Jiménez-Moreno N, Orera I, Williams T, Fernández AB, Villanueva 
M, Ferré J, Caballero P & Ancín-Azpilicueta C. 2019. Unravelling the composition 
of insecticidal crystal proteins in Bacillus thuringiensis by genome sequencing and 
mass spectrometry.
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1. INTRODUCTION 
For decades, the bacterium Bacillus thuringiensis (Berliner) has been the 
most important biological insecticide for crop protection. Its specificity and 
ecotoxicological profile have been key to its development as an alternative to 
synthetic pesticides. The world biopesticide market is currently valued at three billion 
dollars annually (Olson, 2015). Three-quarters of all biopesticides are Bacillus 
thuringiensis (Bt)-based products, which are among the safest and most 
environmentally-benign insecticides available (Raymond and Federici, 2017; Siegel, 
2001). 
Bt produces large parasporal crystals during sporulation. These crystals 
consist of various d-endotoxins, mostly Cry proteins, and, in some Bt strains, 
cytotoxic Cyt proteins (Palma et al., 2014). The Cry proteins are cleaved in the insect 
gut by host proteinases, which give rise to 65–70-kDa activated toxins that form 
pores in the columnar cell brush border membranes, leading to the disruption of ion 
and metabolite transport, and insect death (Bravo et al., 2007). Cyt proteins also 
undergo activation of protoxins (27kDa) by proteolytic cleavage in the insect gut to 
produce an activated toxin of 25 kDa, which interacts directly with non-saturated 
membrane lipids (Li et al., 1996). In many Bt strains, Cry and Cyt proteins are very 
similar, with 86–90% shared amino acid identity in some cases, such as in the well-
known Bt-kurstaki strain HD1. Nevertheless, small sequence differences in the 
critical regions of these proteins are responsible for pronounced differences in the 
insecticidal potency and effective range of target species (Bravo, 1997). A large 
number of cry and cyt genes have been cloned, expressed, and shown to encode 
proteins with specific insecticidal activity against pests from the orders Lepidoptera, 
Diptera, Coleoptera, and Hymenoptera, as well as other invertebrates, such as 
nematodes and mites (Van Frankenhuyzen, 2009).  
Historically, Bt strains have been classified based on the serological 
characteristics associated with the bacterial flagellar antigen (H) into more than 60 
serotypes (H serotypes) and over 80 serological varieties (serovars, also known as 
subspecies), with broadly different cry gene profiles and insecticidal activity spectra 
(Ibrahim et al., 2010). In the absence of any other classification method, the 
insecticidal spectrum of a Bt strain and its potential industrial applicability was 
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frequently presumed based on the serological characteristics. In the past, this 
classification was useful. For example, many Bt strains toxic to lepidopterans belong 
to serovar kurstaki or aizawai (Palma et al., 2014), strains toxic to mosquito larvae 
often belong to serovar israelensis (Floore, 2006), and strains active against 
coleopterans often belong to serovar morrisoni (Kati et al., 2007). However, many 
new Bt strains not belonging to these serovars have also shown to have insecticidal 
activity against these orders of insects. Moreover, classification into a specific 
serovar does not guarantee the presence of a specific set of cry genes or their 
expression (Porcar and Juárez-Pérez, 2003). In part because the serovar system 
does not provide reliable information on the insecticidal spectrum of a given strain, 
this classification system is now considered obsolete. 
Advances in DNA technologies allow Bt strains to be easily characterized 
according to their cry and cyt gene content (Ye et al., 2012). Characterization of the 
d-endotoxin gene content is useful for strain classification, but of limited predictive 
value, as it is the expression of these genes what determines the spectrum of activity 
of a given strain. There are many cry and cyt genes that are cryptic, or with 
insignificant levels of expression, that contribute little to the toxicity of a given strain. 
Therefore, identification of the insecticidal proteins that make up the parasporal 
crystal is essential to infer the insecticidal activity of a particular strain or to 
understand why production batches of a Bt-based insecticide vary in their toxicity 
characteristics. 
To date, attempts to quantify the d-endotoxin content of Bt strains have 
relied on reverse-phase high performance liquid chromatography (RP-HPLC) of 
urea-denatured and trypsinized proteins (Yamamoto, 1983), or ion-exchange liquid 
chromatography at constant pH applied to alkaline-digested peptides (Pusztai-
Carey and Carey, 1994). However, neither of these techniques can be used to 
reliably distinguish proteins with similar amino acid sequences, such as some Cry 
proteins, or those present at low concentrations. An alternative approach involves 
HPLC analysis of semi-trypsinized crystal protein preparations (Masson et al., 
1998). Nonetheless, the partial digestion used by these authors is not effective for 
differentiating among proteins with a high degree of similarity, commonly present in 
the crystals produced by many Bt strains.  
CHAPTER II 
 92 
Due to the difficulties faced in the identification and quantification of the 
different Cry and Cyt proteins in a mixture, commercial Bt-based bioinsecticides 
currently include no description of the composition of the active ingredients - their 
characterization is based entirely on their potency against a reference insect 
species, in comparison with an international Bt standard (Dulmage et al., 1971). A 
major disadvantage of such bioassay-based characterization is that the potency of 
a Bt preparation depends on the insect species tested, notwithstanding the 
individual and population variation in susceptibility that affect the results of 
bioassays. Furthermore, the susceptibility of an insect species cannot be 
extrapolated to other insect species. For example, within the lepidopteran family 
Noctuidae, heliothine species are very susceptible to the Cry1Ac protein, whereas 
species of the genus Spodoptera are usually very tolerant (Bernardi et al., 2014). 
Recent advances in the field of proteomics now allow the quantitative 
characterization of proteins in a mixture. Specifically, the use of liquid 
chromatography coupled to mass spectrometry (LC-MS/MS), in combination with 
multiple reaction monitoring (MRM), allows the precise analysis of complex samples 
in which each component differs by one or more proteotypic peptides (peptides 
generated by a protease treatment and that are unique to a given protein), charge 
and hydrophobicity (Gallien et al., 2011). Indeed, the targeted nature of MRM, its 
high selectivity and wide dynamic range render this technique ideal for quantitative 
proteomics, especially when combined with known quantities of stable isotope-
labelled (SIL) synthetic peptides (Holman et al., 2012; Lange et al., 2008). The 
process, by which a triple quadrupole mass spectrometer operates in an MRM 
assay to provide a highly sensitive, specific and cost-effective analysis, is shown 
schematically in Figure 1. 
Here we describe a novel LC-MS/MS-MRM technique that, for the first 
time, allows reliable quantitative determination of the components of insecticidal 
crystals of Bt strains. Following verification using artificial mixtures of Cry proteins, 
we applied the technique to four Bt-based products (Dipel® DF, Xentari® GD, 
Vectobac® 12S and Novodor®) that are widely used for the control of lepidopteran, 
dipteran and coleopteran pests. The method is rapid, accurate and more 
reproducible than the previous analytical techniques developed for this purpose. 
This technique will also enable improved monitoring of the production processes,  
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Figure 1. Diagram representing the operation of a triple quadrupole mass spectrometer in an 
MRM assay. First, peptides are filtered in the first quadrupole (Q1) according to the mass to 
charge ratio (m/z) of the precursor ion. In the collision cell (second quadrupole or Q2), 
peptides are fragmented by collision-induced dissociation using nitrogen as the collision gas. 
Finally, predefined peptide-specific fragments are selected in the second mass filter (third 
quadrupole or Q3), which is followed by measurement of the intensity of the transitions. 
Transitions are the precursor/product ion pairs, and several transitions are monitored over 
time for each peptide. *LC-ESI, liquid chromatography coupled to electrospray ionization. 
particularly for the optimization of fermentation conditions, control of batch variation, 
and production of Bt-based products with high potency. It will also provide 
phytosanitary product registration authorities with precise information on the 
composition of Bt-based crop protection products. 
2. MATERIAL AND METHODS 
2.1 Bt recombinant strains expressing a single Cry protein  
Three recombinant Bt BMB171 strains, each producing either Cry1Aa, 
Cry2Aa, or Cry6Aa, were obtained from Dr. Colin Berry, University of Cardiff, UK. 
Luria-Bertani (LB) medium was used to grow the samples that were incubated at 28 
ºC overnight. A single colony of each strain was isolated and grown in 50 ml of CCY 
medium (Stewart et al., 1981), enriched with mineral salts and pH adjusted to 7.5. 
Erlenmeyer flasks were used for the 96 h incubation in a shaker-incubator (New 
BrunswickTM Innova 42R) at 28 ± 1 ºC and 200 rpm. NaCl-EDTA was added in order 
to obtain a 1 M - 10 mM suspension before centrifugation at 15,000´g for 10 min. 
The resulting pellet was washed twice in cold 1M NaCl, six times in cold Milli-Q 
water and finally resuspended in 1.5 ml of 10 mM KCl.  
 
Q1 
N2 
Q2 Q3 
LC-ESI* 
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2.2 Purification of parasporal crystals 
Crystals were purified from the mixture by ultracentrifugation in a 
discontinuous sucrose gradient, as previously described (Thomas and Ellar, 1983). 
Briefly, the spore-crystal mixture was sonicated for 20 s using a Soniprep 150 MSE 
apparatus (Curtin Matheson Scientific, Houston, TX), and immediately loaded onto 
a two-layer sucrose gradient composed of 16 ml of 67% (w/v) sucrose solution and 
16 ml of 79% (w/v) sucrose solution. After centrifugation at 70,000´g for 16 h 
(OptimaTM L-100 XP Beckman Coulter, rotor SW 32 Ti), the interphase containing 
the crystals was recovered using a Pasteur pipette, mixed with sterile Milli-Q water 
to a final volume of 50 ml, and centrifuged again (15,000´g, 15 min). This step was 
repeated twice, and the crystal pellet was finally resuspended in 1 ml of sterile Milli-
Q water. Crystal purity was assessed using phase-contrast microscopy (Zeiss AX-
10) under 1000´ magnification using immersion oil (data not shown).  
2.3 Polyacrylamide gel electrophoresis of Bt crystal proteins  
A 100 µl volume of purified crystals was solubilized in 500 µl of a solution 
of 50 mM Na2CO3 (pH 11.3) and 10 mM dithiothreitol (DTT) by gentle agitation for 2 
h at 28 ºC. Unsolubilized crystals were removed by centrifugation at 9000´g for 10 
min at 4 °C. Aliquots (10 µl) of the solubilized proteins in the supernatant, and of the 
spore and crystal mixture, were then resolved by 10% SDS-PAGE (100:1 
acrylamide/bis-acrylamide ratio) at 50 mA for 1 h using a mini-Protean III apparatus 
(Bio-Rad, Hercules, CA). The gels were stained with 50% (v/v) ethanol, 10% (v/v) 
acetic acid, and 0.1% (w/v) Coomassie brilliant blue R250 for 40 min, and then 
destained in a solution of 6.75% (v/v) glacial acetic acid and 9.45% (v/v) ethanol. 
Protein mass-band patterns were determined by comparison with a broad-range 
protein marker (Precision Plus ProteinTM Dual Color Standards, Bio-Rad). 
2.4 Protein quantification and tryptic digestion of Cry proteins 
The concentration in the supernatant of the solubilized proteins was 
determined by the Bradford assay (Bradford, 1976) using bovine serum albumin as 
a standard in order to perform a tryptic digestion of the Cry proteins sample. 
Preliminary tests were performed to establish the appropriate digestion protocol for 
crystal proteins, with urea or RapiGest SF (Waters Corp., Milford, MA) as the 
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denaturant, followed by one or two-steps of trypsin digestion (data not shown). The 
following optimal protocol was established. For protein denaturation, 10 µl of 
denaturing buffer (6 M urea and 100 mM Tris, pH 7.8) was added to previously 
evaporated crystal samples (protein content of approximately 30 µg). Cysteines 
were then reduced with 25 mM (final concentration) DTT for 30 min at 37 °C and 
alkylated with 70 mM (final concentration) iodoacetamide for 30 min in the dark. 
Unreacted iodoacetamide was neutralized by the addition of 6 µl of the reducing 
agent DTT and incubated for 30 min at room temperature. The samples were then 
diluted with 75 μl of 50 mM ammonium bicarbonate so that the final concentration 
of urea was below 1 M. Digestion was then performed at 37 °C overnight with trypsin 
(Gold Trypsin, Promega, Madison, WI), at an enzyme:protein weight ratio of 1:20. 
The reaction was stopped by adding 1 µl of concentrated formic acid (Sigma Aldrich, 
Saint Louis, MO). Two independent tryptic digestions were performed for each 
sample. 
2.5 Preparation of artificial mixtures of Cry proteins  
Two mixtures of Cry proteins were prepared in order to validate the MS-
based Cry protein quantification method. In mixture 1, equal molar amounts of each 
Cry protein were combined (equivalent to a percentage composition of 33.3% each 
of Cry1Aa, Cry2Aa, and Cry6Aa). In mixture 2, Cry1Aa, Cry2Aa, and Cry6Aa were 
combined in a molar ratio of 13:4:13, respectively (equivalent to a percentage 
composition of 43.3% of Cry1Aa, 13.3% of Cry2Aa, and 43.3% of Cry6Aa). Each 
mixture was trypsinized in duplicate, as described in section 2.4. and then analyzed 
by LC-MS/MS-MRM. 
2.6 Protein identification by LC-MS/MS and in silico digestion 
Proteins were identified using a nano-LC system (Tempo MDLC, AB 
Sciex, Framingham, MA) coupled to a hybrid triple quadrupole/linear ion trap mass 
spectrometer (4000 QTRAP, AB Sciex). After pre-column desalting, the tryptic 
digests were separated on a C18 column (Thermo Scientific, Waltham, MA) at a 
flow rate of 300 nl/min, with a 90-min linear gradient from 5 to 35% acetonitrile in 
0.1% formic acid. The mass spectrometer was interfaced with a nanospray source 
equipped with an uncoated fused silica emitter tip (20-µm inner diameter, 10 µm tip; 
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NewObjective, Woburn, MA) and was operated in the positive ion mode. The MS 
source parameters were as follows: capillary voltage, 2800 V; source temperature, 
150 °C; declustering potential, 110 V; curtain and ion source gas (nitrogen), 20 psi; 
and collision gas (nitrogen) set to high. Analyses were performed using an 
information-dependent acquisition (IDA) method, as follows: single enhanced mass 
spectra (400–1400 m/z) were acquired and the eight most intense peaks were 
automatically chosen by the mass spectrometer and subjected to an enhanced 
product ion scan. Proteins were identified by using the search engine Mascot 
(version 2.3, Matrix Science, Boston, MA) to examine the deduced amino acid 
sequences of the Cry proteins predicted from the genome sequence. The database 
used for Mascot searches was built in-house. The following search parameters were 
used: one missed cleavage; carbamidomethylation of cysteines as a fixed 
modification; 0.5 Da peptide mass tolerance; and 0.3 Da fragment mass tolerance. 
Two separate LC- MS/MS analyses were performed for each digestion. 
An in silico trypsin digestion of the predicted Cry protein sequences was 
performed using MS-Digest, a bioinformatics tool in the software package “Protein 
Prospector” of the University of California San Francisco 
(www.prospector.ucsf.edu/prospector/mshome.htm).  
2.7 Synthesis of SIL peptides for protein quantification 
SIL peptides, synthesized by a stepwise solid-phase peptide synthesis on 
an automated peptide synthesizer (Multipep, INTAVIS Bioanalytical Instruments, 
Köln, Germany), were obtained from the Proteomics Facility of the National 
Biotechnology Center (CNB, Madrid, Spain). Amino acid polymerization was 
performed using standard N-(9-fluorenyl) methoxycarbonyl (Fmoc) chemistry and 
PyBOP/n-methylmorpholine as coupling activation reagents. Fmoc-derivatized 
amino acid monomers were obtained from Merck (San Luis, MO). L-Lysine (13C6; 
15N2)- and L-arginine (13C6; 15N4)- preloaded 2-chlorotrityl resins (Cambridge 
Isotope Laboratories, Tewksbury, MA) were used as a solid support. Once 
synthesized, the peptides were cleaved from the resin using a scavenger-containing 
trifluoroacetic acid-water cleavage solution and precipitated by the addition of cold 
ether. Crude peptides were purified by HPLC (Jasco PU-2089) equipped with a 
semi-preparative Kromasil C18 column (Teknokroma, Barcelona, Spain). Purity and 
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labelling efficiency were analyzed by mass spectrometry using a MALDI-TOF/TOF 
4800 instrument (AB Sciex) and freeze-dried. 
Prior to quantification, SIL peptides, isotopically labelled with either 
(13C6,15N2) lysine (+8 Da) or (13C6, 15N4) arginine (+10 Da), were reconstituted in 
30% acetonitrile and 1% formic acid for a 5 nmol/µl stock solution. The stock solution 
was further diluted with 2% acetonitrile and 0.1% formic acid, as required.  
2.8 Protein quantification by Multiple Reaction Monitoring (MRM) 
The development of MRM methods and protein quantification were 
performed using Skyline (version 4.2.0.19009, MacCoss Lab Software, Seattle, 
WA). In MRM assays, the first quadrupole (Q1) acts as a m/z filter of the precursor 
ion of the different peptides, and after the fragmentation in the collision cell (Q2), 
predefined product ions are selected in the second mass filter (Q3). The 
precursor/product ion pair is called transition (Figure 1). Five transitions were 
selected for most peptides based on the intensity of y- or b- fragment ions in the 
MS/MS spectra obtained in the LC-MS/MS analysis described in section 2.6. MRM 
analyses were conducted using the nano-LC system (AB Sciex) coupled to the 
4000QTRAP mass spectrometer (AB Sciex) with the chromatographic and source 
parameter settings as those described in section 2.6. MRM transitions for each 
peptide were recorded with a dwell time of 20 ms. Collision energies were 
automatically computed using the embedded rolling collision energy equations of 
the Skyline software. To confirm the identity of peptides, an MRM-initiated detection 
and sequencing (MIDAS) experiment was performed for each peptide. The mass 
spectrometer was instructed to switch from MRM to enhanced product ion scanning 
mode when an individual MRM transition signal exceeded 2000 counts. MS/MS data 
were analyzed using an in-house Mascot server (v 2.3). The data were compared 
against data deposited in the corresponding in-house database. 
For stable isotope dilution, 20–2000 fmoles of SIL peptides (depending 
on the signal intensity of the endogenous peptide) were spiked into trypsin-digested 
Cry protein samples. To quantify the tryptic peptides in the Cry samples, the sum of 
the transition signal intensities of the endogenous peptides was calculated in 
reference to the sum of the transition intensities of the SIL peptides. 
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2.9 Purification of Bt crystals from Bt-based insecticides 
The crystals of Bt-kurstaki ABTS-351 and Bt-aizawai ABTS-1857 were 
recovered directly from water dispersible granules of the commercial products 
DiPel® DF (Kenogard, Valent BioScience corporation, Barcelona, Spain; 
manufacturing batch 261-355-PG; manufactured in January 2016) and XenTari® GD 
(Kenogard; manufacturing batch 261-355-PG; manufacture in January 2016), 
respectively. Similarly, the crystals of Bt-israelensis AM65-52 and Bt-tenebrionis 
NB-176 were recovered directly from suspension concentrate formulations of the 
commercial products VectoBac® 12AS (Kenogard; manufacturing batch 276-006; 
manufactured in April 2017) and Novodor® (Kenogard; manufacturing batch 272-
803-PG; manufactured in December 2016), respectively. In all cases, a sample of 1 
g (solid formulations) or 1 ml (liquid formulations) was taken and washed six times 
in cold Milli-Q water by centrifugation at 15,000´g for 10 min. The final pellet was 
resuspended in 1 ml of 10 mM KCl and parasporal crystals were then purified as 
described in 2.2 section. 
2.10 Total DNA extraction, genome sequencing and computational analysis 
Bt strains ABTS-351, ABTS-1857, AM65-52, and NB-176 were directly 
isolated from the commercial products DiPel® DF, XenTari® GD, VectoBac® 12AS 
and Novodor®, respectively. Each bacterial strain was grown at 28 °C for 12 h in 5 
ml of sterile CCY medium (Stewart et al., 1981). Total DNA (chromosomal and 
plasmid DNA) was extracted from vegetative cells following the protocol for DNA 
extraction from Gram-positive bacteria supplied in Wizard® genomic DNA 
purification kit (Promega, Madison, WI). Purified DNA samples were used for the 
preparation of DNA libraries and were sequenced using an Illumina NextSeq500 
Sequencer (Genomics Research Hub Laboratory, Cardiff University, UK). The 
resulting reads were assembled using CLC Genomic Workbench 10.1.1 (Qiagen, 
Hilden, Germany) with the de novo assembly tool. Contigs were then analyzed using 
BLASTp (Altschul et al., 1990) against a custom insecticidal toxin database 
constructed using insecticidal protein sequences obtained from the GenBank of the 
National Center for Biotechnology Information (NCBI)  and the BtToxin-scanner (Ye 
et al., 2012).  
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2.11 Determination of the relative proportion of Cry and Cyt proteins in Bt 
commercial products 
Protein quality and band patterns were analyzed as described in section 
2.3, and quantification and tryptic digestion of the purified crystals was performed 
(see section 2.4). Protein identification was achieved by LC-MS/MS analyses and 
in silico trypsin digestions were then performed using the amino acid sequences of 
the proteins identified by IDA analysis (see section 2.6) of Bt strains ABTS-351, 
ABTS-1857, AM65-52, and NB-176; SIL peptides were synthesized and prepared 
prior to quantification (see section 2.7); finally, MRM analyses were performed as 
described in section 2.8 to quantify the protein content of each commercial product. 
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3. RESULTS 
3.1 Validation of the LC-MS/MS-MRM method by analysis of artificial Cry 
protein mixtures 
For the initial validation of the LC-MS/MS-MRM technique, two protein 
mixtures containing Cry1Aa, Cry2Aa, and Cry6Aa were examined. The three 
proteins were identified in both Cry protein mixtures via proteotypic peptide 
detection (Figure 2 and Supplemental material, Table S1).  
Figure 2. Schematic overview of the targeted proteotypic peptide in three Cry proteins present 
in known amounts in artificial mixtures used for LC-MS/MS-MRM method validation. These 
peptides were detected in the IDA analysis and checked against in silico digestion results of 
the artificial protein mixture. Two proteotypic peptides were used to identify Cry1Aa and 
Cry6Aa, and three to identify Cry2Aa. The location of the proteotypic peptides (orange bands) 
within full-length proteins (blue bars) are shown, with different letter corresponding to different 
amino acids and a number indicating the position of the amino acid in the protein. The residues 
in parentheses are the previous and subsequent amino acid in the protein sequence. 
 
Cry1Aa 
133 kDa 
(R448)APTFSWQHR(S458) (R511)VNITAPLSQR(Y522) 
aa1 aa1176 
71 kDa 
Cry2Aa 
(R112)VNAELIGLQANIR(E126) 
(R95)ETEQFLNQR(L105) 
0aa1 aa633 
(R564)VYTVSNVNTTTNNDGVNDNGAR(F587) 
54 kDa 
Cry6Aa 
(K285)QLDSAQHDLDR(D297) 
aa1 aa475 
(K107)SANDIASYGFK(V119) 
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Table 1. Validation of LC-MS/MS-MRM method. Proteins were identified and quantified in two 
artificial mixtures of three Cry proteins 
 
*Cry1Aa, Cry2Aa, and Cry6Aa were mixed in a molar ratio 1:1:1 for mixture 1 (33.3% of each Cry protein) and 13:4:13 for 
mixture 2 (equivalent to 43.3% of Cry1Aa, 13.3% of Cry2Aa, and 43.3% of Cry6Aa). The mixtures were digested with 
trypsin and proteins were identified and quantified, based on proteotypic peptide abundance and by comparing the signal 
intensities of the endogenous and the corresponding SIL peptide. Mean values represent averages of two independent 
analyses for each tryptic digestion (D1 and D2). 
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The MS/MS spectra and extracted ion chromatograms (Supplemental 
material, Figure S1 [A] Cry1Aa, [B] Cry2Aa, and [C] Cry6Aa) and the transitions 
selected for each target peptide (Supplemental material, Table S2) were 
determined. SIL peptides were synthesized and used for protein quantification of 
both artificial mixtures. In mixture 1, which contained equal amounts of each Cry 
protein, the relative abundance (in molarity) of Cry1Aa was determined at 32–35%, 
that of Cry2Aa at 24–26%, and that of Cry6Aa at 39–44% (Table 1). In mixture 2, 
containing Cry1Aa, Cry2Aa, and Cry6Aa in a molar ratio of 13:4:13, the measured 
relative abundances of the different proteins were also comparable with the 
expected relative abundances (in molarity) of 43, 13 and 43%, respectively, as 
follows: Cry1Aa, 43–46%; Cry2Aa, 6%; Cry6Aa, 48–51% (Table 1).  
Therefore, using known mixtures of Cry1Aa, Cry2Aa, and Cry6Aa, three 
aspects of the procedure were validated: (i) all three types of Cry proteins were 
detected independently of their proportions in the mixture; (ii) the relative abundance 
determined by LC/MS-MS–based quantification was close to the true abundance of 
Cry proteins in both mixtures; and (iii) a high degree of reproducibility of the relative 
abundance values was observed in the analyses of different digestions of samples 
(Table 1). This indicated that the method was suitable for the quantification of Cry 
protein mixtures. 
3.2 Gene content of the Bt strains in four commercial biopesticides and 
identification of the proteins present in the parasporal crystals 
Prior to the proteomic analysis, it is necessary to determine which proteins 
could be present in the parasporal crystal according to the genes present in the 
genome of a given Bt strain. This information is necessary to perform the 
information-dependent acquisition (IDA) analysis as well as to select the proteotypic 
peptides that will be used to identify and quantify each crystal protein. Total genomic 
DNA sequencing revealed the different types of Cry and Cyt proteins encoded by 
the four strains of Bt present in the commercial products (Table 2). Once the 
potential composition of the crystals was known, IDA analyses were performed to 
identify which proteins encoded in the genome of each Bt strain were actually 
expressed and integrated into the parasporal crystal (Table 3, Supplemental 
Material Figure S3). In the DiPel® DF sample, peptides from five proteins were 
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detected, namely, Cry1Aa, Cry1Ab, Cry1Ac, Cry2Aa and Cry2Ab. Five proteins 
were detected in the parasporal crystal of XenTari® GD: Cry1Aa, Cry1Ab, Cry1Ca, 
Cry1Da and Cry2Ab. For VectoBac® 12AS, seven different proteins were identified: 
five Cry proteins (Cry4Aa, Cry4Ba, Cry11Aa, Cry60Aa, Cry60Ba) and two Cyt 
proteins (Cyt1Aa1, Cyt1Ca). In the Novodor® sample, all the Cry proteins predicted 
by genome analysis were detected: Cry3Aa, Cry23Aa and Cry37Aa. These results 
agree with the detection of putative insecticidal proteins by SDS-PAGE 
electrophoresis of spore-crystal mixtures and solubilized proteins (Supplemental 
material, Figure S2). 
In the IDA analyses, although most proteins were identified by at least 
four peptides, Cry2Ab in DiPel® DF and Cyt1Ca in VectoBac® 12AS were each 
detected by a single peptide. Consequently, they were considered to be potential 
false positives, even though it could be that these proteins were present at 
concentrations that were below or at the detection limit. Similarly, three insecticidal 
proteins whose genes were identified by genome sequencing (Table 2), were not 
detected in the crystals from the commercial Bt insecticides. These were: Cry9Ea in 
XenTari® GD and Cry10Aa and Cyt2Ba in VectoBac® 12AS. We assume that the 
respective genes are either not expressed or that these proteins are present at 
concentrations below the detection threshold of the current method.  
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Table 2. Insecticidal protein genes identified in the genome of Bt strains isolated from four 
commercial products. 
 
*The Bt strains ABTS-351, ABTS-1857, AM65-52, and NB-176 were isolated from the commercial products DiPel® DF, 
XenTari® GD, VectoBac® 12AS, and Novodor®, respectively. Genomes of these strains were sequenced using an Illumina 
NextSeq500 Sequencer and the resulting reads were assembled using CLC Genomic Workbench 10.1.1 with the de novo 
assembly tool. Contigs were then analyzed against a custom insecticidal toxin database constructed using insecticidal 
protein sequences. + indicates presence and – indicates absence 
 DiPel® 
(ABTS-351) 
XenTari® 
(ABTS-1857) 
VectoBac® 
(AM65-52) 
Novodor® 
(NB-176) 
cry1Aa + + - - 
cry1Ab + + - - 
cry1Ac + - - - 
cry1Ca - + - - 
cry1Da - + - - 
cry2Aa + - - - 
cry2Ab + + - - 
cry3Aa - - - + 
cry4Aa - - + - 
cry4Ba - - + - 
cry9Ea - + - - 
cry10Aa - - + - 
cry11Aa - - + - 
cry23Aa - - - + 
cry37Aa - - - + 
cry60Aa - - + - 
cry60Ba - - + - 
cyt1Aa - - + - 
cyt1Ca - - + - 
cyt2Ba - - + - 
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Table 3.  Cry and Cyt proteins identified by IDA analysis of Bt strains present in four 
insecticidal products 
 
 
 
 
 
 
 
 
*Proteins in parentheses were detected on the basis of the presence of a single peptide. They were therefore considered 
to be potential false positives or present at a low concentration, close to the limit of detection of this technique 
 
3.3 Selection of proteotypic peptides and MRM parameters for improved 
protein quantification 
Next, we proceeded to select the proteotypic peptides that were unique 
for each protein within each mixture and would provide a clear response in the 
instrument. Proteotypic peptides were identified by in silico trypsin digestion of the 
amino acid sequences of the proteins identified by IDA analysis (Supplemental 
material, Tables S3–S6). Cry proteins have a high degree of similarity, therefore the 
selection of target proteotypic peptides depends on the specific composition of each 
Product 
(Bt strain) Protein Accession no. 
Number of 
peptides used for 
protein 
identification 
DiPel® DF Cry1Aa MK184461 6 
(ABTS-351) Cry1Ab MK184462 7 
 Cry1Ac MK184463 9 
 Cry2Aa MK184464 11 
 (Cry2Ab)* MK184465 (1) 
XenTari® GD Cry1Aa MK184475 4 
(ABTS-1857) Cry1Ab MK184476 12 
 Cry1Ca MK184477 12 
 Cry1Da MK184478 4 
 Cry2Ab MK184479 5 
VectoBac® 12AS Cry4Aa MK184469 3 
(AM65-52) Cry4Ba MK184470 17 
 Cry11Aa MK184471 17 
 Cry60Aa MK184472 5 
 Cry60Ba MK184473 8 
 Cyt1Aa MK184474 2 
 (Cyt1Ca)* CAD30104 (1) 
Novodor® Cry3Aa MK184466 16 
(NB-176) Cry23Aa MK184467 7 
 Cry37Aa MK184468 4 
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Bt product. For example, the selected peptides for Cry1Aa in DiPel® DF were not 
necessarily proteotypic for Cry1Aa in XenTari® GD. Identifying proteins based on a 
specific list of Bt proteotypic peptides has the advantage of increasing the precision 
of ensuing identification and quantification. 
MRM-initiated detection and sequencing (MIDAS) analyses (see Methods 
section 2.8) were performed to select the best MRM transition, in terms of sensitivity 
and selectivity, for each peptide. To increase sensitivity, the most intense m/z 
(mass/charge) ratio of each targeted peptide was selected at the first quadrupole, 
and in order to maximize selectivity, fragment ions with m/z ratios higher than those 
of the precursor ion were monitored. During the design of the MRM assays, several 
transitions from each peptide were tested, and those with the highest signal intensity 
and lowest level of interference signals were chosen (Supplemental material, Table 
S7–S10). 
We selected the most suitable proteotypic peptides and MRM transitions 
for each crystal to enable highly-specific quantification of the Cry and Cyt proteins 
of interest. At least two proteotypic peptides were selected for each crystal protein 
in DiPel® DF, XenTari® GD, VectoBac® 12AS, and Novodor® (Supplemental Material, 
Figure S3[A], [B], [C] and [D], respectively). However, this was not always possible 
because of different limitations, especially those involving the high similarity 
between some of these proteins (for more details, see the Discussion section). 
Application of the developed LC-MS/MS-MRM method for the quantification of 
crystal proteins in Bt products Having established the proteins present in each 
sample, we next proceeded to determine the relative composition of the different Bt 
crystals. The relative molar abundance of each crystal protein in the four commercial 
Bt-based insecticides is shown in Figure 3 (and Supplemental material, Tables S11–
S14). In all cases, the crystals contained a major protein that accounted for 
approximately 50% of all identified Cry and Cyt proteins. Parasporal crystals from 
DiPel® DF were found to be mainly composed of Cry2Aa, followed by Cry1Ab and 
Cry1Aa, and Cry1Ac as a minor component. Crystals from XenTari® GD mainly 
contained Cry1Ab and Cry1Aa, with Cry1Ca and Cry1Da as minor components. 
Quantification of Cry2Ab showed residual results and thus, not considered. The 
major component of VectoBac® 12AS crystals was Cyt1Aa, followed by Cry11Aa, 
Cry4Ba, and Cry60Ba, with a very low abundance of Cry60Aa and Cry4Aa. Finally, 
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Cry3Aa was the major protein in Novodor® crystals, followed by the Cry23Aa and 
Cry37Aa pair, which function as binary toxins (Figure 3). The results demonstrate 
that the LC-MS/MS-MRM method is suitable for the determination of the crystal 
protein content of Bt strains with very distinct protein compositions and toxicity 
spectra. 
 
Figure 3. Relative molar composition of proteins in parasporal crystals of Bt-based 
insecticides. The composition is expressed as a range from two independent tryptic digestions 
with two technical replicates each. 
4. DISCUSSION 
In the current study, we developed an LC-MS/MS-MRM method to 
evaluate the protein composition of parasporal crystals purified directly from Bt-
based commercial insecticides or from any Bt product or culture. The novel mass 
spectrometry method can be used not only to identify the components of the crystal, 
but also to determine their relative abundance, thus providing a method for 
qualitative and quantitative characterization of the active ingredients of insecticidal 
preparations based on Bt. 
The set-up of an MRM experiment for the analysis of Bt Cry and Cyt 
proteins is complex and requires several intermediate steps. The major 
experimental hurdle to overcome is the complexity of the mixtures of Cry and Cyt 
proteins, which complicates the selection of suitable proteotypic peptides for the 
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different crystal proteins in the mixture. This selection can be challenging for the 
following reasons: (i) the small size of some proteins reduces the number of 
candidate peptides; (ii) there is a lack of spectral libraries for Bt; and (iii) certain 
proteins show high amino acid sequence similarity (Brun et al., 2009), which limits 
the number of candidate proteotypic peptides. Moreover, once the candidate 
proteotypic peptides are identified by in silico analysis, they have to be filtered to 
fulfill certain analytical criteria. These include sequence length (ideally 6–16 amino 
acids), chemical stability throughout the analytical process, and good detectability 
and MS response characteristics (Alves et al., 2011; Kamiie et al., 2008; Kuster et 
al., 2005). Finally, certain SIL peptides that are too long or with a strong hydrophobic 
character, can be difficult to synthesize and should be avoided (Hoofnagle et al., 
2016). For some Bt proteins these factors make it difficult to select a minimum of 
two proteotypic peptides for every crystal protein detected, in order to provide highly 
selective and sensitive assays. Specifically, Cry1Ab and Cry2Aa in the DiPel® DF 
sample were quantified based on a single proteotypic peptide that was specific for 
each protein. However, given the novelty of the method developed in this study and 
the high reproducibility observed in the results obtained from different digestions of 
the samples, we are confident that the use of a single proteotypic peptide for the 
quantification of some proteins is a valid approach. 
Careful choice of the MRM transitions is critical for the specificity of the 
assay, and the ability to detect and quantify target peptides (Picotti and Aebersold, 
2012). Several transitions for each peptide were monitored in the current study 
(Supplemental material, Tables S7–S10), which resulted in improved discrimination 
of the different crystal toxins. Typically, monitoring three or four transitions per 
peptide provides a suitable balance between selectivity and throughput (Addona et 
al., 2009; Reiter et al., 2011). For this method, we monitored between 4 and 6 
transitions per peptide, and in some cases, we were even able to select transitions 
for the double and triple-charged precursor ion. Overall, double-charged precursor 
ions are favoured by electrospray ionization, but in some cases, such as when the 
peptide sequence contains a histidine residue, triple-charged ions are also favoured 
(Willard and Kinter, 2001). Because of the lack of spectral libraries for Bt Cry 
proteins, we had to determine the precursor ion charge state as well as the product 
ions to be monitored based on the experimental data obtained. In addition, in order 
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to maximize selectivity and minimize background interference, several features 
were considered: (i) product ions with m/z values higher than those of the precursor 
ion were preferentially selected (Gallien et al., 2011), (ii) for a given MRM method, 
there were no peptides with the same m/z (even for those that differed in amino acid 
sequence) or retention time, (iii) runs without a spike of SIL peptides were performed 
previously to confirm the lack of interference in SIL transitions, (iv) the reference 
intensity dot product, which is the relative intensities of the transitions for 
endogenous and SIL peptides, had to be similar for each type of peptide. In this 
way, we ensured that maximum sensitivity and peptide discrimination was achieved. 
Common Bt-based products for controlling pests of different orders 
(Dipel® DF, Xentari® GD, Vectobac® 12S and Novodor®) have been characterized in 
the current study using the novel validated method. The relative abundance of 
different Cry and Cyt proteins within the parasporal crystal of the Bt strain used in 
each product has been revealed for the first time. 
DiPel® DF and XenTari® GD products are widely used in the control of 
lepidopteran pests. Although the former is effective against many leaf-feeding 
lepidopterans, it is less active against pests from the genus Spodoptera (Bravo et 
al., 2011). According to the manufacturer, the active ingredient of Dipel® DF, Bt strain 
ABTS-351, harbors the cry1Aa, cry1Ab, cry1Ac and cry2 genes (not specified), and 
XenTari® GD Bt strain ABTS-1857 contains cry1Aa, cry1Ab, cry1C and cry1D. The 
difference in the gene content explains their spectrum of activity, however, the level 
of expression of these genes in each product is not given by the manufacturer 
(www.kenogard.com). 
In the current study, we initially corroborated that the genes expressed in 
Dipel® DF were Cry1Aa, Cry1Ab, Cry1Ac and Cry2Aa. Next, we determined that the 
protein content in the crystal is distributed approximately evenly between Cry1A and 
Cry2A proteins (Figure 3). The broad spectrum of toxicity against lepidopterans 
attributed to Cry2A proteins, along with a balanced contribution of Cry1 proteins, 
explains the use of this Bt-based product against the recommended target species. 
In XenTari® GD, we confirmed the expression of Cry1Aa, Cry1Ab, Cry1C and Cry1D, 
and determined that crystals comprised up to 15% of Cry1C and Cry1D (Figure 3). 
Despite this small percentage, the occurrence of these two toxins is responsible for 
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the unique toxicity spectrum of this product, which has high toxicity to species in the 
genus Spodoptera that are major pests of horticultural and other crops (Hernández-
Martínez et al., 2008; Porcar et al., 2000). 
VectoBac® 12AS, which is based on a Bt serovar israelensis, is used for 
controlling medically-important vectors, such as mosquitoes (Dominic Amalraj et al., 
2000). In the present study, we showed that Cry4Aa, Cry4Ba, Cry11Aa, Cry60Aa, 
Cry60Ba, Cyt1Aa and Cyt1Ca were expressed, but we found no evidence for the 
presence of Cry10Aa or Cyt2Ba in the commercial product. However, other studies 
using different techniques have reported small amounts of these proteins in the 
parasporal crystals of different strains of Bt-israelensis (Ben-Dov, 2014). 
Approximately 90% of the protein content of the crystals in VectoBac® 12AS was 
found to comprise Cry4Aa, Cry4Ba, Cry11Aa and Cyt1Aa (Figure 3), which are 
toxins with high larvicidal activity in dipterans when found in a mixture (Crickmore et 
al., 1995; Monnerat et al., 2014). The low concentration of Cry60Aa and Cry60Ba 
detected in the current study could suggest that minor crystal components may 
contribute to the toxicity of the parasporal crystal (Berry et al., 2002), by synergizing 
the potency of other Cry proteins in the product and may also contribute to the lack 
of reports of resistance to Bt serovar israelensis in dipteran populations subjected 
to long-term treatment with this type of insecticide (Becker et al., 2018; Ferré and 
Van Rie, 2002).  
Novodor® is widely used for the control of coleopteran pests. We 
confirmed the expression of three Cry proteins (Figure 3). The major insecticidal 
protein found in Novodor® crystals was Cry3Aa, which is toxic to insects in the orders 
Coleoptera, Hemiptera, and Hymenoptera (Van Frankenhuyzen, 2009). Another 
identified component, Cry23A, is active against certain species of Coleoptera only 
in the presence of Cry37 (Donovan et al., 2000), which is believed to facilitate 
binding of the channel-forming toxins to midgut epithelial cells (de Maagd et al., 
2003). The observation that the relative abundance of Cry37Aa in Novodor® crystals 
was similar to that of Cry23Aa supports the notion of a positive interaction between 
these two proteins.  
Although the applicability of this LC-MS/MS-MRM method may be limited 
by the selection of proteotypic peptides and by the availability of the corresponding 
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SIL peptides, when proteins with a high homology are present in the same sample, 
we managed to analyze strains such as Dipel® DF and Xentari® GD that contained 
several isomorphic proteins in their crystals. Also, the need for genome sequencing 
of the bacterium no longer poses a limitation to the use of this method as genome 
sequencing technology is now routine in most laboratories across the world.  
In conclusion, the method developed in the current study allows, for the 
first time, the analysis of novel Bt isolates as well as Bt strains recovered from 
commercial biopesticides targeted at a diversity of insect pests and vectors of 
medical importance. Determination of the composition of Bt parasporal crystals can 
provide direct economic and environmental benefits associated with the production 
of effective biological insecticides with minimal environmental impact (Hokkanen 
and Hajek, 2003; Jouzani et al., 2017). Application of the present method to quantify 
the effect of growth media and fermentation conditions on the production of each 
insecticidal crystal protein will allow unprecedented control over the insecticidal 
characteristics of products based on Bt, which is likely to increase the commercial 
competitiveness of Bt-based products. The novel method could find numerous 
applications in the development and innovation of Bt-based biological insecticides 
and provide precise information for Bt production processes and phytosanitary 
registration authorities responsible for the safety and efficacy of crop protection 
products based on this uniquely-valuable pathogen. 
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Activity of the individual crystal proteins of 
Bacillus thuringiensis serovar aizawai strain 
ABTS-1857 for Spodoptera species: 
insecticidal effects of artificial mixtures of 
proteins 
Abstract 
Bacillus thuringiensis ser. aizawai strains are commonly used for the 
control of Spodoptera species. In this study the toxicity of the Bt strain ABTS-1857 
(Xentari® GD) was estimated against second instars of S. exigua (LC50 = 7.8 ng/µl), 
S. littoralis (LC50 = 28.0 ng/µl) and S. frugiperda (LC50 = 120.2 ng/µl). The individual 
activity of each of the proteins present in the crystal confirmed the efficacy of Cry1Ca 
and Cry1Da against the tested species, which differed markedly in their 
susceptibility. Cry1Ca was highly toxic to S. exigua (LC50 = 3.1 ng/µl) and 
moderately toxic to S. littoralis (LC50 = 19.8 ng/µl), whereas Cry1Da was 1.8-fold 
more toxic to S. frugiperda (LC50 = 10.3 ng/µl) compared to S. littoralis (LC50 = 19.6 
ng/µl). Artificial mixtures that contained four Cry1 proteins at a prevalence of 29% 
Cry1Aa, 58.5% Cry1Ab, 9% Cry1Ca and 3.5% Cry1Da did not differ significantly in 
their toxicity characteristics when compared to the natural mixture present in crystals 
of the wild-type strain in S. exigua (LC50 = 9.9 ng/µl) or S. frugiperda (LC50 = 188.1 
ng/µl). Increasing amounts of Cry1Da, in combination with decreasing quantities of 
either Cry1Aa or Cry1Ab, had no significant effect in the toxicity towards S. exigua 
whereas mortality increased in S. littoralis and S. frugiperda. We conclude that the 
composition and prevalence of crystal proteins within the parasporal crystal of a Bt 
strain is crucial for its insecticidal activity. 
This chapter will be submitted to Toxins as: Caballero J, Villanueva M, Jiménez-Moreno N, Caballero 
P. 2019. Activity of the individual crystal proteins of Bacillus thuringiensis serovar aizawai strain ABTS-
1857 for Spodoptera species: insecticidal effects of artificial mixtures of proteins.  
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1. INTRODUCTION 
Synthetic chemical insecticides have been the most widely used method 
of pest control over the last 70 years but there is currently growing concern related 
to their widespread use related to public health, their impact on pollinators and 
beneficial insect populations and the environment (Carson et al., 2002; Jarman and 
Ballschmiter, 2012). Insecticides based on entomopathogenic microorganisms have 
been proposed as an alternative to chemical insecticides for the control of 
agricultural and forest pests. Among the insecticides of microbial origin, those based 
on Bacillus thuringiensis have experienced the greatest commercial development 
and are now available in most regions of the world (Sanchis and Bourguet, 2008).  
B. thuringiensis (Bt) is a spore forming Gram-positive bacterium that 
synthetizes a parasporal crystal during the sporulation phase of growth. The 
parasporal inclusion is formed by the aggregation of crystal toxins (Cry and Cyt), 
also known as delta-endotoxins, which exhibit insecticidal activity against a wide 
range of insect pests belonging to the orders Lepidoptera, Coleoptera or Diptera, 
among others (Schnepf et al., 1998). Since the cloning of the first cry gene (Schnepf 
and Whiteley, 1981), more than 700 insecticidal proteins have been produced and 
described from strains of Bt (http://www.btnomenclature.info/). 
Cry toxins exhibit activity after solubilization and proteolytic activation in 
the midgut of the insect. Binding to specific receptors located in the brush border of 
epithelial cells enables toxins to form a lytic pore leading to cell disruption and 
subsequent insect death (Bravo et al., 2007; Vachon et al., 2012). These receptor 
interactions are responsible for the high specificity of Bt and a narrower spectrum of 
action compared to many synthetic insecticides. Despite the huge variety of 
characterized Bt strains only a few have been exploited commercially, mainly 
against lepidopteran pests.  
The insecticidal activity of a particular Bt strain depends mainly on the 
proteins that make up the crystal, the relative proportion of each of the proteins and 
the interactions that occur among the component proteins. The relative proportion 
of toxins within the crystal is a further step in the characterization of a Bt strain that 
can provide crucial information on the predicted activity of the isolate prior to testing 
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in a bioassay. Currently, because of the difficulties faced in the identification and 
quantification of the different Cry and Cyt proteins in Bt crystals, commercial Bt-
based bioinsecticides include no description of the composition of active ingredients 
and their characterization is based entirely on protein content and their potency 
against a reference insect species compared with an international Bt standard 
(Dulmage, 1981). 
Recently, we have developed an analytical liquid chromatography-mass 
spectrometry (LC-MS/MS-MRM) based method to evaluate the protein composition 
of parasporal crystals purified directly from Bt-based insecticides or from any Bt 
product or culture. This method can be used not only to identify the components of 
the crystal, but also to determine their relative abundance, thus providing a method 
for qualitative and quantitative characterization of the active ingredients of 
insecticidal preparations based on Bt (Caballero et al., unpublished data). This 
method has been applied to identify and quantify the proteins that make up the 
crystal of some of the Bt strains that serve as an active ingredient in some of the 
most widely used Bt insecticides in the control of agricultural pests including the 
commercial product Xentari® GD (Kenogard) (Caballero et al., unpublished data). 
This product uses the Bt strain ABTS-1857 (ser. aizawai) as an active ingredient, 
which is recommended for the control of lepidopteran pests especially those 
belonging to the genus Spodoptera that are tolerant to other Bt-based insecticides. 
A total of six cry genes were identified in the Bt strain ABTS-1857, but 
only four of them were expressed in sufficient quantity to be detected, including 
Cry1Aa, Cry1Ab, Cry1Ca and Cry1Da, which were found in a relative molar ratio of 
29:58.5:9:3.5, respectively (Caballero et al., not published). Cry1Ca and Cry1Da are 
considered to be amongst the most toxic proteins for Spodoptera exigua, 
Spodoptera littoralis and Spodoptera frugiperda (BenFarhat-Touzri et al., 2019, 
2016; Hernández-Martínez et al., 2008; Silva et al., 2015; Van Frankenhuyzen, 
2009; Van Rie et al., 1989).  
The aim of this study was to determine the toxicity of each of the individual 
crystal proteins against S. exigua, S. littoralis and S. frugiperda. and the influence 
of protein interactions in artificial mixtures comprising different proportions of each 
of the toxins on insect mortality. 
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2. MATERIAL AND METHODS 
2.1. Insect rearing 
Laboratory colonies of S. exigua, S. littoralis and S. frugiperda 
(Lepidoptera: Noctuidae) were maintained in a growth chamber at the Universidad 
Pública de Navarra under controlled conditions (25 ± 2 °C, 70 ± 5% humidity and 
16:8 h light:dark photoperiod). Larvae were reared on a semi-synthetic diet (Greene 
et al., 1976). Adults had ad libitum access to 10% sugar solution. Newly moulted 
second instar larvae were selected for use in toxicity bioassays. 
2.2. Bacterial strains, plasmids and culture media 
The Bt strain ABTS-1857, a B. thuringiensis ser. aizawai, was isolated 
directly from the commercial product XenTari® GD (Kenogard; manufacturing batch 
261-355-PG; manufactured in January 2016). Plasmid pJET (Fermentas) was used 
for cloning PCR fragments and sequencing. Plasmids pSTAB (Park et al., 1998) and 
pSTAB-RBS (a modified vector) were used as expression vectors. E. coli XL1-Blue 
cells were used as the cloning host. The acrystalliferous Bt strain BMB171 was used 
for toxin production and toxicity bioassays. BMB171 containing the empty pSTAB 
plasmid was used as negative control in bioassay experiments. Luria-Bertani (LB) 
broth (1% tryptone, 0.5% yeast extract and 1% NaCl, pH 7) was used to grow both 
B. thuringiensis and E. coli. Ampicillin and erythromycin were used (100 µg/ml and 
20 µg/ml, respectively) for positive clone selection. 
2.3. Total DNA isolation, sequencing and computational analysis 
Spores from the strain ABTS-1857 were inoculated on LB agar and 
incubated at 28 ºC overnight. A single colony was selected and grown at 28 °C for 
12 h in 5 ml of sterile LB broth and total DNA was extracted from vegetative cells 
using the Wizard Genomic DNA Purification Kit (Promega) following the instructions 
for DNA isolation from Gram-positive bacteria. Purified total DNA was used as 
template for gene cloning.  
2.4. PCR amplification of insecticidal genes 
Specific oligonucleotide primer pairs were designed to amplify the open 
reading frames (ORF) of cry1Aa, cry1Ab, cry1Ca and cry1Da based on the 
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published sequence of each gene (GenBank AAA22353, X54939, M73251 and 
X54160, respectively). Primers included restriction sites for cloning (Table 1). DNA 
extracted from the strain ABTS-1857 was used as template in a 50 µl reaction 
mixture containing 10 µl of 5x HF reaction buffer, 1 µl of 100 mM dNTPs, 1 µl of 
each forward and reverse primer (10 µM), 0.5 U Phusion High-fidelity DNA 
polymerase (NEB) and 100 ng of total DNA. PCR cycling conditions were: 1 initial 
denaturation cycle at 98 °C for 30 s, 30 amplification cycles of 98 °C for 10 s, 55 °C 
for 1 min and 72 °C for 3 min and 30 s, followed by a final extension step at 72 °C 
for 10 min in a C1000 Touch thermal cycler (Bio-Rad). The PCR products were 
analyzed by electrophoresis on 1% agarose gel in TAE buffer (40 mM Tris, 20 mM 
acetic acid and 1 mM EDTA, pH 8) at 100 V for 30 min.  
Table 1. Primer sequences with restriction enzyme cleavage sites targeted at the cry1Aa, 
cry1Ab, cry1Ca and cry1Da genes of B. thuringiensis ser. aizawai strain ABTS-1857. 
Primer and restriction 
enzyme* 
Sequence of primer 
F-Cry1A-SalI 5’GGTCGACGGTATCTTAATAAAAGAGATGGAG3’ 
F-Cry1Ca-NcoI 5’CCCATGGAGGAAAATAATCAAAATCAATG3’ 
F-Cry1Da-SalI 5’GGTCGACGGACTTTAGTAATTTAATAAAAAAAGGG3’ 
R-Cry1-PaeI 5’GCATGCTTATT-CCTCCATAAGGAGTAATTCCAC3’ 
F-Seq-Cry1A 5’GATGAATTTTGTCTGGATGAA3’ 
R-Seq-Cry1A 5’GATAGCACTCATCAAAGGTAC3’ 
F-Seq-Cry1C 5’GGGGAGAACTTAACATCTAG3’ 
F-Seq-Cry1D 5’GCTCATACAACACTCTTCAC3’ 
R-Seq-Cry1C-D 5’GAAGTAAACAGGGCATTCAC3’ 
*Restriction enzyme cleavage sites are underlined. F: specific forward primer; R: specific reverse primer; 
Seq: specific intermediate primer.  
 
2.5. Cloning and transformation of insecticidal genes 
The PCR products corresponding to cry1Aa, cry1Ab, cry1Ca and cry1Da 
CDS were purified from the agarose gel with NucleoSpin Gel and PCR clean up kit 
(Macherey-Nagel Inc., Bethlehem, PA) and cloned bluntly into the pJET vector 
(CloneJET PCR Cloning Kit, Fermentas, Canada) to obtain the pJET-protoxin 
constructions (pJET-1Aa, pJET-1Ab, pJET-1Ca and p-JET-1Da). Transformation of 
E. coli XL1-Blue was performed following a standard protocol (Sambrook et al., 
1989) for recombinant plasmid production containing each of the cry gene CDS. 
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Putative positive clones were checked by PCR in a 20 µl reaction mixture containing 
2 µl of 10x NH4 reaction buffer, 1 µl 50 mM MgCl2, 1 µl of 100 mM dNTPs, 1 µl of 
each forward and reverse primer (10 µM), and 0.2 µl of BioTaq Polymerse (Bioline). 
E. coli XL1-Blue cells harbouring the pJET constructions were cultured in 5 ml LB 
broth supplemented with 100 µg/mL ampicillin at 37 °C and with agitation at 200 
rpm overnight. Recombinant plasmids were extracted with a NucleoSpin plasmid kit 
(Macherey-Nagel Inc., Bethlehem, PA) according to the manufacturer’s protocol and 
verified by sequencing using an intermediate forward primer for each gene and the 
forward and reverse primers for the pJET vector (StabVida, Caparica, Portugal). 
Nucleotide sequences were aligned in SnapGene with those of toxins available in 
the GenBank database. Digestion of the pJET-protoxin plasmids were performed 
with the corresponding combination of restriction enzymes (Thermo Scientific). 
Subsequent purification of digestion products, previously resolved in an agarose 
gel, was performed using a NucleoSpin Gel and PCR clean up kit (Macherey-Nagel 
Inc., Bethlehem, PA). The pSTAB/pSTAB-RBS vector, previously digested with the 
corresponding restriction enzymes, was used as receptor for the inserts (pSTAB for 
cry1Aa, cry1Ab and cry1Da; pSTAB-RBS for cry1Ca) using the Rapid DNA ligation 
kit (Thermo Scientific) to obtain recombinant plasmids with the pSTAB/pSTAB-RBS-
protoxin constructions. E. coli XL1-Blue cells were transformed with the ligation 
products as described before, and putative positive clones were checked by colony 
PCR prior to plasmid extraction. An acrystalliferous Bt strain, BMB171 (Li et al., 
2000) was used as receptor in a transformation process performed as described 
previously (Cucarella et al., 2001). Putative positive clones were checked by colony 
PCR. 
2.6. Insecticidal protein expression 
The B. thuringiensis ser. aizawai strain ABTS-1857 and each of the 
BMB171-protoxin constructions were cultured in 50 ml CCY medium supplemented 
with 20 µg/ml erythromycin for the recombinant strains, in a rotary shaker set at 28 
°C and 200 rpm for two-three days, until sporulation and lysis of 95% of the cells 
was observed. Inclusion bodies were observed by phase contrast microscopy at 
x1000 magnification. Spore and crystal mixtures were then centrifuged at 9000×g 
for 10 min at 4 °C. Pellets were washed three times in 1 M NaCl, six times in cold 
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distilled water and finally resuspended in 1.5 ml of 10 mM KCl. A volume (200 µl) 
was pelleted and then solubilized in 200 µl of 50 mM Na2CO3 (pH 11.3) and 10 mM 
dithiothreitol (DTT) solution by gentle agitation during 2 h at 37 ºC. Non-solubilized 
crystals were removed by centrifugation at 9000´g for 10 min at 4 °C. An aliquot (10 
µl) was used for protein quantification by Bradford assay (Bradford, 1976) (Bio-Rad) 
using bovine serum albumin (BSA) as standard. For quality control, spore and 
crystal mixtures and solubilized proteins were resolved using a Criterion TGX™ 4-
20% Precast Gel (BIO-RAD) at 50 mA for 1 h. The gels were stained with 
Coomassie brilliant blue R250 (Bio-Rad) for 40 min, and then distained in a solution 
of 10% (v/v) glacial acetic acid and 30% (v/v) ethanol. Protein mass-band patterns 
were determined by comparison with a broad-range protein marker (Precision Plus 
ProteinTM Dual Colour Standards, Bio-Rad). 
2.7. Protein toxicity bioassay 
To determine the concentration-mortality response of insects inoculated 
with the wild-type Bt strain ABTS-1857, the individual Cry toxins and the protein 
mixtures, a total of six concentrations of solubilized crystals were prepared from the 
original solubilized protein stock to obtain final concentrations of 300, 100, 33.3, 
11.1, 3.7, 1.4 ng/µl. Bioassays were performed using groups of 28 recently molted 
S. exigua, S. littoralis and S. frugiperda second instars using the droplet feeding 
method (Hughes and Wood, 1981). Toxicity experiments were replicated three times 
on different days using independent spore and crystal preparations. Combinations 
of two, three or four solubilized proteins were also prepared and tested in three 
independent replicates according to their relative abundance in the parasporal 
crystal of the strain ABTS-1857 (29% Cry1Aa, 58.5% Cry1Ab, 9% Cry1Ca and 3.5% 
Cry1Da), determined previously (Caballero et al., ms in revision). A total of 10 
replicates using a single concentration (100 ng/µl) were performed to estimate 
percentage of mortality of the natural strain and the artificial mixture containing all 
four Cry1 proteins. Increasing amounts of the Cry1Da protein, ranging from 3.5 to 
20 ng/µl, with corresponding reductions in Cry1Aa or Cry1Ab, were also tested for 
the three species, performing up to three independent bioassays. The strain 
BMB171 containing an empty pSTAB vector served as negative control. Larvae that 
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consumed inoculum suspension within a 10 min period were incubated individually 
on semi-synthetic diet at 25 ± 2 °C for 5 days and were then checked for mortality. 
Concentration-mortality data were subjected to Probit analysis (Finney, 
1971) using the POLO-PC software (LeOra Software, 1987). Mean lethal 
concentration (LC50) values were considered to differ significantly if their 95% 
fiducial limits did not overlap. A paired t-test (SAS Institute, 1999) was used to 
compare the percentage of mortality obtained with the artificial mixture that 
contained the four Cry1 proteins with that obtained for the natural crystal when 
tested at 100 ng/µl against the three insect species.  
3. RESULTS 
3.1. Cloning and expression of single insecticidal genes 
PCR amplification, with specific oligonucleotide primers for cry1Aa, 
cry1Ab, cry1Ca and cry1Da genes, resulted in amplicons of 3574, 3468, 3570 and 
3497 bp, respectively. These sequences had 99% similarity with the corresponding 
sequences from GenBank (data not shown). In all cases, the recombinant strain 
BMB171 that individually expressed the cry1Aa, cry1Ab, cry1Ca, and cry1Da genes 
had a bipyramidal crystal located at the opposite end of the cell to that of the 
endospore. Protein profiles of the Bt wild-type isolate and the individual recombinant 
Cry toxins showed protein bands migrating at 130 kDa in all cases, which 
correspond to the expected size of Cry1 protoxins. A second band at 60-70 kDa 
appeared clearly in the wild-type isolate (Figure 1, lanes 1 and 2) and also in 
individual Cry1 crystal protein (Figure 1, lanes 5, 6 and 9-12) probably as the result 
of proteolysis. Single proteins showed a double band pattern (100-130 kDa), 
probably due to a partial proteolysis (Figure 1). 
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Figure 1. SDS-PAGE of B. thuringiensis ser. aizawai strain ABTS-1857 and its individual 
crystal proteins. M. Molecular weight marker; 1. ABTS-1857 spore/crystal mixture; 2. ABTS-
1857 solubilized crystal proteins; 3. BMB171 acrystalliferous Bt strain spores; 4. 
Acrystalliferous Bt strain BMB171 after solubilization; 5. Cry1Aa spore/crystal mixture; 6. 
Cry1Aa solubilized crystal proteins; 7. Cry1Ab spore/crystal mixture; 8. Cry1Ab solubilized 
crystal proteins; 9. Cry1Ca spore/crystal mixture; 10. Cry1Ca solubilized crystal proteins; 11. 
Cry1Da spore/crystal mixture; 12. Cry1Da solubilized crystal proteins. 
3.2. Toxicity of the Bt strain ABTS-1857 for Spodoptera species 
The concentration-mortality results showed significant differences in the 
LC50 values of strain ABTS-1857 among the three insect species, which ranged from 
7.8 to 120.2 ng/µl. This strain exhibited high toxicity towards S. exigua and S. 
littoralis, whereas S. frugiperda larvae were less susceptible (Table 2). In the control 
treatments larval mortality was less than 10% in all cases. 
Table 2. Probit regression of concentration-mortality results for S. exigua, S. littoralis and S. 
frugiperda second instars treated with strain ABTS-1857. The median lethal concentration 
(LC50) and relative potency values were calculated for each species. 
F.L: 95% fiducial limits; c2: goodness-of-fit test; df: degrees freedom 
 Regression   F.L 95%   
Spodoptera Slope ± SE Intercept 
LC50 
(ng/µl) 
Relative 
Potency 
Low High c2 df 
exigua 1.0 ± 0.1 3.9 7.8 14.5 9.7 21.8 2.0 3 
littoralis 2.2 ± 0.3 1.7 28.0 4.3 2.9 6.2 3.7 3 
frugiperda 1.0 ± 0.1 2.9  120.2 1 - - 0.5 3 
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3.3. Toxicity of the recombinant Cry1 proteins  
The toxicity results of the individual Cry1Aa, Cry1Ab, Cry1Ca, and 
Cry1Da proteins were subjected to probit regression for S. exigua, S. littoralis and 
S. frugiperda second instars (Table 3). Crystal proteins Cry1Aa and Cry1Ab only 
showed little activity against S. exigua (data not shown), but the estimated LC50 
value for all three species tested in this study consistently exceeded the highest 
concentration tested, 300 ng/µl. Cry1Ca was the most active protein for S. exigua 
larvae with an estimated LC50 of 3.1 ng/µl, and also showed moderate activity 
against S. littoralis larvae (LC50 = 19.8 ng/µl), but was not active for S. frugiperda 
larvae at the highest concentration of 300 ng/µl. Cry1Da showed low activity against 
S. exigua larvae and moderate toxicity to S. littoralis (LC50 = 19.6 ng/µl). This was 
the only active toxin against S. frugiperda with an estimated LC50 of 10.3 ng/µl (Table 
3).  
Table 3. Probit regression of concentration-mortality results for S. exigua, S. littoralis and S. 
frugiperda second instars treated with recombinant Cry1Aa, Cry1Ab, Cry1Ca, and Cry1Da 
proteins. Mean lethal concentration (LC50) and relative potency values were calculated for 
each species. Missing values indicate that insect mortality did no-t exceed 50% at the highest 
concentration tested. 
SE: standard error; Int: intercept; F.L: fiducial limits; c2: goodness-of-fit with 3 degrees of freedom. 
Species Cry1 
Regression line LC50  
(ng/µl) 
Relative 
Potency 
F.L 95% 
c2 
Slope ± SE Intercept Low High 
S
. e
xi
gu
a  
Aa 0.5 ± 0.2 3.7 >300 - - - - 
Ab 1.5 ± 0.4 1.7 >300 - - - - 
Ca 1.2 ± 0.1  4.4 3.1 27 9.7 75.6 13.3 
Da 0.5 ± 0.1  4.1 83.0 1 - - 1.8 
S
. l
itt
or
al
is
 Aa  14.1 ± 0.1 -25 >300 - - - . 
Ab 13.6 ± 0.1 -24 >300 - - - . 
Ca 1.5 ± 0.1 3.1 19.8 1 - - 2.4 
Da 1.2 ± 0.1 4.4 19.6 1 0.8 1.34 1.9 
S
. f
ru
gi
pe
rd
a Aa - - >300 - - - . 
Ab - - >300 - - - . 
Ca - - >300 - - - . 
Da 1.5 ± 0.2 4.6 10.3 1 - - 0.6 
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3.4. Toxicity of the different recombinant protein combinations  
Different mixtures of recombinant proteins, in relative proportions similar 
to that found in the crystal produced by wild-type strain ABTS-1857, were tested for 
protein interactions. In S. exigua, recombinant protein mixtures containing two 
solubilized protoxins showed that those containing the Cry1Ca protein produced the 
highest mortalities (71-74%), whereas the lowest mortalities (<27%) were registered 
in mixtures that did not include Cry1Ca (Table 4).  
Table 4. Percentage of mortality observed in S. exigua, S. littoralis and S. frugiperda second 
instars following inoculation with different mixtures of recombinant proteins. 
 
Similar results were obtained when mixtures that included three 
recombinant proteins were used, where Cry1Ca appeared to be the determinant 
toxic component for mortality in S. exigua larvae, with 62-86% mortality (Table 4). 
The absence of Cry1Ca showed a negative impact in mortality (33%). Finally, the 
artificial combination that reflects the natural mixture occurring in the parasporal 
crystal of the strain ABTS-1857 resulted in 85% mortality, similar to the 93% 
mortality observed when 100 ng/µl of the solubilized crystal proteins of the wild-type 
isolate were used to inoculate S. exigua larvae (p = 0.31).  
 
Cry1 mixtures 
Concentration 
(ng/µl) 
Mortality ± SE (%) 
S. exigua S. littoralis S. frugiperda 
Aa + Ab 29 + 58.5 26 ± 9.4 5 ± 7.1 1.6 ± 2.6 
Aa + Ca 29 + 9 71 ± 18.5 35 ± 18.6 5 ± 2.1 
Ab + Ca 58.5 + 9 74 ± 11.5 45 ± 21.7 0 ± 0 
Aa + Da 29 + 3.5 27 ± 18.2 46 ± 18.2 30 ± 5.0 
Ab + Da 58.5 + 3.5 7 ± 1.8 47 ± 15.0 33 ± 4.2 
Ca + Da 9 + 3.5 71 ± 14.5 71 ± 18.7 33 ± 12.0 
Aa + Ab + Ca 29 + 58.5 + 9 80 ± 9.0 57 ± 22.4 7 ± 5.7 
Aa + Ab + Da 29 + 58.5 + 3.5 33 ± 10.5 54 ± 19.8 21 ± 6.2 
Aa + Ca + Da 29 + 9 + 3.5 62 ± 18.4 77 ± 13.1 31 ± 6.0 
Ab + Ca + Da 58.5 + 9 + 3.5 86 ± 9.1 81 ± 10.3 33 ± 10.0 
Aa + Ab + Ca + Da 29 + 58.5 + 9 + 3.5 85 ± 10.6 76 ± 16.5 38 ± 9.7 
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In S. littoralis the mixture of recombinant proteins Cry1Aa + Cry1Ab 
resulted in larval mortalities of 5% at the tested concentration (Table 4). However, 
mixtures of two proteins containing Cry1Ca or Cry1Da resulted in moderate mortality 
(35-47%), while the Cry1Ca + Cry1Da mixture produced the highest mortality (71%) 
(Table 4). The same trend was observed in combinations of three proteins although, 
in general, higher percentages of mortality (54-81%) were observed. No statistical 
differences were observed when S. littoralis larvae were treated with the natural 
mixture or an artificial combination of the four expressed proteins, scoring 76% 
mortality when compared to the solubilized wildtype crystal (85%) (p = 0.30). In S. 
frugiperda no mortality was registered for the Cry1Aa + Cry1Ab combination. Only 
protein combinations of either two or three toxins that included Cry1Da resulted in 
mortality ranging from 21 to 33% (Table 4). Similar mortality for the artificial mixture 
(38%) was obtained when compared to the natural solubilized crystal (40%) (p = 
0.24). 
3.5. Toxicity of the natural and the predicted artificial protein mixture  
The LC50 for the artificial mixture containing the four proteins at their 
predicted abundance was estimated for S. exigua and S. frugiperda second instars 
and compared to that obtained for the natural mixture (Table 2). For S. exigua the 
LC50 value for the artificial mixture was 9.9 ng/µl and was 188.1 ng/µl for S. 
frugiperda compared to 7.8 and 120.2 ng/µl for the natural mixture, respectively 
(Table 5).  
Table 5. Mean lethal concentration (LC50) and relative potency (R. P.) values for the natural 
and artificial mixture of proteins expressed in the Bt strain ABTS-1857 at the estimated relative 
abundance for S. exigua and S. frugiperda second instars. 
F.L: fiducial limits; c2 goodness of fit test with 3 degrees of freedom. 
  Regression   95% F.L.  
Species Mixture Slope ± SE Int. 
LC50 
(ng/µl) 
Relative 
Potency 
Low High c2 
S. exigua 
Natural 1.1 ± 0.1 4.0 7.8 1.3 0.8 2.1 1.6 
Artificial 0.9 ± 0.1 4.2 9.9 1 - - 2.5 
S. 
frugiperda 
Natural 1.0 ± 0.1 3.0 120.2 1.6 0.6 3.8 0.7 
Artificial 1.0 ± 0.2  2.7 188.1 1 - - 1.4 
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3.6. Toxicity effects of increased amounts of Cry1Da 
Due to the low proportion of Cry1Da in the parasporal crystal, different 
combinations containing increasing amounts of this toxin with corresponding 
reductions in Cry1Aa and Cry1Ab, were tested against second instar larvae of the 
three Spodoptera species (Table 6). For S. exigua no enhanced activity was 
observed, with mortality that varied from 92% for the original mixture to 88-92% at 
the highest dose (mixture containing 20 ng/µl of Cry1Da). For S. littoralis mortality 
increased from 76% to 86-87% in mixtures containing 10 ng/µl of Cry1Da and to 96-
99% when the mixture contained 20 ng/µl of this toxin. Finally, a marked increase 
was detected for S. frugiperda when larvae were inoculated with mixtures containing 
10 ng/µl (52-53% mortality) or 20 ng/µl (82-83% mortality) of Cry1Da (Table 6). 
Table 6. Percentages of mortality of S. exigua, S. littoralis and S. frugiperda second instars 
inoculated with artificial mixtures containing increased amounts of recombinant Cry1Da (total 
Cry protein concentration of 100 ng/µl). 
Cry1 protein mixture 
(Aa + Ab + Ca + Da) 
Mortality ± SE (%) 
S. exigua S. littoralis S. frugiperda 
29 + 58.5 + 9 + 3.5 92 ± 7.5 76 ± 3.7 35 ± 5.0 
22.5 + 58.5 + 9 + 10 
29 + 52 + 9 + 10 
86 ± 4.9 
84 ± 7.5 
87 ± 1.5 
86 ± 7.0 
53 ± 3.0 
52 ± 6.5 
12.5 + 58.5 + 9 + 20 92 ± 4.0 96 ± 5.5 83 ± 4.9 
29 + 42 + 9 + 20 88 ± 12 99 ± 1.3 82 ± 6.5 
4. DISCUSSION 
In this study, the toxicity of the Bt strain ABTS-1857 and of each of the 
four proteins that make up its crystal (Cry1Aa, Cry1Ab, Cry1Ca, and Cry1Da), was 
determined in S. exigua, S. littoralis and S. frugiperda larvae. The contribution of 
each of the expressed proteins to the toxicity of different artificial mixtures that 
included two, three, or four proteins was also elucidated. S. exigua larvae, was the 
most susceptible species for solubilized crystals from the Bt strain ABTS-1857, 
followed by S. littoralis and S. frugiperda as the least susceptible species, in line 
with the results of published previously (Hernández-Martínez et al., 2010; Horikoshi 
et al., 2019). The composition of the parasporal crystal of the strain ABTS-1857, 
was determined by proteomic analysis by which Cry1Aa, Cry1Ab, Cry1Ca, and 
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Cry1Da were quantified in relative proportions of 0.29, 0.585, 0.09, and 0.035, 
respectively (Caballero et al., unpublished data).  
Since the toxicity of a Bt isolate is due to the combination of different Cry 
proteins we first attempted to determine the concentration-mortality data of each of 
the individual Cry proteins in order to identify the protein or proteins that constitute 
the main mortality factor for each of the three species of Spodoptera. Cry1Aa and 
Cry1Ab, despite being the proteins with major representation in the crystal (29 and 
58,5%, respectively), showed low or no activity against the tested insects, as 
consistent with the results of previous studies (Xue et al., 2005; Yinghua et al., 
2017). Nevertheless, the two remaining proteins (Cry1Ca and Cry1Da), which 
represented just 12.5% of total toxin produced by the strain ABTS-1857, were both 
toxic to all three Spodoptera species, as reported previously (BenFarhat-Touzri et 
al., 2019; Hernández-Martínez et al., 2008; Jakka et al., 2014; Valicente et al., 2010; 
Van Frankenhuyzen, 2009). Toxicity of the Bt isolate can be attributed to the 
presence of both toxins, which are considered among the most toxic insecticidal 
proteins against Spodoptera species (Van Rie et al., 1989). Proteins with high 
insecticidal activity, albeit at a low abundance in the crystal, have been also reported 
by others (Masson et al., 1998). Rather than low expression per se, small amounts 
of these proteins might be required in order to function synergistically with other 
toxins (BenFarhat-Touzri et al., 2018; Chang et al., 2001).  
The three Spodoptera species tested in our study were not all equally 
susceptible to both proteins. Whether S. exigua showed to be very susceptible to 
Cry1Ca, S. littoralis was 3.3-fold more tolerant and S. frugiperda was resistant to 
this toxin in our study. In contrast, Cry1Da had low toxicity against the beet 
armyworm, but was highly toxic to the other species of Spodoptera. Determining the 
most toxic protein for each species can provide useful information for the 
development of future insecticidal products or engineering of transgenic plants 
(Christov et al., 2005; Lin et al., 2003).  
Proteins with no activity when inoculated individually may be very active 
when combined in a determined proportion (Ben-Dov, 2014; Monnerat et al., 2014). 
Consequently, we tested mixtures of 2 - 4 proteins to identify the most toxic 
combinations. Mixtures that included Cry1Ca where the most active against S. 
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exigua larvae (62-86% mortality) and S. littoralis (35-81% mortality), whereas 
mixtures containing Cry1Da appeared to be the most toxic to S. littoralis (46-81%) 
and S. frugiperda (21-33% mortality). A previous study reported toxicity of Cry1Ca 
against S. frugiperda (Soares Figueiredo et al., 2019). Lastly, a combination of the 
four proteins in the proportions in which they are found in the wild-type strain did not 
differ significantly in toxicity compared to the wild-type crystal. Furthermore, the 
toxicity of the artificial mixture was estimated for S. exigua and S. frugiperda larvae 
and no significant differences were detected for either of these species. The low 
proportion of Cry1Da, despite its high toxicity towards some Spodoptera species, 
suggests that this toxin was only required in small amounts in order to exert toxic 
activity (Chang et al., 2001; Masson et al., 1998). However, when Cry1Da was 
supplemented in the natural mixture, enhanced toxicity was detected in S. littoralis 
(BenFarhat-Touzri et al., 2018). We examined the effect of increasing the amount 
of Cry1Da with corresponding reductions in Cry1Aa or Cry1Ab. No effect was 
detected in S. exigua, probably due to the low performance of the toxin. However, 
increased mortality was recorded in S. littoralis and S. frugiperda when the 
concentration of Cry1Da was present at 10 or 20 ng/µl, whereas no differences were 
detected when the substituted proteins were Cry1Aa or Cry1Ab.  
In conclusion, experimental evidence on the role of each protein alone 
and in mixtures in the insecticidal activity of the wild-type strain was elucidated. We 
also corroborated previous findings on the relative proportions of Cry1Aa, Cry1Ab, 
Cry1Ca and Cry1Da in Bt ser. aizawai strain ABTS-1857 in terms of insect mortality 
when testing artificial mixtures containing the four solubilized crystal proteins 
compared to the toxicity of the natural solubilized crystal. 
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CHAPTER IV 
General discussion 
Bacillus thuringiensis-based products have been used worldwide as an 
alternative to chemical pesticides for pest control during the last decades. Recently, 
many chemical compounds have been banned by the authorities due to their 
negative effect on the ecosystem, including the killing of beneficial insects and 
pollinators, and the persistence of high levels of toxic residues on the food and 
water. This increase the risk for human health and the conservation of the 
environment affecting the survival of different animal and plant species (Carson et 
al., 2002; Fishel, 2016; Jarman and Ballschmiter, 2012; WHO, 1990). The mode of 
action of conventional chemical pesticides is not specific to target insects since they 
are nervous toxins and the nervous system is one of the most widespread life 
systems in the animal kingdom (Das, 2013). The repeated and systematic use of 
the same active ingredients has caused a high pressure of selection upon the insect 
population leading to the selection of resistant biotypes, which may show cross-
resistance events to different compounds, generating an alert upon companies of 
the sector (Tabashnik, 2008). An increasing need for alternatives to chemical 
pesticides has raised in the last decades, and microbial agents, among others, have 
proven effective, specific and secure in their use (Chandler et al., 2011). 
The entomopathogenic bacterium B. thuringiensis (Bt) was at first 
considered to be effective only for the control of lepidopteran species in the field. 
However, the discovery of new Bt isolates and novel insecticidal genes active 
against dipteran and coleopteran species (Goldberg and Margalit, 1977; Krieg et al., 
1983) expanded the host spectrum and B. thuringiensis turned out as the most used 
microbe for the development of biological solutions due to: 1) the huge variety of 
reported insecticidal genes which now cover the entire spectrum of hosts causing 
economic losses in crops and 2) because it is a facultative pathogen that can be 
produced in large fermenters at a very competitive cost. The insecticidal genes from 
Bt have been engineered to express one or more insecticidal proteins in order to 
obtain resistant plants to one or more insect pests (de Maagd et al., 1999; Zhao et 
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al., 2003). The active ingredient of Bt-based sprayable products is comprised by the 
spore and the parasporal crystal of a natural strain, which is responsible for the 
insecticidal potency and the host spectrum activity (Schnepf et al., 1998). The 
parasporal crystal is made up of proteins commonly known as delta-endotoxins (Cry 
and Cyt) which aggregate during the stationary phase of growth. Generally, Bt 
strains have been classified according to their flagellar antigen (H serotyping), which 
have led to Bt serovars subdivided in serotypes (Lecadet et al., 1999); however, this 
classification has no relation with the insecticidal activity of the strain. It was believed 
that strains belonging to the same serovar would harbour a similar arsenal of cry 
genes, such as cry1Ca and cry1Da in ser. aizawai strains, but this was dismissed. 
The genomic sequence of a Bt isolate provides essential information on the content 
of insecticidal genes. This information, although necessary, is not sufficient by itself 
to predict the potential target pests. Therefore, a very useful complementary 
information to anticipate the insecticide activity of the crystal produced by a Bt strain 
would consist in the knowledge of the proteins that are part of the crystal and the 
relative proportion each of them. Routine laboratory methods, including acrylamide 
gels (SDS-PAGE), are used to correlate the protein band patterns with the gene 
expression. However, this technique is not always reliable since many proteins that 
are very similar in their physicochemical characteristics and have the same 
electrophoretic mobility exhibit very different insecticidal properties. Thus, a key 
factor is the gene expression and their level of expression (Martinez et al., 2004; 
Porcar et al., 2000). An infallible tool to determine the toxicity is an in vivo bioassay 
using a described method according to the feeding behaviour of the target species 
(Navon and Ascher, 2000). But bioassays are a tough and time-consuming task 
where different factors, such as bacteria culture, preparation of dilutions, and in 
occasions the researcher’s subjectivity in mortality registration, may alter the results.  
The composition of chemical pesticides is reflected in the label of the 
products and described in detail providing the exact amount of each compound in 
the formulation. Regarding this information, appliers can identify which are the active 
molecules that give the product its insecticidal power (www.syngenta-
us.com/insecticides/) (Alewu B, 2018). However, and in contrast to traditional 
pesticides, Bt-based products only provide information related to the strain that is 
used as active ingredient, according to its H serotyping, and its potency, defined by 
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International Units (IU), which express the efficacy of an isolate compared to a 
defined Bt standard strain against a model insect (Dulmage, 1981). But the serovar 
of the Bt strains does not provide the users information referred to the insecticidal 
components responsible for the insecticidal activity, making the selection of the most 
suitable product a hard task for farmers. On the other hand, the IU only reflect the 
efficacy of the Bt strain compared to a single Bt standard strain against a certain 
insect pest. This value does not permit the users to predict the toxicity of the product 
against other insect species, but the reference used to estimate the IU. Companies 
usually provide appliers with commercial information about the products and 
indicate the gene content of the used Bt strains and very few venture to estimate 
the protein abundance present in the formulation, and when provided do not show 
how the prediction was made.  
The identification and quantification of the insecticidal components that are 
present in the synthetized parasporal crystal would allow to predict the insecticidal 
activity of a strain and fully characterize a Bt isolate unravelling the mystery within 
the crystal. Several attempts using different techniques have been made in order to 
quantify the relative abundance of d-endotoxins of Bt strains (Masson et al., 1998; 
Pusztai-Carey, M. & Carey, 1994; Yamamoto, 1983), but these approaches have 
not been successful when proteins with similar amino acid sequences are present 
in the same crystal. The main objective of this thesis was to develop a method that 
elucidated the presence and the relative molar proportion of each protein that make 
up the crystal of natural Bt strains (Chapter II). A mass spectrometry method (LC- 
MS/MS-MRM) using isotopically-labelled proteotypic peptides (SIL) was developed 
to accomplish this task and efficiently used to determine the parasporal composition 
of four Bt-based products that are most widely used today worldwide. The method 
was set up using two mixtures containing three Cry proteins (1Aa, 2Aa and 6Aa) 
that contained equal molar amounts of each of the toxins (1:1:1), and molar ratios 
of 43:13:43, respectively. The proteomic analysis output revealed a 32-35% of 
Cry1Aa, 24-26% of Cry2Aa and a 39-44% of Cry6Aa for the first mixture, and a 43-
46% of Cry1Aa, 6% of Cry2Aa and a 48-51% of Cry6Aa, for the second mixture. 
The obtained results were very consistent with the input proportions, certifying the 
accuracy and reproducibility of the method.  
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The validated proteomic method was applied to the parasporal inclusions 
of the Bt strains used as active ingredients in DiPel® DF, XenTari® GD, VectoBac® 
12S and Novodor®. One of the hardest tasks was to select proteotypic peptides for 
each protein in the mixture, due to the high similarity between the amino acidic 
sequences of some toxins, mainly those sharing up to 95% identity (Brun et al., 
2009; Crickmore et al., 2018), or due to difficulties, in terms of hydrophobicity, in the 
synthesis of some of them. The genomic sequencing revealed the presence of 5 
genes in the total DNA extracted from the Bt ser. kurstaki strain ABTS-351 (DiPel®). 
We corroborated the presence of 4 proteins in the crystal as indicated by the 
manufacturer (www.kenogard.com), but also quantified their molar rates (13-22% 
Cry1Aa, 16-29% Cry1Ab, 6-12% Cry1Ac and 40-64% Cry2Aa). This composition is 
consistent with the target species of this product, which turns to be wide due mainly 
to the presence of several Cry1A proteins that make up half of the crystal and a 
major Cry2 protein. These proteins are highly toxic to several leaf-feeding 
lepidopteran species such as, Helicoverpa armigera, Heliothis virescens, Mamestra 
brassicae, Trichoplusia ni or Lymantria dispar, excluding the genus Spodoptera, 
among others (Avilla et al., 2005; Bravo et al., 2011; Lenin et al., 2001; Li et al., 
2006). A total of 6 genes were identified in the Bt ser. aizawai strain ABTS-1857 
(XenTari®) but only 4 were expressed taking part in the parasporal crystal. The major 
protein was Cry1Ab (57-60%) followed by Cry1Aa (26-33%). Surprisingly the 
responsible toxins for the insecticidal activity towards Spodoptera species only 
represent 10-15% of the parasporal crystal (7-11% Cry1Ca and 3-4% Cry1Da) (Van 
Frankenhuyzen, 2009), which suggests a high toxicity effect of these two proteins. 
The genome of the Bt ser. israelensis strain AM65-52 (VectoBac®) harboured up to 
8 insecticidal genes but only 6 were detected according to the developed LC-
MS/MS-MRM method. Cyt1Aa was the major component of the parasporal crystal 
(38-61%) despite its low toxicity towards some dipteran species when administered 
alone (Ben-Dov, 2014). Almost half of the inclusion body was comprised by Cry4Ba 
(10-28%), Cry11Aa (10-27%) and Cry60Ba (5-12%), with a small contribution of 
Cry4Aa (2-4%) and Cry60Aa (2-4%). The insecticidal activity of the strain is mainly 
attributed to the Cry4 and Cry11 proteins, but the Cyt1Aa plays a crucial role in 
delaying the selection of resistant biotypes (Monnerat et al., 2014; Wirth et al., 
2005). The role of Cry60 proteins has not been yet elucidated, but their low 
proportion could suggest their contribution to toxicity via synergism effects or by 
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avoiding resistance. In the Bt ser. tenebrionis strain NB-74 (Novodor®) all the 
identified genes were expressed and the parasporal crystal was comprised by 
Cry3Aa, Cry23Aa and Cry37Aa proteins, 70-75%, 14-16%, 10-14% at molar ratios, 
respectively. The former protein is well studied and show a high toxicity effect 
against species of the orders Coleoptera, Hemiptera, and Hymenoptera (Kurt et al., 
2005; López-Pazos et al., 2009; Porcar et al., 2010; Van Frankenhuyzen, 2009). 
The latter proteins act as binary toxins, so both of them are needed in order to exert 
toxicity against some coleopteran species. It is believed that Cry37 facilitate the 
binding of the Cry23 which forms a toxic channel in midgut epithelial cells (Donovan 
et al., 2000). The estimated amount of each of the two components of this binary 
toxin was very similar, which is an indirect confirmation of the efficacy of the 
developed LC-MS/MS-MRM method.  
The composition of the parasporal crystal gives a very valuable information 
that allow researchers to predict the insecticidal potency as well as the host range 
of a certain Bt strain. However, in each insect species the interactions between the 
toxins that make up the crystal have a direct impact in mortality ratios. In this thesis 
we deeply studied the Bt ser. aizawai strain ABTS-1857 (Chapter III), used in the 
commercial product XenTari® and the role of each individual protein expressed in 
the parasporal crystal. First, we tested the solubilized natural strain against three 
species of the genus Spodoptera, including S. exigua, S. littoralis and S. frugiperda, 
in order to verify its activity as reported by other studies (Smith and Terry, 2001). 
The most susceptible insect was S. exigua with an estimated LC50 of 7.8 ng/µl 
followed by S. littoralis. which was 3.3-fold more tolerant, showing a LC50 of 28 ng/µl. 
S. frugiperda larvae showed a much higher LC50, scoring 120.2 ng/µl to kill 50% of 
the insect population. According to these results we could confirm the toxicity of the 
Bt strain ABTS-1857 towards the tested Spodoptera species but remarked that 
susceptibility is dependent on species. This event could be due to the different 
activity of individual toxins, so we estimated their toxic effect against each pest 
under the same laboratory conditions. The major proteins that comprised the 
parasporal crystal, Cry1Aa and Cry1Ab, did not perform well when administered to 
second instar larvae (LC50 > 300 ng/µl) as previously described (Hernández-
Martínez et al., 2008; Yinghua et al., 2017), although some authors have indicated 
a toxicity of Cry1Ab towards S. exigua, we did not obtain mortalities over 30% at the 
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maximum concentration (Hernández-Martínez et al., 2008; MacIntosh et al., 1990; 
Moar et al., 1990). According to several studies, Cry1Ca and Cry1Da are the main 
responsible proteins for the toxicity against the cotton leafworm and the armyworms 
(Lee et al., 2001; Porcar et al., 2000; Van Rie et al., 1989). S. exigua turned to be 
very susceptible to the former protein (LC50 = 3.1 ng/µl) but not to the latter protein 
(LC50 = 83 ng/µl) (Luo et al., 1999). Cry1Ca and Cry1Da showed to be equally active 
against S. littoralis larvae, with estimated LC50 values of 19.8 ng/µl and 19.6 ng/µl, 
respectively. We observed that S. frugiperda was only susceptible to Cry1Da with a 
calculated LC50 = 10.3 ng/µl, as previously described. However, some authors also 
report a positive effect of Cry1C against the fall armyworm whether by exerting a 
weak toxicity or by forming cation channels in the brush border membrane of the 
larvae (Lorence et al., 1995; Luo et al., 1999). According to these resulted we 
concluded that i) Cry1Ca was the best protein for the control of the beet armyworm, 
ii) Cry1Ca and Cry1Da caused the same mortal effect on the cotton leafworm, and 
iii) Cry1Da was the only protein, within the crystal of the Bt strain ABTS-1857, toxic 
for the fall armyworm. It is important to notice that the obtained results in a laboratory 
are subjected to the populations used and maintained in it, meaning that the same 
crystal protein dilutions may perform different against other insect populations 
maintained elsewhere or natural populations. Some reports have concluded 
different susceptibilities of S. exigua populations when treated with the Cry1Ca 
protein, supporting this idea (Hernández-Martínez et al., 2008). Field trials are then 
mandatory when registering a Bt-based product, preferably at the locations where 
the biopesticide will be sprayed out. 
Proteins in a mixture may interact having an important impact in the 
mortality results. The mode of action of Cry proteins in lepidopterans has been 
widely studied and interactions with specific receptors located in the brush border 
of epithelial cells of the midgut seems to be a crucial step for their high specificity 
(Gómez et al., 2007; Soberón et al., 2016). However, some crystal toxins may share 
binding sites in some insect populations which leads to variations in susceptibility or 
the appearance of cross-resistance events (Hernández and Ferré, 2005). In this 
work we studied the effect of different artificial mixtures containing two, three or four 
Cry1 proteins according to their concentration in 100 ng/µl of solubilized Cry1 crystal 
proteins (29 -Aa, 58.5 -Ab, 9 -Ca and 3.5 ng/µl -Da) against the three Spodoptera 
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species. For S. exigua all combinations that contained Cry1Ca performed much 
better than those without it, scoring mortalities from 62-86%. These results are 
consistent with the high toxicity observed when inoculated individually. We 
corroborated the absence of synergism between Cry1Aa and Cry1Ab, which were 
not toxic when inoculated individually, as suggested by other authors (Moar et al., 
1990). Nevertheless, we could not detect the described synergistic effect when 
larvae were treated simultaneously with Cry1Aa and Cry1C (Xue et al., 2005) at the 
tested concentrations. For S. littoralis we observed that Cry1Ca and Cry1Da gave 
the same activity when combined with the rest of the proteins in mixtures of two or 
three toxins, and the best results were obtained when administered together, 
reaching 71 ± 18.7% mortality with the Cry1Ca + Cry1Da mixture, and 81± 10.3% 
with the Cry1Ab + Cry1Ca + Cry1Da mixture. For S. frugiperda only combinations 
that contained Cry1Da showed insecticidal activity towards second instar larvae as 
expected, reaching up to around 33% mortality in the best cases (Cry1Ab + Cry1Da; 
Cry1Ca + Cry1Da or Cry1Ab + Cry1Ca + Cry1Da). An artificial combination that 
contained the four proteins in the estimated concentration of 29, 58.5, 9 and 3.5 
ng/µl for each protein (Cry1-Aa, -Ab, -Ca and -Da, respectively), was tested and 
compared to the natural mixture found in the wildtype strain ABTS-1857. No 
significant differences were detected between the artificial and the natural mixture 
(p>0.05) when treating the three Spodoptera species. Furthermore, the LC50 of the 
artificial mixture was estimated for S. exigua (9.9 ng/µl) and S. frugiperda larvae 
(188.1 ng/µl) and the potency of the insecticidal protein combination was compared 
to that obtained for the parasporal crystal of the wildtype strain. No significant 
differences were obtained for neither of the two species. This data supports the 
hypothesis of the determined proportions for the four Cry1 proteins in the parasporal 
crystal of the strain ABTS-1857. 
According to some researchers Cry1D is only required in small amounts in 
order to exert toxicity when in presence of other toxins, including Cry1C (Chang et 
al., 2001; Masson et al., 1998). However, this hypothesis was discarded when 
increasing amounts of Cry1D, along with the natural strain HD-133, resulted in 
higher mortality rates for S. littoralis larvae (BenFarhat-Touzri et al., 2018). In our 
research we introduced some changes in the molar ratios of the four proteins, and 
increased the proportion of Cry1Da, from 3.5% to 20%, combined with decreased 
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amounts of either Cry1Aa or Cry1Ab. We demonstrated that increasing amounts of 
Cry1Da resulted in higher toxicity for S. littoralis and specially for S. frugiperda, 
reaching up to 96-100% and 83-88% mortality, respectively, at higher molar ratios 
of Cry1Da. No apparent differences were detected when the increments were made 
in substitution of Cry1Aa or Cry1Ab.  
The use of B. thuringiensis as microbial control agent presents many 
advantages compared to chemical pesticides, including the high specificity of its 
insecticidal crystal proteins and the security for non-target organisms. A huge 
number of genes have been described, meaning an enormous reservoir of 
insecticidal weapons to combat different pests belonging to different orders. We 
have demonstrated that the development of a method to determine the qualitative 
and quantitative abundance of crystal proteins is of great interest to fully 
characterize Bt isolates and enable the prediction of their potency and host range 
activity.  
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CONCLUSIONES 
 
1. Se ha puesto a punto un método rápido, fiable y preciso que permite determinar 
la composición cualitativa y cuantitativa del cristal de las cepas de Bacillus 
thuringiensis. La aplicación eficiente del método requiere disponer de 
información sobre la secuencia completa del genoma y de las proteínas que 
presumiblemente forman parte del cristal. Los péptidos proteotípicos de cada 
proteína presente en cristal se identifican mediante cromatografía líquida 
acoplada a un espectrómetro de masas (LC-MS/MS) en combinación con una 
monitorización de múltiples reacciones (MRM). La síntesis de dichos péptidos, 
marcados isotópicamente (SIL), permite determinar la proporción molar relativa 
de cada proteína en el cristal.  
2. Para validar el método, se emplearon las proteínas Cry1Aa, Cry2Aa y Cry6Aa 
y se determinó su proporción relativa en dos mezclas artificiales donde sus 
respectivas concentraciones molares fueron (1:1:1) y (13:1:13). La fiabilidad y 
precisión de los resultados obtenidos permitieron verificar la utilidad del método 
para el propósito que ha sido desarrollado. 
3. El método puesto a punto se empleó con éxito para determinar la composición 
cualitativa y cuantitativa del cristal de las cepas Bt que constituyen el 
ingrediente activo de cuatro de los productos comerciales más utilizados en el 
control de plagas de lepidópteros (DiPel® DF y XenTari® GD), dípteros 
(VectoBac® 12AS) y coleópteros (Novodor®). 
4. Se confirmó la toxicidad del producto comercial XenTari® GD para las tres 
especies del género Spodoptera (S. exigua, S. littoralis y S. frugiperda) 
evaluadas. No obstante, el valor estimado de la CL50 para la mezcla de esporas 
y cristales producida por la cepa ABTS-1857 fue significativamente diferente 
para larvas L2 de S. exigua (7.8 ng/µl), S. littoralis (28.0 ng/µl) y S.frugiperda 
(120.2 ng/µl).  
5. Las proteínas individuales (Cry1Aa, Cry1Ab, Cry1Ca y Cry1Da) que componen 
el cristal de la cepa ABTS-1857, mostraron una toxicidad especifica para cada
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una de las tres especies de Spodoptera. La toxicidad de Cry1Aa y Cry1Ab fue 
muy baja para las tres especies de Spodoptera (CL50 > 300 ng/µl). Cry1Ca fue 
la más tóxica para larvas de S. exigua (CL50= 3.1 ng/µl) seguida por Cry1Da 
(CL50= 83 ng/µl). Las larvas de S. littoralis fueron igualmente susceptibles a 
Cry1Ca (19.8 ng/µl) y Cry1Da (19.6 ng/µl), mientras que las larvas de S. 
frugiperda sólo fueron susceptibles a Cry1Da (CL50= 10.3 ng/µl). 
6. Se analizaron distintas combinaciones de dos, tres o cuatro proteínas del cristal 
de la cepa ABTS-1857, para determinar posibles interacciones entre ellas. Las 
combinaciones que incluían Cry1Ca fueron las que presentaron una mayor 
actividad (62-86%) para larvas L2 de S. exigua. Las larvas L2 de S. littoralis 
fueron más susceptibles a las mezclas que incluían Cry1Ca y Cry1Da (71-
81%). Todas las combinaciones que incluían la proteína Cry1Da presentaron 
los porcentajes de mortalidad más elevados (21-33%) en larvas L2 de S. 
frugiperda. 
7. Se demostró experimentalmente que los valores de la CL50 estimados para la 
mezcla de espora y cristales de la cepa silvestre ABTS-1857 en larvas L2 de S. 
exigua y S. frugiperda no difirieron estadísticamente de los valores obtenidos 
para una mezcla artificial de las cuatro proteínas recombinantes simulando la 
composición natural del cristal.  
8.  La actividad insecticida de mezclas artificiales con crecientes concentraciones 
de Cry1Da, en detrimento de Cry1Aa o Cry1Ab, resultó en un notable 
incremento de la mortalidad larvaria en S. littoralis (10-20%) y en S. frugiperda 
(15-50%). Este efecto se atribuyó a la susceptibilidad de ambas especies a 
Cry1Da. En cambio, dicho efecto no se observó en las larvas de S. exigua, 
debido a la baja toxicidad de Cry1Da para esta especie. 
9. Los resultados de esta tesis doctoral son de gran aplicación en la 
caracterización de productos basados en Bt y proporciona información sobre el 
posible rango de huéspedes de insecticidas si se conoce la toxicidad de los 
componentes del cristal. Adicionalmente, permite un preciso y fiable control de 
calidad de los distintos lotes de Bt producidos a nivel industrial y el control de 
calidad del producto final. 
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CONCLUSIONS 
 
1. A fast, reliable and precise method has been developed to determine the 
qualitative and quantitative crystal composition of B. thuringiensis strains. For 
an efficient application of the method the information related to the complete 
sequence of the genome and the proteins that are presumably present in the 
crystal are required. The proteotypic peptides of each protein that make up the 
crystal are identified by liquid chromatography coupled to a mass spectrum(LC-
MS/MS) in combination with multiple monitored reactions (MRM). The synthesis 
of isotopically labelled peptides (SIL), allow the determination of the relative 
molar proportion of each protein in the crystal. 
2. To validate the method, the Cry1Aa, Cry2Aa and Cry6Aa proteins were used 
and their relative proportion was determined in two artificial mixtures with (1: 1: 
1) and (13: 1: 13) molar concentrations, respectively. The reliability and 
precision of the obtained results allowed us to verify the usefulness of the 
method for the purpose to which has been developed 
3. The developed method was successfully applied to determine the qualitative 
and quantitative composition of the crystal of the Bt strains that constitute the 
active ingredient of four of the most used commercial products for the control of 
lepidopteran (DiPel® DF and XenTari® GD), dipteran (VectoBac® 12AS) and 
coleopteran pests (Novodor®). 
4. The toxicity of the commercial product XenTari® GD against three species of 
the genus Spodoptera (S. exigua, S. littoralis and S. frugiperda) was confirmed. 
However, the estimated value of the LC50 for the mixture of spores and crystals 
produced by the strain ABTS-1857 was significantly different for S. exigua (7.8 
ng/μl), S. littoralis (28.0 ng/μl) and S. frugiperda (120.2 ng/µl) second instar. 
5. The individual proteins (Cry1Aa, Cry1Ab, Cry1Ca and Cry1Da) that make up 
the crystal of the strain ABTS-1857, showed a specific toxicity for each of the 
three Spodoptera species. Cry1Aa and Cry1Ab showed a very low toxicity for 
the three species of Spodoptera (LC50 > 300 ng/μl). Cry1Ca was the most toxic
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 protein for of S. exigua larvae (LC50 = 3.1 ng/µl) followed by Cry1Da (LC50 = 83 
ng/µl). S. littoralis second instar were equally susceptible to Cry1Ca (19.8 ng/µl) 
and Cry1Da (19.6 ng/µl), whereas S. frugiperda was only susceptible to the 
Cry1Da protein (LC50 = 10.3 ng/µl). 
6. Different combinations containing two, three or four crystal proteins of the strain 
ABTS-1857 were analyzed to determine possible interactions between them. 
The combinations that included Cry1Ca showed the highest activity (62-86%) 
for S. exigua larvae. S. littoralis second instar were more susceptible to mixtures 
that contained the Cry1Ca and Cry1Da proteins (71-81%). All combinations that 
included the Cry1Da protein showed the highest mortality percentages (21-
33%) in S. frugiperda. 
7. The estimated LC50 values for the mixture of spores and crystals of the wild 
strain ABTS-1857 in S. exigua and S. frugiperda second instar were not 
statistically different from the obtained values for an artificial mixture that 
contained the four recombinant proteins simulating the natural composition of 
the crystal. 
8.  The insecticidal activity of artificial mixtures with increased concentrations of 
Cry1Da to the detriment of Cry1Aa or Cry1Ab, resulted in a notable increase in 
larval mortality in S. littoralis (10-20%) and S. frugiperda (15-50%). This effect 
was attributed to the fact that both species are quite susceptible to the Cry1Da 
protein. In contrast, this effect was not observed in S. exigua larvae, due to the 
low toxicity of Cry1Da for this species. 
9. The results obtained in this doctoral thesis are of great application in the 
characterization of Bt-based products and provide information on the possible 
range of insecticide hosts if the toxicity of the crystal components is known. 
Additionally, it allows a precise and reliable quality control of different batches 
in the industrial production of Bt and the quality control of the final product. 
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Figure S1. Example MS/MS spectra and extracted ion chromatograms of targeted proteotypic 
peptides in protein mixtures analysed by LC-MS/MS-MRM. MS/MS spectrum (y-ions and b-
ions) of a targeted proteotypic peptide, and extracted ion chromatograms showing the five 
monitored transitions for the endogenous peptide (left) and the SIL (heavy)-labelled peptide 
(right) of a targeted peptide of Cry1Aa (A), Cry2Aa (B), and Cry6Aa (C) present in mixtures 
comprising known amounts of these three proteins. Data in (A), (B), and (C) are from the 
dataset shown in Table A1. 
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Figure S1. Continued 
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Figure S1. Continued. 
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Figure S2. SDS-PAGE analysis of spore and crystal preparations, and solubilized proteins 
from four Bt strains grown from insecticide products. Bt spores were isolated directly from the 
commercial products and grown in CCY medium until lysis of sporulated cells. Mixtures of 
spores and crystals were sedimented by centrifugation and washed in distilled water. A total 
amount ranging from 5-10 µg of sample were loaded per lane. Different major protein bands 
were detected in the spore and crystal samples. DiPel® DF revealed the presence of two major 
bands at 130 kDa and 70 kDa, which may correspond to Cry1 and Cry2 proteins, respectively, 
while a protein band of 130 kDa was detected in the XenTari® GD sample, which is consistent 
with the presence of Cry1 protein. In VectoBac® 12S the three observed protein bands of 130 
would correspond to Cry4 and Cry10, while the protein bands of 70 and 25 kDa would 
correspond to Cry11, and Cry60 and Cyt1 proteins, respectively. In the Novodor® sample a 
major band at 70kDa was resolved, in agreement with the size of Cry3 proteins. Cry23 and 
Cry37 in this product would be represented by the bands at 30 and 15 kDa, respectively. 
Three independent biological replicates were evaluated. 
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Figure S3. Proteins and proteotypic peptides selected for Dipel® DF (A), XenTari® GD (B), 
VectoBac® 12AS (C) and Novodor® (D) crystals. These peptides were detected in the IDA 
analysis and checked against the in silico digestion results. The location of the proteotypic 
peptides (orange bands) within full-length proteins (blue bars) are shown. Lower cases with 
numbers represent the initial and last amino acid within the sequence; and upper cases 
represent the amino acid sequence of each of the proteotypic peptides in each protein, 
indicating their position with numbers within the whole protein with different letters 
corresponding to different amino acids and the number indicating the position of the amino 
acid in the protein. 
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Figure S3. Continued. 
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Table S1. Proteotypic peptides in Cry protein mixtures. The protein mixtures contained 
Cry1Aa, Cry2Aa, and Cry6Aa proteins. Cry proteins were subjected to in silico tryptic 
digestion. The target peptides used to quantify the Cry proteins are shown in bold. Residues 
in parentheses are the previous and subsequent amino acid in the protein sequence.  
Protein Proteotypic peptide sequence (N to C) Position in protein 
Cry 1Aa (R)VCPGR(G) 
(R)GMAQR(I)  
(R)VTAYK(E)  
(K)IDESK(L)  
(R)VHSIR(E)  
(R)LSDER(N)  
(R)GYILR(V)  
(R)AGFSHR(L)  
(K)CGEPNR(C)  
(R)NQAISR(L)  
(K)SYTDGR(R)  
(R)YNQFR(R)  
(K)QELSEK(V)  
(R)IEEFAR(N)  
(R)IEQNIR(Q)  
(R)YNDLTR(L)  
(K)TQDGHAR(L)  
(R)TVSQLTR(E)  
(R)VWGPDSR(D)  
(R)DVSVFGQR(W)  
(R)TLSSPLYR(R)  
(R)ENPCEFNR(G)  
(R)WYNTGLER(V)  
(R)TSPGQISTLR(V)  
(K)GPGFTGGDILR(R)  
(R)VNITAPLSQR(Y)  
(R)NLLQDPNFR(G)  
(R)APTFSWQHR(S)  
(K)STNLGSGTSVVK(G)  
(R)WGFDAATINSR(Y)  
(K)ELEYFPETDK(V)  
(R)LIGNYTDYAVR(W)  
(K)LEWETNIVYK(E)  
(R)IFTAFSLYDAR(N)  
(R)DYTPLPVGYVTK(E)  
(R)EWEADPTNPALR(E)  
(K)GHVDVEEQNNQR(S)  
(R)GSTDITIQGGDDVFK(E)  
(K)NGDFNNGLSCWNVK(G)  
(K)AVNELFTSSNQIGLK(T)  
(R)GYIEDSQDLEIYLIR(Y)  
(R)CAPHLEWNPDLDCSCR(D)  
(R)EIYTNPVLENFDGSFR(G)  
(R)LEGLSNLYQIYAESFR(E)  
(R)LSHVTMLSQAAGAVYTLR(A)  
(R)SVLVLPEWEAEVSQEVR(V)  
(R)GTVDSLDVIPPQDNSVPPR(A)  
(R)GYNEAPSVPADYASVYEEK(S)  
1022-1026 
282–286 
1032–1036 
737–741 
935–939 
676–680 
1027–1031 
425–430 
794–799 
94–99 
1113–1118 
229–233 
664–669 
88–93 
287–292 
193–198 
852–858 
259–265 
218–224 
174–181 
360–367 
1120–1127 
210–217 
502–511 
490–500 
512–521 
681–689 
449–457 
478–489 
182–192 
1143–1152 
199–209 
892–901 
964–974 
1131–1142 
116–127 
993–1004 
701–715 
979–992 
622–636 
752–766 
800–815 
266–281 
100–115 
431–448 
1005–1021 
406–424 
1094–1112 
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(R)LGNLEFLEEKPLVGEALAR(V)  
(R)IEFVPAEVTFEAEYDLER(A)  
(R)ELTLTVLDIVALFSNYDSR(R)  
(R)SAEFNNIIPSSQITQIPLTK(S)  
(R)QPHLMDILNSITIYTDVHR(G)  
(K)EGYGEGCVTIHEIENNTDELK(F)  
(K)HETVNVPGTGSLWPLSAQSPIGK(C)  
(K)ENYVTLLGTFDECYPTYLYQK(I)  
(R)EAYLPELSVIPGVNAAIFEELEGR(I)  
(K)VWIEIGETEGTFIVDSVELLLMEE(-)  
(K)TDVTDYHIDQVSNLVECLSDEFCLDEK(Q)  
(-)MDNNPNINECIPYNCLSNPEVEVLGGER(I)  
(K)ESVDALFVNSQYDQLQADTNIAMIHAADK(R)  
(K)CAHHSHHFSLDIDVGCTDLNEDLGVWVIFK(I)  
(R)TVGFTTPFNFSNGSSVFTLSAHVFNSGNEVYIDR(I)  
(R)IILGSGPNNQELFVLDGTEFSFASLTTNLPSTIYR(Q)  
(K)FSNCVEEEIYPNNTVTCNDYTVNQEEYGGAYTSR(N) 
859–877 
601–618 
235–253 
458–477 
293–311 
1037–1057 
771–793 
716–736 
940–963 
1153–1176 
637–663 
1–28 
905–933 
820–849 
567–600 
369–403 
1058–1091 
Cry 2Aa (K)GLNTR(L)  
(R)VTINGR(V)  
(K)VGSLIGK(R)  
(R)CGAFSAR(G)  
(R)TFISEK(F)  
(K)SLDTIQK(E)  
(R)LNTDTLAR(V)  
(K)EWMEWK(R)  
(K)FGNQGDSLR(F)  
(-)MNNVLNSGR(T)  
(R)VSSIGNSTIR(V)  
(R)SWLDSGTDR(E)  
(R)FEQSNTTAR(Y)  
(R)AYLVSVHNR(K)  
(R)LHDMLEFR(T)  
(R)NISGVPLVIR(N)  
(R)ETEQFLNQR(L)  
(R)NIESPSGTPGGAR(A)  
(R)GNGNSYNLYLR(V)  
(R)VNAELIGLQANIR(E)  
(R)GNSNYFPDYFIR(N)  
(R)NEDLTRPLHYNQIR(N)  
(R)DYSNYCINTYQSAFK(G)  
(R)DVILNADEWGISAATLR(T)  
(R)TDHSLYVAPVVGTVSSFLLK(K)  
(R)TYMFLNVFEYVSIWSLFK(Y)  
(R)TTICDAYNVVAHDPFSFEHK(S)  
(R)VYTVSNVNTTTNNDGVNDNGAR(F)  
(R)EGVATSTNWQTESFQTTLSLR(C)  
(R)LSITFPNIGGLPGSTTTHSLNSAR(V)  
(R)ILSELWGIIFPSGSTNLMQDILR(E)  
(R)LPQFQIQGYQLLLLPLFAQAANLHLSFIR(D)  
(R)VNYSGGVSSGLIGATNLNHNFNCSTVLPPLSTPFVR(S) 
233–237 
559–564 
65–71 
406–412 
510–515 
30–36 
105–112 
37–42 
516–524 
1–9 
549–558 
376–384 
525–533 
462–470 
238–245 
425–434 
96–104 
449–461 
538–548 
113–125 
413–424 
435–448 
218–232 
190–206 
44–63 
246–263 
10–29 
565–586 
385–405 
316–339 
73–95 
161–189 
340–375 
Cry 6Aa 
 
 
 
(K)LNSNK(K)  
(K)TTLPR(H)  
(K)TTLER(T)  
(K)DGYFK(K)  
(K)ELLEK(V)  
20–24 
7–11 
234–238 
128–132 
224–228 
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(R)CGILIK(E)  
(-)MIIDSK(T)  
(K)VAGDPSIK(K)  
(K)AEQDLEK(K)  
(K)QYEEAAK(N)  
(K)NQIDEIK(K)  
(R)NSNLEYK(C)  
(R)HSLIHTIK(L)  
(K)NLYPLIIK(S)  
(K)LEGVINIQK(R)  
(K)TSAEWWNK(N)  
(K)SANDIASYGFK(V)  
(K)QLDSAQHDLDR(D)  
(R)DFTLNAYSTNSR(Q)  
(K)NIVTSLDQFLHGDQK(K)  
(K)YGPGDMTNGNQFIISK(Q)  
(K)LQGIWATIGAQIENLR(T)  
(K)EVQTALNQAHGESSPAHK(E)  
(K)LQDELDNIVDNNSDDDAIAK(A)  
(K)IIGMLNSINTDIDNLYSQGQEAIK(V)  
(K)QEWATIGAYIQTGLGLPVNEQQLR(T)  
(R)THVNLSQDISIPSDFSQLYDVYCSDK(T)  
(K)VEYSFLLGPLLGFVVYEILENTAVQHIK(N)  
(K)CPENNFMIYWYNNSDWYNNSDWYNN(-)  
(R)TTSLQEVQDSDDADEIQIELEDASDAWLVVAQEAR(D) 
162–167 
1–6 
119–126 
242–248 
171–177 
278–284 
444–450 
12–19 
100–107 
194–202 
92–99 
108–118 
286–296 
379–390 
178–192 
26–41 
328–343 
206–223 
134–153 
300–323 
42–65 
66–91 
250–277 
451–475 
344–378 
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Table S2. MRM parameters for the detection and quantification of proteotypic peptides used 
for the quantification of Cry proteins in defined laboratory mixtures of Cry1Aa, Cry2Aa, and 
Cry6Aa proteins. The parameters were obtained after the analysis of two mixtures with 
different molar ratios of the proteins (from 13% to 43%). Two independent tryptic digestions 
of each protein mixture and two separate analyses for each digested sample were performed  
Protein Peptide sequence (N to C) 
Precursor 
ion 
(m/z) 
Collision 
energy 
(V) 
Product 
ion 
(m/z) 
(z=+1) 
Fragment 
ion 
Cry1Aa APTFSWQHR 565.3 
(z=+2) 
28.0 961.5 
860.4 
713.3 
626.3 
440.2 
y7 
y6 
y5 
y4 
y3 
  570.3 
(z=+2) 
28.0 971.5 
870.4 
723.4 
636.3 
450.2 
y7 
y6 
y5 
y4 
y3 
 VNITAPLSQR 549.8 
(z=+2) 
27.1 999.6 
885.5 
772.4 
671.4 
600.3 
y9 
y8 
y7 
y6 
y5 
  554.8 
(z=+2) 
27.1 1009.6 
895.5 
782.4 
681.4 
610.4 
y9 
y8 
y7 
y6 
y5 
Cry2Aa ETEQFLNQR 582.8 
(z=+2) 
29.0 934.5 
805.4 
677.4 
530.3 
417.2 
y7 
y6 
y5 
y4 
y3 
  587.8 
(z=+2) 
29.0 944.5 
815.4 
687.4 
540.3 
427.2 
y7 
y6 
y5 
y4 
y3 
 VNAELIGLQANIR 705.9 
(z=+2) 
36.0 884.5 
771.4 
714.4 
601.3 
473.3 
y8 
y7 
y6 
y5 
y4 
  710.9 
(z=+2) 
36.0 894.5 
781.5 
724.4 
611.4 
483.3 
y8 
y7 
y6 
y5 
y4 
 VYTVSNVNTTTNNDGVND
NGAR 
1163.0 
(z=+2) 
62.0 646.3 
532.2 
y6 
y5 
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417.2 
303.2 
701.3 
y4 
y3 
b3 
  1168.0 
(z=+2) 
62.0 656.3 
542.3 
427.2 
313.2 
364.2 
y6 
y5 
y4 
y3 
b3 
  775.7 
(z=+3) 
31.1 646.3 
532.2 
417.2 
303.2 
364.2 
y6 
y5 
y4 
y3 
b3 
  779.0 
(z=+3) 
31.1 656.2 
542.3 
427.2 
313.2 
364.2 
y6 
y5 
y4 
y3 
b3 
Cry6Aa SANDIASYGFK 586.8 
(z=+2) 
29.2 1014.5 
900.4 
785.4 
672.3 
601.3 
y9 
y8 
y7 
y6 
y5 
  590.8 
(z=+2) 
29.2 1022.5 
908.5 
793.4 
680.3 
609.3 
y9 
y8 
y7 
y6 
y5 
 QLDSAQHDLDR 649.3 
(z=+2) 
32.7 941.4 
783.4 
655.3 
518.3 
403.2 
y8 
y6 
y5 
y4 
y3 
  654.3 
(z=+2) 
32.7 951.5 
793.4 
665.3 
528.3 
413.2 
y8 
y6 
y5 
y4 
y3 
  433.2 
(z=+3) 
20.5 854.4 
783.4 
655.3 
518.3 
403.2 
y7 
y6 
y5 
y4 
y3 
  436.5 
(z=+3) 
20.5 864.4 
793.4 
665.3 
528.3 
413.2 
y7 
y6 
y5 
y4 
y3 
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Table S3. Proteotypic peptides of Cry proteins predicted by in silico tryptic digestion of DiPel® 
DF crystals. The target peptides used to quantify the Cry proteins are shown in bold. Residues 
in parentheses are the previous and subsequent amino acids in the protein sequence 
Protein Proteotypic peptide (N to C) Position in protein 
Cry1Aa (R)GMAQR(I) 
(R)AGFSHR(L) 
(R)IEQNIR(Q) 
(R)TLSSPLYR(R) 
(R)APTFSWQHR(S) 
(R)LSHVTMLSQAAGAVYTLR(A) 
(R)GTVDSLDVIPPQDNSVPPR(A) 
(R)ELTLTVLDIVALFSNYDSR(R) 
(R)QPHLMDILNSITIYTDVHR(G) 
(R)IILGSGPNNQELFVLDGTEFSFASLTTNLPSTIYR(Q) 
282–286 
425–430 
287–292 
360–367 
449–457 
431–448 
406–424 
235–253 
293–311 
369–403 
Cry1Ab (R)TYPIR(T) 
(K)AYTDGR(R) 
(R)DNPCESNR(G) 
(R)TLSSTLYR(R) 
(R)GSAQGIEGSIR(S) 
(R)SGFSNSSVSIIR(A) 
(R)LIGNYTDHAVR(W) 
(K)GHVDVEEQNNHR(S) 
(R)GYGDYTPLPAGYVTK(E) 
(R)LQADTNIAMIHAADK(R) 
(K)ESVDALFVNSQYDR(L) 
(R)ELTLTVLDIVSLFPNYDSR(T) 
(K)HETVNVPGTGSLWPLSAPSPIGK(C) 
(R)GYDGAYESNSSVPADYASAYEEK(A) 
(K)FSNCVEEEVYPNNTVTCNDYTATQEEYEGTYTSR(N) 
254–258 
1092–1097 
1099–1106 
361–368 
282–292 
438–449 
199–209 
968–979 
1107–1121 
894–908 
880–893 
235–253 
772–794 
1069–1091 
1033–1066 
Cry1Ac (R)GSAQGIER(S)  
(R)TLSSTFYR(R) 
(R)NLLQDSNFK(D) 
(R)SGSSSSVSIIR(A) 
(R)LNSSGNNIQNR(G)  
(R)NFSGTAGVIIDR(F)  
(K)AVNALFTSTNQLGLK(T)  
(R)GYIEVPIHFPSTSTR(Y)  
(R)GWGGSTGITIQGGDDVFK(E) 
(R)SAEFNNIIASDSITQIPAVK(G)  
(R)FEFIPVTATLEAEYNLER(A)  
(R)ELTLTVLDIVALFPNYDSR(R)  
(K)GNFLFNGSVISGPGFTGGDLVR(L)  
(K)ENYVTLSGTFDECYPTYLYQK(I)  
(K)TNVTDYHIDQVSNLVTYLSDEFCLDEK(R) 
282–289 
361–368 
682–690 
438–448 
500–510 
590–601 
623–637 
511–525 
699–716 
458–477 
602–619 
235–253 
478–499 
717–737 
638–664 
Cry2Aa (K)VGSLIGK(R) 
(R)CGAFSAR(G) 
(K)SLDTIQK(E) 
(K)EWMEWK(R) 
(-)MNNVLNSGR(T) 
(R)SWLDSGTDR(E) 
(R)FEQSNTTAR(Y) 
65–71 
406–412 
30–36 
37–42 
1–9 
376–384 
525–533 
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(R)AYLVSVHNR(K) 
(R)NISGVPLVIR(N) 
(R)ETEQFLNQR(L) 
(R)NIESPSGTPGGAR(A) 
(R)VNAELIGLQANIR(E) 
(R)NEDLTRPLHYNQIR(N) 
(R)DYSNYCINTYQTAFR(G) 
(R)TDHSLYVAPVVGTVSSFLLK(K) 
(R)TTICDAYNVVAHDPFSFEHK(S) 
(R)VYTVSNVNTTTNNDGVNDNGAR(F) 
(R)EGVATSTNWQTESFQTTLSLR(C) 
(R)LSITFPNIGGLPGSTTTHSLNSAR(V) 
(R)ILSELWGIIFPSGSTNLMQDILR(E) 
(R)VNYSGGVSSGLIGATNLNHNFNCSTVLPPLSTPFVR(S) 
462–470 
425–434 
96–104 
449–461 
113–125 
435–448 
218–232 
44–63 
10–29 
565–586 
385–405 
316–339 
73–95 
340–375 
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Table S4. Proteotypic peptides of Cry proteins predicted by in silico tryptic digestion of 
XenTari® GD crystals. The target peptides used to quantify the Cry proteins are shown in bold. 
Residues in parentheses are the previous and subsequent amino acids in the protein 
sequence 
Protein Proteotypic peptide (N to C) Position in protein 
Cry1Aa (R)GMAQR(I) 
(R)AGFSHR(L) 
(R)IEQNIR(Q) 
(R)TLSSPLYR(R) 
(R)APTFSWQHR(S) 
(R)LIGNYTDYAVR(W) 
(R)LSHVTMLSQAAGAVYTLR(A) 
(R)GTVDSLDVIPPQDNSVPPR(A) 
(R)ELTLTVLDIVALFSNYDSR(R) 
(R)SAEFNNIIPSSQVTQIPLTK(S) 
(R)QPHLMDILNSITIYTDVHR(G) 
(K)HETVNVPGTGSLWPLSAQSPIGK(C) 
(K)VWIEIGETEGTFIVDSVELLLMEEVDA(-) 
(R)TVGFTTPFNFPNGSSVFTLSAHVFNSGNEVYIDR(I) 
(R)IILGSGPNNQELFVLDGTEFSFASLTTNLPSTIYR(Q) 
(K)FSNCVEEEVYPNNTVTCNDYTATQEEYEGTYTSR(N) 
282–286 
425–430 
287–292 
360–367 
449–457 
199–209 
431–448 
406–424 
235–253 
458–477 
293–311 
771–793 
1157–1183 
567–600 
369–403 
1058–1091 
Cry1Ab (R)TYPIR(T)  
(R)QGFSHR(L)  
(R)TLSSTLYR(R)  
(R)LSHVSMFR(S)  
(R)ALAQGIEGSIR(S)  
(R)APMFSWIHR(S)  
(R)IVAQLGQGVYR(T)  
(R)SGFSNSSVSIIR(A)  
(R)LIGNYTDHAVR(W) 
(K)GHVDVEEQNNQR(S) 
(K)SGTVDSLDEIPPQNNNVPPR(Q)  
(R)ELTLTVLDIVSLFPNYDSR(T)  
(R)SPHLMDILNSITIYTDAHR(G)  
(R)SAEFNNIIPSSQITQIPLTK(S)  
(K)HETVNVPGTGSLWPLSAPSPIGK(C)  
(R)TVGFTTPFNFSNGSSVFTLSAHVFNSGNEVYIDR(I)  
(R)RPFNIGINNQQLSVLDGTEFAYGTSSNLPSAVYR(K) 
254–258 
424–429 
361–368 
430–437 
282–292 
450–458 
350–360 
438–449 
199–209 
968–979 
404–423 
235–253 
293–311 
459–478 
772–794 
568–601 
369–402 
Cry1Ca (R)YASSR(D) 
(K)SYTDGR(R) 
(R)IAEFAR(N) 
(R)DIPSFR(I) 
(R)EGYSHR(L) 
(R)GLNNLPK(S) 
(R)TLSNPTLR(L) 
(R)DSVIFGER(W) 
(R)INQIPLVK(G) 
(R)ILDGLLER(D) 
(R)EANQEPPR(S) 
(R)NFYWGGHR(V) 
(R)LCHATFVQR(S) 
525–529 
1126–1131 
87–92 
143–148 
423–428 
213–219 
363–370 
173–180 
467–474 
135–142 
345–352 
319–326 
429–437 
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(R)SFTFNGPVFR(T)  
(K)LQLETNIVYK(E) 
(K)TMEIGENLTSR(T)  
(K)DLEYFPETDK(V)  
(R)YPIQPVGQLTR(E)  
(R)SATLTNTIDPER(I)  
(R)IFTAYSLYDAR(N)  
(R)YTDFSNPFSFR(A)  
(K)STYQDWITYNR(L)  
(K)EWEEDPNNPATR(T)  
(K)AVNALFTSSNQIGLK(T)  
(R)LQVDTNIAMIHAADK(R)  
(R)LLQQPWPAPPFNLR(G)  
(R)WGLTTINVNENYNR(L)  
(R)VISSLIGGGNITSPIYGR(E)  
(R)HIDEYADHCANTYNR(G)  
(R)GVEGVEFSTPTNSFTYR(G)  
(R)SGTPFLTTGVVFSWTHR(S)  
(R)VWGGTSVITGPGFTGGDILR(R)  
(R)GTVDSLTELPPEDNSVPPR(E)  
(K)IEIILADATFEAESDLER(A)  
(R)DLTLTVLDIAAFFPNYDNR(R)  
(R)NTFGDFVSLQVNINSPITQR(Y)  
(R)VIVLTGAASTGVGGQVSVNMPLQK(T)  
(K)EGYGEGCVTIHEIEDNTDELK(F)  
(R)NAAIANLEGLGNNFNIYVEAFK(E)  
(K)HEIVNVPGTGSLWPLSAQSPIGK(C)  
(K)ENYVTLPGTVDECYPTYLYQK(I)  
(R)ISGFEVPLLSVYAQAANLHLAILR(D)  
(R)NPHLFDILNNLTIFTDWFSVGR(N)  
(R)NQGYDEAYGNNPSVPADYASVYEEK(S)  
(R)ANPDIIGISEQPLFGAGSISSGELYIDK(I)  
(K)TDVTDYHIDQVSNLVDCLSDEFCLDEK(Q)  
(-)MEENNQNQCIPYNCLSNPEEVLLDGER(I)  
(K)CAHHSHHFTLDIDVGCTDLNEDLGVWVIFK(I)  
(R)EVYTDPLINFNPQLQSVAQLPTFNVMESSAIR(N)  
(K)FSNCVEEEVYPNNTVTCNNYTGTQEEYEGTYTSR(N) 
353–362 
901–910 
557–567 
1156–1165 
254–264 
455–466 
973–983 
571–581 
220–230 
115–126 
631–645 
928–942 
371–384 
181–194 
327–344 
198–212 
385–401 
438–454 
478–497 
404–422 
610–627 
234–252 
499–518 
533–556 
1046–1066 
93–114 
780–802 
725–745 
149–172 
297–318 
1101–1125 
582–609 
646–672 
1–27 
829–858 
265–296 
1067–1100 
Cry1Da (R)ISGPR(I)  
(R)SGTFR(Y)  
(K)SYTDR(R)  
(R)VTFTGR(L)  
(R)SPLYGR(E)  
(R)YASVANR(S)  
(R)AFSDWEK(D)  
(K)DPTNPALR(E)  
(R)DVSVFGER(W)  
(K)EIILGEER(L)  
(R)TGTTTNLIR(S) 
(R)ITQIPWVK(A) 
(R)LEGLSNLYK(V)  
(R)LPQSYYIR(F)  
(R)NSMGELGTLR(V)  
(R)LCHATFLER(I)  
(K)AHTLASGASVIK(G)  
(K)TMDAGEPLTSR(S)  
432–436 
525–529 
1102–1106 
502–507 
338–343 
518–524 
112–118 
119–126 
173–180 
20–27 
329–337 
460–467 
99–107 
508–515 
492–501 
423–431 
468–479 
543–553 
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(K)GPGFTGGDILTR(N)  
(R)SASPTNEVSPSR(I)  
(R)IAGTVFSWTHR(S)  
(R)WGYDTATINNR(Y)  
(R)FLSDWIVYNR(F)  
(R)TYPIQTATQLTR(E)  
(R)ETLQLETTIVYK(E)  
(K)GHVEVEEQNNHR(S)  
(R)YSQPPSYGISFPK(T)  
(R)YAYWGGHLVNSFR(T)  
(K)VVNALFTSTNQLGLK(T)  
(R)SFAHTTLFTPITFSR(A)  
(R)CAPHLEWNPDLHCSCR(D)  
(R)AQEEFDLYIQSGVYIDR(I)  
(R)IQFNDMNSALITAIPLFR(V)  
(R)IEFIPVTATFEAEYDLER(A)  
(R)EGNTERPVTITASPSVPIFR(T)  
(-)MEINNQNQCVPYNCLSNPK(E)  
(R)QLTISVLDIVAFFPNYDIR(T)  
(R)SPHLVDFLNSFTIYTDSLAR(Y)  
(R)GYDEAYGNNPSVPADYASVYEEK(S)  
(K)ENYVTLPGTFDECYPTYLYQK(I)  
(R)EAYLPELSVIPGVNAAIFEELEER(I)  
(R)VQNYEVALLSVYVQAANLHLSILR(D)  
(K)SGPIDSFSELPPQDASVSPAIGYSHR(L)  
(R)YSDLTSLIHVYTNHCVDTYNQGLR(R)  
(R)TLSYITGLDNSNPVAGIEGVEFQNTISR(S)  
(K)TDVTDYHIDQVSNLVACLSDEFCLDEK(R)  
(K)HEIVNVPGTGSLWPLSVENQIGPCGEPNR(C)  
(R)EVYLDLPFINENLSPAASYPTFSAAESAIIR(S)  
(K)FNNCVEEEVYPNNTVTCINYTATQEEYEGTYTSR(N) 
480–491 
448–459 
437–447 
181–191 
221–230 
253–264 
875–886 
978–989 
530–542 
316–328 
607–621 
554–568 
785–800 
569–585 
131–148 
586–603 
344–363 
1–19 
234–252 
296–315 
1079–1101 
701–721 
925–948 
149–172 
397–422 
192–215 
364–391 
622–648 
756–784 
265–295 
1043–1076 
Cry2Ab (K)GLNTR(L)  
(R)NEDLR(R)  
(R)VTINGR(V)  
(K)VGSLVGK(R)  
(K)FLNQR(L)  
(R)SGAFTAR(G)  
(R)TFISEK(F)  
(R)ILSELR(N)  
(K)SLDTVQK(E)  
(K)EWTEWK(K)  
(R)LNTDTLAR(V)  
(-)MNSVLNSGR(T)  
(K)FGNQGDSLR(F)  
(R)SWLDSGSDR(E)  
(R)VSSIGNSTIR(V)  
(R)NISGVPLVVR(N)  
(R)LHDMLEFR(T)  
(R)AYMVSVHNR(K)  
(R)FEQNNTTAR(Y)  
(R)NIASPSGTPGGAR(A)  
(R)RPLHYNEIR(N)  
(R)QVDNFLNPNR(N)  
(R)GNGNSYNLYLR(V)  
(R)GNSNYFPDYFIR(N)  
233–237 
435–439 
559–564 
65–71 
100–104 
406–412 
510–515 
73–78 
30–36 
37–42 
105–112 
1–9 
516–524 
376–384 
549–558 
425–434 
238–245 
462–470 
525–533 
449–461 
440–448 
130–139 
538–548 
413–424 
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(R)DYSNYCINTYQSAFK(G)  
(R)DVILNADEWGISAATLR(T)  
(R)VNAELTGLQANVEEFNR(Q)  
(R)NLIFPSGSTNLMQDILR(E)  
(K)NNHSLYLDPIVGTVASFLLK(K)  
(R)TTICDAYNVAAHDPFSFQHK(S)  
(R)TYMFLNVFEYVSIWSLFK(Y)  
(R)VYTATNVNTTTNNDGVNDNGAR(F)  
(R)NAVPLSITSSVNTMQQLFLNR(L)  
(R)EGVATVTNWQTESFETTLGLR(S)  
(R)LSNTFPNIVGLPGSTTTHALLAAR(V)  
(R)LPQFQMQGYQLLLLPLFAQAANLHLSFIR(D)  
(R)VNYSGGISSGDIGASPFNQNFNCSTFLPPLLTPFVR(S) 
218–232 
190–206 
113–129 
79–95 
44–63 
10–29 
246–263 
565–586 
140–160 
385–405 
316–339 
161–189 
340–375 
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Table S5. Proteotypic peptides of Cry proteins predicted by in silico tryptic digestion of 
VectoBac® 12AS. The target peptides used to quantify the Cry proteins are shown in bold. 
Residues in parentheses are the previous and subsequent amino acids in the protein 
sequence 
Protein Proteotypic peptide (N to C) Position in protein 
Cry4Aa (K)GLNLIK(T) 
(K)FEAYLK(N) 
(K)ANSLGTASK(V) 
(-)MNPYQNK(N)  
(R)YPIENSPK(Q)  
(K)SLSIPATYK(T) 
(K)IEFLPITR(S) 
(K)NIFGLPILK(R) 
(R)YASNGSANTR(A) 
(K)LNISNNYTR(Y) 
(K)QLLQSTNYK(D) 
(K)MDFFITNGTR(L) 
(K)YLNDYNNISK(M) 
(K)YPIGVQSELTR(E) 
(K)NEYETLNASQK(K) 
(K)SSVFGNHNVTDK(L) 
(K)EIASTYISNANK(I) 
(R)SDVYTNTTVLIDK(I) 
(K)DFQYLEFSNEVK(F) 
(K)FAPNQNISLVFNR(S) 
(R)SFNVISTYHNHLK(T) 
(K)ELTAGSGQITYDVNK(N) 
(K)VVQGPGHTGGDLIDFK(D) 
(K)AIEDYTNYCVTTYK(K) 
(K)NTIYTHLTTQIPAVK(A) 
(K)YYDFQYQEDSLTR(R) 
(R)EIYQVLNFEESPYK(Y) 
(K)TWENNPNPQNTQDVR(T) 
(K)TQVYTFAWTHSSVDPK(N) 
(K)ITCQHSNFQQSYFIR(I) 
(K)LETVQQIINTFYANPIK(N) 
(R)RPHLFTWLDSLNFYEK(A) 
(K)MTTAVLDLVALFPNYDVGK(Y) 
(K)SLGLATNIYIFLLNVISLDNK(Y) 
(K)TTPDSNLDGNINWNTYNTYR(T) 
(R)QFDYLEPLPTAIDYYPVLTK(A) 
(R)ENQGNPTLFPTYDNYSHILSFIK(S) 
(R)AVINLSIPGVAELGMALNPTFSGTDYTNLK(Y) 
(K)AQTTPNNFFTSHYNMFHYTLDNISQK(S) 
(K)NTLQSELTDYDIDQAANLVECISEELYPK(E) 
271–276 
227–232 
546–554 
1–7 
29–36 
506–514 
672–679 
472–480 
592–601 
20–28 
37–45 
443–452 
433–442 
318–328 
8–18 
398–409 
128–139 
659–671 
634–645 
646–658 
144–156 
457–471 
555–570 
256–269 
531–545 
343–355 
329–342 
157–171 
515–530 
575–589 
690–706 
356–371 
299–317 
412–432 
277–296 
236–255 
483–505 
602–631 
372–397 
707–735 
Cry4Ba (K)MTVVK(D)  
(K)IDNTK(L)  
(R)YPADK(I)  
(R)SYGLR(I)  
(R)TDANAK(M) 
(K)NTNYK(D) 
(K)TEFTR(E)  
116–120 
277–281 
272–276 
536–540 
110–115 
17–21 
285–289 
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(K)VAGAILK(F)  
(K)GLDVLR(N)  
(R)FLSANK(I)  
(K)FNTWK(R)  
(K)MDFYK(I)  
(K)YEEFR(Y) 
(R)MEIQCK(T) 
(K)SNFLNATAK(V) 
(R)VSFAWTHK(I) 
(R)EPNNQSYR(T) 
(K)TSIFNDPTR(S) 
(K)SIAALEAALTR(D) 
(K)DYLDQYTTK(F) 
(R)DVHLFTWLK(R) 
(K)DPFDAIVPMR(L) 
(K)TDVIDYNSNR(V) 
(K)TSITDTSSPSNR(V) 
(R)EVVNALFTNDAK(D) 
(R)TAVITQFNLTSAK(L) 
(R)EIYTALVESPSSK(S) 
(K)SNGQWITFNDYK(R) 
(R)DGLINAQEWSLAR(S) 
(K)EYIAHSITWYNK(G) 
(R)VDFWTNTIYQDLR(F) 
(R)SAGDQLYNTMVQYTK(E) 
(-)MNSGYPLANDLQGSMK(N) 
(K)GPGHTGGDLVALTSNGTLSGR(M) 
(K)IDGTLASYNSNITPTPEGLR(T) 
(R)YAANSPIVLNVSYVLQGVSR(G) 
(R)EMTIQVLDILALFASYDPR(R) 
(K)IVDPNNQIYTDAITQVPAVK(S) 
(R)GTTISTESTFSRPNNIIPTDLK(Y) 
(R)VWNDFMTNTGNLIDQTVTAYVR(T) 
(R)IEIIPITQSVLDETENQNLESER(E) 
(R)LSSNQLITIAIQPLNMTSNNQVIIDR(I) 
(K)DWLAMCENNQQYGVNPAAINSSSVSTALK(V) 
(K)FVNPPAGTVLTVLSAVLPILWPTNTPTPER(V) 
(K)DALNIGTTDYDIDQAANLVECISEELYPK(E) 
(R)TTFFGFSTNENTPNQPTVNDYTHILSYIK(T) 
(R)ETAVYFSNLVGYELLLLPIYAQVANFNLLLIR(D) 
51–57 
231–236 
337–342 
130–134 
396–400 
585–589 
521–526 
488–496 
460–467 
136–143 
527–535 
303–313 
121–129 
314–322 
592–601 
450–459 
381–392 
651–662 
144–156 
290–302 
239–250 
191–203 
219–230 
324–336 
204–218 
1–16 
500–520 
401–420 
543–562 
252–270 
468–487 
563–584 
88–109 
628–650  
602–627  
22–50  
58–87  
663–691  
421–449  
159–190 
Cry11Aa (K)AAFSK(V)  
(R)LTTVK(F)  
(R)YEGLK(L)  
(K)LSQDR(V)  
(R)LPAGIR(V)  
(K)LFNQK(V)  
(K)DFYSK(K)  
(K)VLDYR(T)  
(K)DGLTFR(N)  
(R)AISACPR(G) 
(K)NADINVK(F) 
(R)TFISNEAK(Y) 
(K)QPGFTPATAK(G) 
(R)MYTEEFGR(L) 
(K)LLMGEVNQR(L) 
56–60 
286–290 
244–248 
89–93 
559–564 
190–194 
476–480 
195–199 
220–225 
431–437 
382–388 
525–532 
117–126 
205–212 
277–285 
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(K)LGTQTVLSSR(T) 
(R)VNILNAEYR(G) 
(R)LNTGFNTATR(Y) 
(R)VQSQNSGNNR(M) 
(R)TEVETLINQK(L) 
(K)GYFLNLSGAIIQR(L) 
(K)ESAFTTQINPLLK(-) 
(R)GIIEVSDVFDAYIK(Q) 
(K)VLSLIFPGSQPATMEK(V) 
(R)SFLEDTPDQATDGSIK(F) 
(K)FNYSFTNEPADIPAR(E) 
(R)TQTFYQNPNNEPIAPR(D) 
(K)FTQWFQSTLYGWNIK(L) 
(R)GVSLAYNHDLTTLTYNR(I) 
(R)TGTIPPNYLAYDGYYIR(A) 
(R)DIINQILTAPAPADLFFK(N) 
(R)GVHPIYDPSSGLTGWIGNGR(T) 
(R)TNNFNFADNNGNEIMEVR(T) 
(R)NMCNLYVFPFAEAWSLMR(Y) 
(K)DGILAGSAWGFTQADVDSFIK(L) 
(R)IEYDSPTTENIIVGFAPDNTK(D) 
(K)SHYLSETNDSYVIPALQFAEVSDR(S) 
(K)LQSSLSLWDYVGVSIPVNYNEWGGLVYK(L) 
(R)LPQFEVQTYEGVSIALFTQMCTLHLTLLK(D) 
404–413 
94–102 
537–546 
565–574 
79–88 
127–139 
634–646 
103–116 
61–76 
506–521 
291–305 
348–363 
389–403 
438–454 
414–430 
364–381 
310–329 
330–347 
226–243 
169–189 
455–475 
482–505 
249–276 
140–168 
Cry60Aa (K)IGGAIK(V)  
(R)YSSPGK(T)  
(R)GIVKPVR(L) 
(K)GLYAFIR(Y) 
(R)TEMISPASR(L) 
(R)YTETPLDR(Y) 
(-)MEITDIVLK(I) 
(R)SSQTQLHTIK(F) 
(K)TWDSNLIHLR(D) 
(R)VPMILNSNLIGK(R) 
(R)DGQILNVYDNR(G) 
(K)MESVTNTTVHGFK(I) 
(R)LANQSWPGKPIVFK(S) 
(K)AIYEYELNDTVTIPETK(V) 
(K)SGGSNGSLNLSGFGYSDLYK(G) 
(K)VFQTTPIPIASALTITENR(S) 
(R)YYDDYANMFFSYIFQSK(T) 
(K)IYDFIEWDYVTNQDGIPYTLFDK(A) 
(K)TWEITENVSVASHTSLTSQLIIMQADIR(V) 
97–102 
267–272 
294–300 
252–258 
209–217 
259–266 
1–9 
69–78 
273–282 
175–186 
283–293 
84–96 
218–231 
33–49 
232–251 
50–68 
188–204 
10–32 
147–174 
Cry60Ba (K)IGGGIK(S)  
(K)IPYCDR(S)  
(K)TWYSDK(V)  
(R)EIPGYINR(Q)  
(R)VTSTLIIMK(T)  
(R)DYTNWDGTR(E)  
(R)VPMELTTNLR(G)  
(K)VVETTTHTTTK(G)  
(-)MTITNIELAIR(D)  
(R)QDQTPLSGYPGETK(T)  
(K)LWEITDNITVPPHSR(V)  
(R)IVTLPSNADVNMSQTAK(I)  
99–104 
313–318 
283–288 
21–28 
164–172 
12–20 
177–186 
85–95 
1–11 
269–282 
149–163 
296–312 
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(R)QVIDGPNIYDYVISDSVAVPK(T)  
(R)GTNSSGEGSFPTSNGLFSYTTSAR(G)  
(K)TVIFNVNPTPYTGPNIISENNTDVNQNK(R)  
(K)FPVGELGFEQTLELPLTGEYNSSSTTGNTCANEK(L) 
29–49 
187–210 
50–77 
115–148 
Cyt1Aa (K)VSAVK(E) 
(R)VITLR(V) 
(R)FSMPK(G) 
(K)VNPWK(T) 
(K)VLEVLK(T) 
(K)TPQSTAR(V) 
(K)NEAWIFWGK(E) 
(-)MENLNHCPLEDIK(V) 
(K)FAQPLVSSSQYPIADLTSAINGTL(-) 
(K)EQVLFFTIQDSASYNVNIQSLK(F) 
(K)TVLGVALSGSVIDQLTAAVTNTFTNLNTQK(N) 
(K)GLEIANTITPMGAVVSYVDQNVTQTNNQVSVMINK(V) 
(K)ETANQTNYTYNVLFAIQNAQTGGVMYCVPVGFEIK(V) 
199–203 
26–30 
79–83 
14–18 
119–124 
19–25 
155–163 
1–13 
226–249 
204–225 
125–154 
84–118 
164–198 
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Table S6. Proteotypic peptides of Cry proteins in Novodor® crystals obtained by in silico tryptic 
digestion. The target peptides used to quantify the Cry proteins are shown in bold. Residues 
in parentheses are the previous and subsequent amino acids in the protein sequence 
Protein Proteotypic peptide (N to C) 
Position 
in 
protein 
Cry3Aa (K)DVIQK(G) 
(K)TELTR(D) 
(K)VYIDK(I)  
(K)NPVSSR(N) 
(K)IADYAK(N)  
(-)MNPNNR(S)  
(R)NPHSQGR(I)  
(R)IQFHTR(F)  
(R)SEHDTIK(T)  
(K)IEFIPVN(-)  
(K)ITQLPLVK(A)  
(K)WYNVGLDK(L)  
(K)EDIAEFYK(R)  
(K)LQSGASVVAGPR(F)  
(R)GTIPVLTWTHK(S)  
(K)SVDFFNMIDSK(K)  
(R)KPHLFDYLHR(I)  
(K)LTQEYTDHCVK(W)  
(R)ELFSQAESHFR(N)  
(R)GSSYESWVNFNR(Y)  
(R)DVLTDPIVGVNNLR(G)  
(K)AFMEQVEALMDQK(I)  
(K)SSEPVQNLEFNGEK(V)  
(K)DAQIYGEEWGYEK(E)  
(R)GYGTTFSNIENYIR(K)  
(R)MTADNNTEALDSSTTK(D)  
(R)AVANTNLAVWPSAVYSGVTK(V)  
(K)GYSHQLNYVMCFLMQGSR(G)  
(R)EMTLTVLDLIALFPLYDVR(L)  
(K)VEFSQYNDQTDEASTQTYDSK(R)  
(R)NVGAVSWDSIDQLPPETTDEPLEK(G)  
(K)ALAELQGLQNNVEDYVSALSSWQK(N)  
(R)FTGGDIIQCTENGSAATIYVTPDVSYSQK(Y)  
(R)IHYASTSQITFTLSLDGAPFNQYYFDK(T)  
(K)TTENNEVPTNHVQYPLAETPNPTLEDLNYK(E)  
(R)NSMPSFAISGYEVLFLTTYAQAANTHLFLLK(D)  
(K)GDTLTYNSFNLASFSTPFELSGNNLQIGVTGLSAGDK(V) 
64–68 
297–301 
633–637 
153–158 
121–126 
1–6 
159–165 
340–345 
7–13 
638–644 
509–516 
246–253 
223–230 
520–531 
486–496 
497–507 
330–339 
235–245 
168–178 
256–267 
302–315 
108–120 
385–398 
210–222 
316–329 
48–63 
402–421 
468–485 
271–289 
422–442 
444–467 
129–152 
532–560 
565–591 
14–43 
179–209 
596–632 
Cry23Aa (K)NSNIK(F) 
(K)VTIPPK(T)  
(K)AGTSISTK(Q)  
(K)GDGIAHFK(G)  
(K)STYDPSFK(V)  
(K)EVYGATTVK(S)  
(K)GSGFIEGAQGLR(S)  
(R)SIIQVTEYPLDDNK(G)  
(-)MGIINIQDEINNYMK(E)  
(R)STPITYLINGSLAPNVTLK(N)  
262–266 
140–145 
91–98 
207–214 
25–32 
16–24 
215–226 
227–240 
1–15 
243–261 
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(K)VFNESVTPQFTEIPTEPVNNQLTTK(R)  
(R)DGALIAAVYVSVADLADYNPNLNLTNK(G) 
(R)VDNTGSYPVESTVSFTWTETHTETSAVTEGVK(A)  
(K)TYVEAAYIIQNGTYNVPVNVECDMSGTLFCR(G) 
33–57 
180–206 
59–90 
146–176 
Cry37Aa (K)STPER(S)  
(K)YSLTPA(-) 
(R)LDGDEK(G)  
(K)QDDWGK(S)  
(K)GSYVTIK(Y)  
(R)STYTQTIK(I)  
(K)VCSTPGVTVR(L)  
(K)AYLTNPDHDFEIWK(Q)  
(K)EYDVGNADDILAYPSQK(V)  
(K)ISSDTGSPINQMCFYGDVK(E)  
(-)MTVYNATFTINFYNEGEWGGPEPYGYIK(A)  
49–53 
121–126 
108–113 
43–48 
114–120 
54–61 
98–107 
29–42 
81–97 
62–80 
1–28 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Material 
 184 
Table S7. MRM parameters for the detection and quantification of proteotypic peptides used 
for the quantification of Cry proteins in DiPel® DF parasporal crystals. The parameters were 
obtained after two LC-MS/MS-MRM analyses of two independent tryptic digestions of DiPel® 
DF purified and solubilized crystals 
Protein Peptide sequence (N to C) 
Precursor 
ion 
(m/z) 
Collision 
energy 
(V) 
Product 
ion 
(m/z) 
(z = +1) 
Fragment 
ion 
Cry1Aa APTFSWQHR 565.3 
(z = +2) 
28 961.5 
860.4 
713.3 
626.3 
270.1 
y7 
y6 
y5 
y4 
b3 
  570.3 
(z = +2) 
28 971.5 
870.4 
723.4 
636.3 
270.1 
y7 
y6 
y5 
y4 
b3 
 TLSSPLYR 468.8 
(z = +2) 
22.5 835.5 
722.4 
635.4 
548.3 
451.3 
y7 
y6 
y5 
y4 
y3 
  473.8 
(z = +2) 
22.5 845.5 
732.4 
645.4 
558.3 
461.3 
y7 
y6 
y5 
y4 
y3 
Cry1Ab HETVNVPGTGSLWPLSAP
SPIGK 
782.1 
(z = +3) 
31.3 966.6 
756.4 
669.4 
598.4 
414.3 
680.3 
y10 
y8 
y7 
y6 
y4 
b6 
  784.8 
(z = +3) 
31.3 974.6 
764.4 
677.4 
606.4 
422.3 
680.3 
y10 
y8 
y7 
y6 
y4 
b6 
 GSAQGIEGSIR 537.8 
(z = +2) 
26.4 731.4 
674.4 
561.3 
432.3 
375.2 
y7 
y6 
y5 
y4 
y3 
  542.8 
(z = +2) 
26.4 741.4 
684.4 
571.3 
442.3 
385.2 
y7 
y6 
y5 
y4 
y3 
Cry1Ac GYIEVPIHFPSTSTR 852.4 
(z = +2) 
44.3 1142.6 
932.5 
y10 
y8 
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648.3 
334.2 
463.2 
y6 
b3 
b4 
  857.4 
(z = +2) 
44.3 1152.6 
942.5 
658.3 
334.2 
463.2 
y10 
y8 
y6 
b3 
b4 
  568.6 
(z = +3) 
24.7 1142.6 
932.5 
795.4 
648.3 
464.2 
y10 
y8 
y7 
y6 
y4 
  572.0 
(z = +3) 
24.7 1152.6 
942.5 
805.4 
658.3 
474.3 
y10 
y8 
y7 
y6 
y4 
 GWGGSTGITIQGGDDVFK 897.9 
(z = +2) 
46.9 737.3 
680.3 
623.3 
508.3 
393.2 
y7 
y6 
y5 
y4 
y3 
  901.9 
(z = +2) 
46.9 745.4 
688.3 
631.3 
516.3 
401.3 
y7 
y6 
y5 
y4 
y3 
  599.0 
(z = +3) 
25.6 737.3 
680.3 
623.3 
508.3 
393.2 
y7 
y6 
y5 
y4 
y3 
  601.6 
(z = +3) 
25.6 745.4 
688.3 
631.3 
516.3 
401.3 
y7 
y6 
y5 
y4 
y3 
Cry2Aa VNAELIGLQANIR 705.9 
(z = +2) 
36 884.5 
771.4 
714.4 
601.3 
473.3 
y8 
y7 
y6 
y5 
y4 
  710.9 
(z = +2) 
36 894.5 
781.5 
724.4 
611.3 
483.3 
y8 
y7 
y6 
y5 
y4 
  470.9 
(z = +3) 
21.7 771.4 
714.4 
601.3 
473.3 
402.2 
y7 
y6 
y5 
y4 
y3 
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  474.3 
(z = +3) 
21.7 781.5 
724.4 
611.3 
483.3 
412.3 
y7 
y6 
y5 
y4 
y3 
 VYTVSNVNTTTNNDGVND
NGAR 
1163.0 
(z = +2) 
62 646.3 
532.2 
417.2 
303.2 
364.2 
y6 
y5 
y4 
y3 
b3 
  1168.0 
(z = +2) 
62 656.3 
542.3 
427.2 
313.2 
364.2 
y6 
y5 
y4 
y3 
b3 
  775.7 
(z = +3) 
31.1 802.4 
745.4 
646.3 
532.2 
417.2 
y8 
y7 
y6 
y5 
y4 
  779.0 
(z = +3) 
31.1 812.4 
755.4 
656.3 
542.3 
427.2 
y8 
y7 
y6 
y5 
y4 
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Table S8. MRM parameters for the detection and quantification of proteotypic peptides used 
for the quantification of Cry proteins in XenTari® GD parasporal crystals. The parameters were 
obtained after two LC-MS/MS-MRM analyses of two independent tryptic digestions of Xentari® 
GD purified and solubilized crystals  
Protein Peptide sequence (N to C) 
Precursor 
ion 
(m/z) 
Collision 
energy 
(V) 
Product 
ion 
(m/z) 
(z = +1) 
Fragment 
ion 
Cry1Aa TLSSPLYR 468.8 
(z = +2) 
22.5 722.4 
635.4 
548.3 
451.3 
y6 
y5 
y4 
y3 
  473.8 
(z = +2) 
22.5 732.4 
645.4 
558.3 
461.3 
y6 
y5 
y4 
y3 
 LIGNYTDYAVR 642.8 
(z = +2) 
32.4 887.4 
724.4 
623.3 
508.3 
345.2 
y7 
y6 
y5 
y4 
y3 
  647.8 
(z = +2) 
32.4 897.4 
734.4 
633.3 
518.3 
355.2 
y7 
y6 
y5 
y4 
y3 
 APTFSWQHR 565.3 
(z = +2) 
28 961.5 
860.4 
713.3 
626.3 
440.2 
270.1 
y7 
y6 
y5 
y4 
y3 
b3 
  570.3 
(z = +2) 
28 971.5 
870.4 
723.3 
636.3 
450.2 
270.1 
y7 
y6 
y5 
y4 
y3 
b3 
Cry1Ab TLSSTLYR 470.8 
(z = +2) 
22.6 839.5 
726.4 
639.3 
552.3 
451.3 
y7 
y6 
y5 
y4 
y3 
  475.8 
(z = +2) 
22.6 849.5 
736.4 
649.3 
562.3 
461.3 
y7 
y6 
y5 
y4 
y3 
 IVAQLGQGVYR 602.3 
(z = +2) 
30.1 792.4 
679.4 
622.3 
y7 
y6 
y5 
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494.3 
437.3 
y4 
y3 
  607.3 
(z = +2) 
30.1 802.4 
689.4 
632.3 
504.3 
447.3 
y7 
y6 
y5 
y4 
y3 
  401.9 
(z = +3) 
19.5 792.4 
679.4 
622.3 
494.3 
437.3 
y7 
y6 
y5 
y4 
y3 
  405.2 
(z = +3) 
19.5 802.4 
689.4 
632.3 
504.3 
447.3 
y7 
y6 
y5 
y4 
y3 
 HETVNVPGTGSLWPLSAP
SPIGK 
782.1 
(z = +3) 
31.3 966.6 
756.4 
669.4 
598.4 
414.3 
680.3 
y10 
y8 
y7 
y6 
y4 
b6 
  784.8 
(z = +3) 
31.3 974.6 
764.4 
677.4 
606.4 
422.3 
680.3 
y10 
y8 
y7 
y6 
y4 
b6 
Cry1Ca YTDFSNPFSFR 690.8 
(z = +2) 
35.1 1116.5 
854.4 
767.4 
653.3 
y9 
y7 
y6 
y5 
  695.8 
(z = +2) 
35.1 1126.5 
864.4 
777.4 
663.3 
y9 
y7 
y6 
y5 
 SATLTNTIDPER 659.3 
(z = +2) 
33.3 945.5 
844.4 
516.2 
401.2 
y8 
y7 
y4 
y3 
  664.3 
(z = +2) 
33.3 955.5 
854.4 
526.2 
411.2 
y8 
y7 
y4 
y3 
 INQIPLVK 462.8 
(z = +2) 
22.1 811.5 
697.5 
569.4 
456.3 
y7 
y6 
y5 
y4 
  466.8 
(z = +2) 
22.1 819.5 
705.5 
577.4 
464.3 
y7 
y6 
y5 
y4 
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 TLSNPTLR 451.3 
(z = +2) 
21.5 800.5 
687.4 
600.3 
486.3 
389.3 
y7 
y6 
y5 
y4 
y3 
  456.3 
(z = +2) 
21.5 810.5 
697.4 
610.4 
496.3 
399.3 
y7 
y6 
y5 
y4 
y3 
Cry1Da NSMGELGTLR 539.3 
(z = +2) 
26.5 876.5 
745.4 
559.4 
446.3 
y8 
y7 
y5 
y4 
  544.3 
(z = +2) 
26.5 876.5 
745.4 
559.4 
446.3 
y8 
y7 
y5 
y4 
 EIILGEER 479.8 
(z = +2) 
23.1 716.4 
603.3 
490.2 
433.2 
y6 
y5 
y4 
y3 
  484.8 
(z = +2) 
23.1 726.4 
613.3 
500.2 
443.2 
y6 
y5 
y4 
y3 
 GPGFTGGDILTR 595.8 
(z = +2) 
29.7 731.4 
674.4 
502.3 
389.3 
y7 
y6 
y4 
y3 
  600.8 
(z = +2) 
29.7 741.4 
684.4 
512.3 
399.3 
y7 
y6 
y4 
y3 
Cry2Ab VSSIGNSTIR 517.3 
(z = +2) 
25.2 934.5 
847.5 
647.3 
590.3 
y9 
y8 
y6 
y5 
  522.3 
(z = +2) 
25.2 944.5 
857.5 
657.4 
600.3 
y9 
y8 
y6 
y5 
 FGNQGDSLR 497.2 
(z = +2) 
24.1 846.4 
547.3 
490.3 
375.2 
y8 
y5 
y4 
y3 
  502.2 
(z = +2) 
24.1 856.4 
557.3 
500.3 
385.2 
y8 
y5 
y4 
y3 
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Table S9. MRM parameters for the detection and quantification of proteotypic peptides used 
for the quantification of Cry proteins in VectoBac® 12AS parasporal crystals. The parameters 
were obtained after two LC-MS/MS-MRM analyses of two independent tryptic digestions of 
VectoBac® 12AS purified and solubilized crystals 
Protein Peptide sequence (N to C) 
Precursor 
ion 
(m/z) 
Collision 
energy 
(V) 
Product 
ion (m/z) 
(z = +1) 
Fragment 
ion 
Cry4Aa IEFLPITR 494.8 
(z = +2) 
23.9 875.5 
746.5 
599.4 
486.3 
389.3 
y7 
y6 
y5 
y4 
y3 
  499.8 
(z = +2) 
23.9 885.5 
756.5 
609.4 
496.3 
399.3 
y7 
y6 
y5 
y4 
y3 
 NIFGLPILK 507.8 
(z = +2) 
24.7 787.5 
640.4 
583.4 
470.3 
373.3 
y7 
y6 
y5 
y4 
y3 
  511.8 
(z = +2) 
24.7 795.5 
648.5 
591.4 
478.3 
381.3 
y7 
y6 
y5 
y4 
y3 
Cry4Ba SNFLNATAK 483.3 
(z = +2) 
23.3 764.4 
617.4 
504.3 
390.2 
319.2 
y7 
y6 
y5 
y4 
y3 
  487.3 
(z = +2) 
23.3 772.4 
625.4 
512.3 
398.2 
327.2 
y7 
y6 
y5 
y4 
y3 
 TSIFNDPTR 525.8 
(z = +2) 
25.7 862.4 
749.4 
602.3 
488.2 
373.2 
y7 
y6 
y5 
y4 
y3 
  530.8 
(z = +2) 
25.7 872.5 
759.4 
612.3 
498.3 
383.2 
y7 
y6 
y5 
y4 
y3 
Cry11Aa VNILNAEYR 546.3 
(z = +2) 
26.9 878.5 
765.4 
652.3 
538.3 
y7 
y6 
y5 
y4 
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467.2 y3 
  551.3 
(z = +2) 
26.9 888.5 
775.4 
662.3 
548.3 
477.2 
y7 
y6 
y5 
y4 
y3 
 LGTQTVLSSR 531.3 
(z = +2) 
26.0 790.4 
662.4 
561.3 
462.3 
349.2 
y7 
y6 
y5 
y4 
y3 
  536.3 
(z = +2) 
26.0 800.4 
672.4 
571.3 
472.3 
359.2 
y7 
y6 
y5 
y4 
y3 
 LNTGFNTATR 547.8 
(z = +2) 
27.0 867.4 
766.4 
709.4 
562.3 
448.3 
y8 
y7 
y6 
y5 
y4 
  552.8 
(z = +2) 
27.0 877.4 
776.4 
719.4 
572.3 
458.3 
y8 
y7 
y6 
y5 
y4 
Cry60Aa YTETPLDR 497.7 
(z = +2) 
24.1 730.4 
601.3 
500.3 
403.2 
290.1 
y6 
y5 
y4 
y3 
y2 
  502.7 
(z = +2) 
24.1 740.4 
611.3 
510.3 
413.2 
300.2 
y6 
y5 
y4 
y3 
y2 
 TEMISPASR 496.2 
(z = +2) 
24.0 761.4 
630.4 
517.3 
430.2 
y7 
y6 
y5 
y4 
  501.3 
(z = +2) 
24.0 771.4 
640.4 
527.3 
440.2 
y7 
y6 
y5 
y4 
Cry60Ba EIPGYINR 481.3 
(z = +2) 
23.2 719.4 
622.3 
565.3 
402.2 
y6 
y5 
y4 
y3 
  486.3 
(z = +2) 
23.2 729.4 
632.3 
575.3 
412.3 
y6 
y5 
y4 
y3 
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 QDQTPLSGYPGETK 760.9 
(z = +2) 
39.1 751.4 
694.3 
531.3 
434.2 
377.2 
y7 
y6 
y5 
y4 
y3 
  764.9 
(z = +2) 
39.1 759.4 
702.4 
539.3 
442.2 
385.2 
y7 
y6 
y5 
y4 
y3 
 DYTNWDGTR 564.2 
(z = +2) 
27.9 849.4 
748.3 
634.3 
448.2 
333.2 
y7 
y6 
y5 
y4 
y3 
  569.2 
(z = +2) 
27.9 859.4 
758.3 
644.3 
458.2 
343.2 
y7 
y6 
y5 
y4 
y3 
Cyt1A NEAWIFWGK 575.8 
(z = +2) 
28.6 907.5 
836.4 
650.4 
537.3 
390.2 
y7 
y6 
y5 
y4 
y3 
  579.8 
(z = +2) 
28.6 915.5 
844.5 
658.4 
545.3 
398.2 
y7 
y6 
y5 
y4 
y3 
 VLEVLK 350.7 
(z = +2) 
15.7 601.4 
488.3 
359.3 
260.2 
y5 
y4 
y3 
y2 
  354.7 
(z = +2) 
15.7 609.4 
496.3 
367.3 
268.2 
y5 
y4 
y3 
y2 
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Table S10. MRM parameters for the detection and quantification of proteotypic peptides used 
for the quantification of Cry proteins in Novodor® parasporal crystals. The parameters were 
obtained after two LC-MS/MS-MRM analyses of two independent tryptic digestions of 
Novodor® purified and solubilized crystals 
Protein Peptide sequence (N to C) 
Precursor 
ion 
(m/z) 
Collision 
energy 
(V) 
Product 
ion 
(m/z) 
(z = +1) 
Fragment 
ion 
Cry3Aa WYNVGLDK 497.8 
(z=+2) 
24.1 808.4 
645.4 
531.3 
432.2 
y7 
y6 
y5 
y4 
  501.8 
(z=+2) 
24.1 816.4 
653.4 
539.3 
440.3 
y7 
y6 
y5 
y4 
 ELFSQAESHFR 675.8 
(z=+2) 
34.3 961.5 
874.4 
746.4 
675.3 
546.3 
y8 
y7 
y6 
y5 
y4 
  680.8 
(z=+2) 
34.3 971.5 
884.4 
756.4 
685.3 
556.3 
y8 
y7 
y6 
y5 
y4 
  450.9 
(z=+3) 
21.1 874.4 
746.4 
675.3 
546.3 
459.3 
y7 
y6 
y5 
y4 
y3 
  454.2 
(z=+3) 
21.1 884.4 
756.4 
685.3 
556.3 
469.3 
y7 
y6 
y5 
y4 
y3 
 GSSYESWVNFNR 723.3 
(z=+2) 
37.0 1301.6 
1214.6 
1051.5 
922.5 
835.4 
y10 
y9 
y8 
y7 
y6 
  728.3 
(z=+2) 
37.0 1311.6 
1224.6 
1061.5 
932.5 
845.4 
y10 
y9 
y8 
y7 
y6 
  482.6 
(z=+3) 
22.0 1051.5 
922.5 
835.4 
649.3 
550.3 
y8 
y7 
y6 
y5 
y4 
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  485.9 
(z=+3) 
22.0 1061.5 
932.5 
845.4 
659.3 
560.3 
y8 
y7 
y6 
y5 
y4 
Cry23Aa GSGFIEGAQGLR 596.3 
(z=+2) 
29.7 843.5 
730.4 
601.3 
544.3 
473.3 
y8 
y7 
y6 
y5 
y4 
  601.3 
(z=+2) 
29.7 853.5 
740.4 
611.3 
554.3 
483.3 
y8 
y7 
y6 
y5 
y4 
 EVYGATTVK 484.3 
(z=+2) 
23.3 739.4 
576.3 
519.3 
448.3 
347.2 
y7 
y6 
y5 
y4 
y3 
  488.3 
(z=+2) 
23.3 747.4 
584.3 
527.3 
456.3 
355.2 
y7 
y6 
y5 
y4 
y3 
 SIIQVTEYPLDDNK 545.6 
(z=+3) 
24.0 993.5 
864.4 
701.3 
604.3 
491.2 
y8 
y7 
y6 
y5 
y4 
  548.3 
(z=+3) 
24.0 1001.5 
872.4 
709.4 
612.3 
499.2 
y8 
y7 
y6 
y5 
y4 
Cry37Aa VCSTPGVTVR† 538.3 
(z=+2) 
26.4 976.5 
816.5 
729.4 
628.4 
y9 
y8 
y7 
y6 
  543.3 
(z=+2) 
26.4 986.5 
826.5 
739.4 
638.4 
y9 
y8 
y7 
y6 
 EYDVGNADDILAYPSQK 949.4 
(z=+2) 
49.9 1149.6 
806.4 
693.4 
622.3 
459.3 
y10 
y7 
y6 
y5 
y4 
  953.5 
(z=+2) 
49.9 1157.6 
814.5 
701.4 
630.3 
y10 
y7 
y6 
y5 
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467.3 y4 
633.3 
(z=+3) 
26.7 1034.6 
919.5 
806.4 
693.4 
459.3 
y9 
y8 
y7 
y6 
y4 
636.0 
(z=+3) 
26.7 1042.6 
927.5 
814.5 
701.4 
467.3 
y9 
y8 
y7 
y6 
y4 
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Table S11. Quantification of the targeted peptides in proteins identified in DiPel® DF 
parasporal crystals. Peptides were obtained in the course of two separate tryptic digestions 
(D1 and D2), and each digested sample was analyzed twice (MS/MS injections I1 and I2) 
Protein 
Digestion 
and 
injection 
Proteotypic peptide 
Spiked-in 
SIL 
peptide 
(fmol) 
Ratio* 
Endogenous
peptide 
(fmol) 
Cry1Aa 
 
D1, I1 APTFSWQHR 
TLSSPLYR 
800 
800 
0.7 
1.4 
561 
1107 
 D1, I2 
APTFSWQHR 
TLSSPLPLYR 
800 
800 
0.8 
1.0 
674 
836 
 D2, I1 APTFSWQHR TLSSPL 
800 
800 
0.8 
1.1 
652 
874 
 D2, I2 
APTFSWQHR 
TLSSPLYR 
800 
800 
1.4 
1.7 
1097 
1336 
Cry1Ab 
 
D1, I1 HETVNVPGTGSLWPLSAP
SPIGK 
GSAQGIEGSIR 
800 
800 
NQ 
1.8 
NQ 
1400 
 
D1, I2 HETVNVPGTGSLWPLSAPSPIGK 
GSAQGIEGSIR 
800 
800 
NQ 
1.2 
NQ 
952 
 
D2, I1 HETVNVPGTGSLWPLSAP
SPIGK 
GSAQGIEGSIR 
800 
800 
NQ 
1.1 
NQ 
890 
 
D2, I2 HETVNVPGTGSLWPLSAPSPIGK 
GSAQGIEGSIR 
800 
800 
NQ 
1.7 
NQ 
1395 
Cry1Ac 
 
D1, I1 GYIEVPIHFPSTSTR 
GWGGSTGITIQGGDDVFK 
400 
400 
0.8 
1.0 
312 
416 
 D1, I2 GYIEVPIHFPSTSTR GWGGSTGITIQGGDDVFK 
400 
400 
0.8 
1.0 
307 
420 
 D2, I1 GYIEVPIHFPSTSTR GWGGSTGITIQGGDDVFK 
400 
400 
1.8 
1.3 
309 
529 
 D2, I2 GYIEVPIHFPSTSTR GWGGSTGITIQGGDDVFK 
400 
400 
1.0 
1.2 
410 
475 
Cry2Aa 
 
D1, I1 VNAELIGLQANIR 
VYTVSNVNTTTNNDGVND
NGAR 
2000 
2000 
NQ 
1.1 
NQ 
2152 
 
D1, I2 VNAELIGLQANIR 
VYTVSNVNTTTNNDGVND
NGAR 
2000 
2000 
NQ 
1.9 
NQ 
3760 
 
D2, I1 VNAELIGLQANIR 
VYTVSNVNTTTNNDGVND
NGAR 
2000 
2000 
NQ 
0.7 
NQ 
1372 
 
D2, I2 VNAELIGLQANIR 
VYTVSNVNTTTNNDGVND
NGAR 
2000 
2000 
NQ 
1.3 
NQ 
2523 
NQ = not quantified; *SIL peptide:endogenous peptide ratio 
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Table S12. Quantification of the targeted peptides in proteins identified in XenTari® GD 
parasporal crystals. Peptides were obtained in the course of two separate tryptic digestions 
(D1 and D2), and each digested sample was analysed twice (MS/MS injections I1 and I2) 
Protein 
Digestion 
and 
injection 
Proteotypic peptide 
Spiked-
in SIL 
peptide 
(fmol) 
Ratio* 
Endogenous 
peptide 
(fmol) 
Cry1Aa 
 
D1, I1 APTFSWQHR 
LIGNYTDYAVR 
TLSSPLYR 
1200 
1200 
1200 
0.59 
0.28 
0.87 
713 
334 
1043 
 
D1, I2 APTFSWQHR 
LIGNYTDYAVR 
TLSSPLYR 
1200 
1200 
1200 
0.48 
0.29 
0.78 
572 
344 
932 
 
D1, I1 APTFSWQHR 
LIGNYTDYAVR 
TLSSPLYR 
1200 
1200 
1200 
0.35 
0.20 
0.53 
416 
244 
634 
 
D1, I2 APTFSWQHR 
LIGNYTDYAVR 
TLSSPLYR 
1200 
1200 
1200 
0.32 
0.19 
0.60 
390 
223 
723 
Cry1Ab 
 
D1, I1 HETVNVPGTGSLWPLSAPSPIGK 
IVAQLGQGVYR 
TLSSTLYR 
1200 
1200 
1200 
1.52 
0.99 
0.47 
1825 
1188 
568 
 
D1, I2 HETVNVPGTGSLWPLSAPSPIGK 
IVAQLGQGVYR 
TLSSTLYR 
1200 
1200 
1200 
1.35 
1.38 
0.69 
1623 
1651 
826 
 
D1, I1 HETVNVPGTGSLWPLSAPSPIGK 
IVAQLGQGVYR 
TLSSTLYR 
1200 
1200 
1200 
1.20 
0.87 
0.46 
1443 
1047 
557 
 
D1, I2 HETVNVPGTGSLWPLSAPSPIGK 
IVAQLGQGVYR 
TLSSTLYR 
1200 
1200 
1200 
1.24 
0.84 
0.46 
1489 
1005 
556 
Cry1Ca 
 
D1, I1 INQIPLVK 
SATLTNTIDPER 
TLSNPTLR 
YTDFSNPFSFR 
200 
200 
200 
200 
0.66 
0.40 
1.05 
0.84 
131 
81 
209 
169 
 
D1, I2 INQIPLVK 
SATLTNTIDPER 
TLSNPTLR 
YTDFSNPFSFR 
200 
200 
200 
200 
1.18 
0.74 
1.38 
1.54 
236 
148 
276 
307 
 
D1, I1 INQIPLVK 
SATLTNTIDPER 
TLSNPTLR 
YTDFSNPFSFR 
200 
200 
200 
200 
0.85 
0.51 
1.27 
0.99 
170 
102 
254 
197 
 
D1, I2 INQIPLVK 
SATLTNTIDPER 
TLSNPTLR 
YTDFSNPFSFR 
200 
200 
200 
200 
0.85 
0.59 
1.15 
1.06 
170 
118 
230 
213 
Cry1Da D1, I1 EIILGEER 
GPGFTGGDILTR 
80 
80 
1.91 
0.46 
153 
36 
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NSMGELGTLR 80 0.39 31 
 
D1, I2 EIILGEER 
GPGFTGGDILTR 
NSMGELGTLR 
80 
80 
80 
1.97 
0.57 
0.37 
158 
46 
29 
 
D1, I1 EIILGEER 
GPGFTGGDILTR 
NSMGELGTLR 
80 
80 
80 
1.45 
0.54 
0.34 
116 
43 
27 
 
D1, I2 EIILGEER 
GPGFTGGDILTR 
NSMGELGTLR 
80 
80 
80 
1.35 
0.56 
0.41 
108 
45 
33 
Cry2Ab D1, I1 FGNQGDSLR 
VSSIGNSTIR 
20 
20 
NQ 
NQ 
NQ 
NQ 
 D1, I2 FGNQGDSLR VSSIGNSTIR 
20 
20 
NQ 
NQ 
NQ 
NQ 
 D1, I1 FGNQGDSLR VSSIGNSTIR 
20 
20 
NQ 
NQ 
NQ 
NQ 
 D1, I2 FGNQGDSLR VSSIGNSTIR 
20 
20 
NQ 
NQ 
NQ 
NQ 
NQ = not quantified; *SIL peptide:endogenous peptide ratio 
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Table S13. Quantification of the targeted peptides in proteins identified in VectoBac® 12AS 
parasporal crystals. Peptides were obtained in the course of two separate tryptic digestions 
(D1 and D2), and each digested sample was analysed twice (MS/MS injections I1 and I2) 
Protein 
Digestion 
and 
injection 
Proteotypic peptide 
Spiked-
in SIL 
peptide 
(fmol) 
Ratio* Endogenous peptide (fmol) 
Cry4Aa 
 
D1, I1 IEFLPITR 
NIFGLPILK 
100 
100 
0.3 
0.7 
31 
65 
 D1, I2 IEFLPITR 
NIFGLPILK 
100 
100 
0.05 
0.3 
5 
34 
 D1, I1 IEFLPITR NIFGLPILK 
100 
100 
1.0 
1.1 
100 
110 
 D1, I2 IEFLPITR NIFGLPILK 
100 
100 
0.9 
1.0 
92 
97 
Cry4Ba 
 
D1, I1 SNFLNATAK 
TSIFNDPTR 
200 
200 
0.7 
1.3 
142 
253 
 D1, I2 SNFLNATAK TSIFNDPTR 
200 
200 
1.3 
1.8 
267 
363 
 D1, I1 SNFLNATAK TSIFNDPTR 
200 
200 
1.1 
2.0 
228 
390 
 D1, I2 SNFLNATAK TSIFNDPTR 
200 
200 
1.1 
1.9 
224 
383 
Cry11Aa 
 
D1, I1 VNILNAEYR 
LGTQTVLSSR 
LNTGFNTATR 
200 
200 
200 
2.3 
1.3 
1.2 
463 
266 
238 
 
D1, I2 VNILNAEYR 
LGTQTVLSSR 
LNTGFNTATR 
200 
200 
200 
1.0 
0.4 
0.3 
207 
84 
52 
 
D1, I1 VNILNAEYR 
LGTQTVLSSR 
LNTGFNTATR 
200 
200 
200 
4.1 
2.7 
2.3 
815 
547 
460 
 
D1, I2 VNILNAEYR 
LGTQTVLSSR 
LNTGFNTATR 
200 
200 
200 
3.6 
2.8 
2.3 
729 
563 
462 
Cry60Aa 
 
D1, I1 YTETPLDR 
TEMISPASR 
60 
60 
0.8 
0.8 
45 
49 
 D1, I2 YTETPLDR TEMISPASR 
60 
60 
0.6 
0.6 
38 
39 
 D1, I1 YTETPLDR TEMISPASR 
60 
60 
1.3 
1.4 
75 
85 
 D1, I2 YTETPLDR TEMISPASR 
60 
60 
1.2 
1.3 
71 
80 
Cry60Ba 
 
D1, I1 EIPGYINR 
QDQTPLSGYPGETK 
DYTNWDGTR 
200 
200 
200 
0.5 
0.5 
0.8 
109 
98 
160 
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D1, I2 EIPGYINR 
QDQTPLSGYPGETK 
DYTNWDGTR 
200 
200 
200 
0.8 
0.5 
0.7 
166 
92 
136 
 
D1, I1 EIPGYINR 
QDQTPLSGYPGETK 
DYTNWDGTR 
200 
200 
200 
0.8 
0.6 
1.1 
153 
120 
214 
 
D1, I2 EIPGYINR 
QDQTPLSGYPGETK 
DYTNWDGTR 
200 
200 
200 
0.8 
0.6 
1.2 
155 
129 
239 
Cyt1A 
 
D1, I1 NEAWIFWGK 
VLEVLK 
400 
400 
1.6 
0.7 
631 
261 
 D1, I2 NEAWIFWGK VLEVLK 
400 
400 
1.9 
0.5 
772 
204 
 D1, I1 NEAWIFWGK VLEVLK 
400 
400 
6.7 
2.5 
2672 
1014 
 D1, I2 NEAWIFWGK VLEVLK 
400 
400 
6.9 
2.7 
2756 
1067 
*SIL peptide:endogenous peptide ratio 
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Table S14. Quantification of the targeted peptides in proteins identified in Novodor® 
parasporal crystals. Peptides were obtained in the course of two separate tryptic digestions 
(D1 and D2), and each digested sample was analysed twice (MS/MS injections I1 and I2) 
Protein 
Digestion 
and 
injection 
Proteotypic peptide 
Spiked-
in SIL 
peptide 
(fmol) 
Ratio‡ Endogenouspeptide (fmol) 
Cry3Aa D1, I1 WYNVGLDK 
ELFSQAESHFR 
GSSYESWVNFNR 
1600 
1600 
1600 
0.2 
0.5 
1.4 
282 
803 
2234 
D1, I2 WYNVGLDK 
ELFSQAESHFR 
GSSYESWVNFNR 
1600 
1600 
1600 
0.2 
0.5 
1.5 
276 
810 
2412 
D1, I1 WYNVGLDK 
ELFSQAESHFR 
GSSYESWVNFNR 
1600 
1600 
1600 
0.5 
1.4 
2.8 
765 
2180 
4525 
D1, I2 WYNVGLDK 
ELFSQAESHFR 
GSSYESWVNFNR 
1600 
1600 
1600 
0.5 
1.4 
3.0 
776 
2302 
4824 
Cry23Aa D1, I1 GSGFIEGAQGLR 
EVYGATTVK 
SIIQVTEYPLDDNK 
400 
400 
400 
1.1 
0.3 
0.4 
455 
114 
177 
D1, I2 GSGFIEGAQGLR 
EVYGATTVK 
SIIQVTEYPLDDNK 
400 
400 
400 
1.2 
0.3 
0.5 
484 
107 
187 
D1, I1 GSGFIEGAQGLR 
EVYGATTVK 
SIIQVTEYPLDDNK 
400 
400 
400 
2.0 
0.5 
1.1 
798 
181 
423 
D1, I2 GSGFIEGAQGLR 
EVYGATTVK 
SIIQVTEYPLDDNK 
400 
400 
400 
2.2 
0.4 
1.2 
894 
157 
473 
Cry37Aa D1, I1 VCSTPGVTVR 
EYDVGNADDILAYPSQK 
300 
300 
0.8 
0.6 
250 
176 
D1, I2 VCSTPGVTVR 
EYDVGNADDILAYPSQK 
300 
300 
0.9 
0.6 
278 
189 
D1, I1 VCSTPGVTVR 
EYDVGNADDILAYPSQK 
300 
300 
1.1 
1.2 
344 
348 
D1, I2 VCSTPGVTVR 
EYDVGNADDILAYPSQK 
300 
300 
1.3 
1.2 
398 
373 
*SIL peptide:endogenous peptide ratio
